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1.1 Epithelial adhesins from Candida glabrata 
Epithelial adhesins (Epa) are crucial  proteins in the colonization,  pathogenesis and virulence of 
Candida glabrata. These adhesins have a similar modular structure to  Saccharomyces cerevisiae 
flocculins, with an N-terminal adhesive A domain, a central neck-like B domain, and an anchorage 
C-terminal C domain. A hallmark of many fungal adhesins is the presence of a calcium binding 
PA14 domain within the A domain. The PA14 domain is responsible for carbohydrate binding in a 
calcium dependent manner, which allows for the classification of these proteins as C-type lectins[1]. 
In this  study,  it  was possible  to  elucidate  the crystal  structures of  Epa1A and three variants  at 
resolutions from 1.4 to 2.0 Å. The latter were meant to emulate the specificities of Epa2, Epa3 and 
Epa6 adhesive domains. The results yielded a profound knowledge of the binding pocket of Epa1A 
and  the  mechanisms  through  which  specificity  is  controlled  in  the  Epa  A domain.  Especially 
surprising was the fact that, even though the proteins were crystallized in the presence of lactose,  
the protein co-crystals  never  showed the aforementioned sugar.  Instead,  a galactoseβ1-3glucose 
disaccharide unit could be modeled into the electron density. The disaccharide is commonly found 
on cell surfaces and milk derivates, from which the employed lactose was obtained[2]. 
Epa1A ,  Epa1→2A,  Epa1→3A and  Epa1→6A were  also  functionally  characterized  by  semi-
quantitative, high-throughput methodologies. In collaboration with the consortium for functional 
glycomics, fluorescently labeled proteins were set in contact with large-scale glycan arrays. The 
results  showed a marked preference  for  galactoseβ1-3  terminal  oligosaccharides  in  the  case  of 
Epa1A. For the other proteins, varying degrees of promiscuity were noted. Epa1→6A presented a 
very  similar  binding  profile  to  the  one  presented  by  Zupancic  et.  al.  in  2008  for  Epa6A, 
demonstrating the validity of the method. Epa1→2A and Epa1→3A were much less active, and 
presented a preference for sulfated glycans, along with terminal galactose. Fluorescence titrations 
showed  for  Epa1A  a  ~20  time  stronger  affinity  for  the  T  antigen  (galactoseβ1-3N-acetyl-
galactosamine) than for the milk-derived lactose, showing how marked the adhesin preference for 
β1-3 linkages is, as compared to β1-4 glycosidic bonds. 
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1.2 Adhesins of Helicobacter pylori 
The  adhesins  of  H.  pylori have  been  shown  to  be  critical  for  the  colonization  and  immune 
recognition of the bacterium during gastric invasion and disease development[3]. BabA and SabA 
figure prominently, as the former is the primary adhesin during early stage colonization, while the 
latter binds strongly to inflamed tissue[4]. Both of them are autotransporters, with a C-terminal, 
membrane  bound  translocation  unit  and  an  N-terminal  passenger  domain  which  contains  the 
adhesive portion of the protein[5]. 
Pure,  soluble  passenger  domains  of  BabA  and  SabA  were  successfully overproduced  by 
recombinant expression in Escherichia coli. BabA could be functionally characterized by the same 
method as the Epa proteins. The results showed that BabA activity was strongly pH dependent, with 
a ~100 times stronger activity at pH 5.8 than at pH 2.5. This behavior could be further characterized 
through circular dichroism spectroscopy and size exclusion chromatography, which showed that 
BabA  is in a reversible molten globule-like, aggregation-prone and relaxed conformation at pH 2.5. 
At pH 5.8, on the other hand, the protein is in a much more compact, defined conformation with a 
strong tendency to precipitate.  H. pylori has been shown to present many pH dependent virulence 
factors,  like the urea transporter,  but up  to now no direct biochemical data had been presented 
supporting pH dependent conformational changes in its adhesins.
1.3 Epitheladhäsine von C. glabrata
Die Epitheladhäsine (Epa) sind zentrale Proteine in der Kolonisierung, Pathogenese und Virulenz 
von  C.  glabrata.  Diese  Adhäsine  haben  einen  ähnlichen  modularen  Aufbau  wie  S.  cerevisiae 
Flokuline,  mit  einer  N-terminalen adhäsiven A-Domäne,  einer  halsartigen B-Domäne und einer 
C-terminalen  C-Domäne,  die  als  Verankerung  an der  Zellwand  dient.  Flokulin-artige  Adhäsine 
können in vielen Fällen eine Calcium-bindende PA14 Domäne innerhalb der A-Domäne beinhalten. 
Diese  Proteinen  wurden als  C-Typ Lektine  eingestuft,  da  die  PA14 Domäne  für  eine  Calcium 
abhängige Glycan-Bindung verantwortlich ist[1].
In der folgenden Arbeit war es möglich, die Kristallstrukturen von Epa1A und drei Varianten mit 
Auflösungen von 1,4 bis 2,0 Å zu lösen. Die Varianten sollten die Spezifitäten der Epa2-, Epa3- und 
Epa6-  adhäsiven A-Domänen  emulieren.  Diese  Erkenntnisse   erlaubten  eine  detaillierte 
Beschreibung der Bindungstasche von Epa1A und die Mechanismen, durch die die Spezifität in der 
Epa A- Domäne bestimmt  werden. Besonders überraschend war die Tatsache,  dass,  obwohl die 
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Proteine in Gegenwart von Laktose kristallisiert wurden, die Co-Kristalle keine Laktose  zeigten. 
Stattdessen konnte nur ein Galaktoseβ1-3glukose Disaccharid in die Elektronendichte modelliert 
werden.  Dieses  Disaccharid  findet  sich  für  gewöhnlich  auf  Zelloberflächen  und  in 
Milchderivaten[2], aus denen die verwendete Laktose stammte.
Die funktionelle Charakterisierung von Epa1A , Epa1→2A, Epa1→3A und Epa1→6A  verlief über 
semiquantitative,  Hochurchsatz Analysen in Zusammenarbeit mit dem Consortium for Functional  
Glycomics (CFG).  Mit  Fluoroforen  markierte  Proteine  wurden  mit  Glykan  Arrays  in  Kontakt 
gesetzt. Die Ergebnisse zeigten eine deutliche Präferenz im Falle von Epa1A für Oligosaccharide 
mit einer terminalen Galaktoseβ1-3 Verknüpfung. Für die anderen Proteinen konnte gezeigt werden, 
dass  die  Spezifität  in  unterschiedlichen  Massen  verringert  war.  Das Epa1→6A Bindungsprofil 
konnte mit der von Zupancic  et.  al.  2008 publizierten Daten für Epa6A verglichen werden und 
zeigte  große  Ähnlichkeit.  Epa1→2A und  3A waren  deutlich  weniger  aktiv,  zeigten  aber  eine 
Präferenz  für  sulfatierte  Glykane  sowie  für  terminale  Galaktosen.  Quantitative 
Fluoreszenztitrationen ergaben ungefähr  zwanzigfach höhere Affinitäten für das T-Antigen als für 
die aus Milch gewonnene Laktose, wodurch die Präferenz für  β1-3 über  β1-4 Verbindungen weiter 
bestätigt werden konnte.
1.4 Adhäsine von Helicobacter pylori
Die Adhäsine von H. pylori zeigten sich als kritisch bei der Kolonisierung  und Immunerkennung 
des Bakteriums während des Eindringens in den Magen und der Entstehung und Entwicklung der 
Krankheit[3]. BabA und SabA sind zwei besonders wichtige Adhäsine, da ersteres bei einer frühen 
Kolonisierung als Primäradhäsin  wirkt, während SabA stark an entzündetes Gewebe bindet[4]. Es 
handelt  sich  bei  beiden  um  Autotransporter,  die  mit  einer  C-terminalen,  membrangebundenen 
Translokationseinheit und einer N-terminalen, adhäsiven transportierte Domäne versetzt sind.
Reine,  lösliche  transportierte  Domänen  von  BabA und  SabA wurden  in  großen  Mengen  in 
Escherichia coli rekombinant überproduziert. BabA konnte, wie die Epa Proteine, mit Hilfe von 
Glykan  Arrays  funktionell  charakterisiert werden.  BabA-Aktivität erwies sich  als  stark 
pH-abhängig, da  sich  bei pH 5.8 eine etwa hundertfach stärkere Bindung als bei pH 2.5 zeigte. 
Dieses Verhalten  konnte  durch  Circular-Dichroismus  Spektroskopie  und  chromatographische 
Analyse weiter untersucht werden. Es zeigte sich, dass BabA bei pH 2.5 sich in eine relaxierten, 
molten-globule  ähnlichen Konformation  befand,  die  leicht  aggregierte.  Bei  pH 5.8  andererseits 
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befand sich das Protein in einer viel kompakteren, klarer definierten Konformation mit einer starken 
Tendenz zur Präzipitat-Entstehung. Es konnten schon mehrere H. pylori Virulenzfaktoren gefunden 
werden, deren Aktivität pH abhängig ist, aber bis jetzt gab es noch keine biochemischen Daten, die 




2.1 Mucins are primary targets for pathogenic adhesins
Mucins  are  the  main  non-cellular  component  of  the mammalian  mucosa[6].  Mucins  are  highly 
glycosylated glycoproteins, which are generally classified as tethered mucins or secreted mucins, 
depending on whether they are bound on the cell surface or secreted into the intercellular space[7]. 
The  glycans  decorating  mucins  are  the  target  for  the  adhesins  of  several  microbial  adhesins, 
including those of Helicobacter pylori and Candida glabrata[8][9].
2.1.1 Mucin structure and function
Around 20 different mucin genes have been characterized through data mining, RT PCR and other 
methods[6] (Fig.  2.1).  Mucins  show  an  extremely  diverse  and  tissue  specific  splicing  and 
glycosylation behavior,  which  gives  rise  to  a  wide variety of  gene  products,  that  are  unevenly 
spread through the different tissues of the mammalian organism[10]. All  mucins have a similar 
“bottle brush” structure with a long, extended protein core unto which mucin-type O-glycans are 
bound (Fig. 2.1), which constitute at  least  50% of the molecular mass of the glycoprotein.  The 
hallmark  of  all  mucins  is  the  presence  of  “variable  number  tandem  repeats”  (VNTR),  serine 
threonine rich regions that act as O-glycan binding sites. Cysteine rich regions and Von Willenbrand 
factor like D-domains may act in the polymerization of mucins[11]. Most tethered mucins have also 
been shown to contain N-glycosylation sites near their C-terminal regions (Fig. 2.1).
Secreted mucins act as a buffering system, protect the epithelium from invasion of pathogens, keep 
it lubricated and protect it from the action of proteases[12][13]. Tethered mucins, on the other hand, 
have been shown to have many different functions beyond the aforementioned; they are involved in 
cellular  signaling  [14],  adhesion  and  anti-adhesion  between  mammalian  cells[15],  and  also  in 
disease, both neoplastic[16], genetic  [17][18] and infectious[19]. Although mucins act  to  prevent 
infection, it has been shown that at least in the case of Pseudomonas aeruginosa[19], Helicobacter  
pylori[20][7], and Escherichia coli[21], mucins can act as adhesion targets during tissue invasion. 
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2.1.2 Mucin tissue localization
Out of the ~20 identified mucins, only a small subset is to be found in any given tissue[6]. There 
has been extensive research to determine the localization of the different mucin gene products[22]
[23][24] and a general tissue specificity has been determined (Table  2.1). Mucins are extremely 
variable in their splicing and glycosylation pattern, and these two variables seem to be also tissue 
dependent and of an even greater importance than the mere coding gene for function and tissue 
recognition[16].  Unfortunately,  our knowledge of  the mucin glycosylation and splicing patterns 
remains sketchy at best[6]. It has been shown that healthy mucins are mostly glycosylated with core 
2 mucin-type O-glycans,  while  neoplastic  mucins tend to  present  core 1 mucin-type O-glycans 
(Figure 2.2)[25], a general distribution for sialylated and sulfated mucins has been established and 
several carbohydrates  have been characterized as being presented by different mucins (Table  2.2) 
[7], but until now, the tissue specificity of carbohydrate distribution has remained elusive. 
Several pathogens have been shown to interact specifically with the human host tissue, including H. 
pylori[4] and C. glabrata[8]. Even though C. glabrata is  relatively unspecific in the type of mucosa 
it  invades,  including oral,  vaginal  and urethral  (Table  2.1),  the surface-displayed adhesin array 
changes  strongly  between the  different  niches[26][27].  Such polymorphic  behavior hints  at  the 
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Figure  2.1: Simplified structure of an archetypal mucin. Mucins show extended peptidic cores which are  
covered with long mucin-type O-glycans. O-glycosylated regions characteristically have high amounts of  
serin, threonin and prolin and are called Variable Number Tandem Repeats (VNTR). Most tethered mucins  
also contain an N-glycosylated (NG) region in the extracellular C-terminus. Glycosylated regions may be  
flanked by either cysteine rich regions (CYS), von Willenbrand factor like D domains (VWD)or both. Both  
features help in the polymerization of mucins in the extracellular space, either through covalent bonds (CYS)  
or non-covalent interactions (VWD). All mucins present an N-terminal signal peptide, shown in green, which 
targets the proteins for export through the plasma membrane. Tethered mucins are proteolyzed upon export  
in a specific proteolysis site (PS), which gives rise to either the correponding secreted mucin or the mature  
tethered mucin. Mature tethered mucins are formed as heterodimers from the large, glycosylated subunit and 
the small, membrane bound subunit resulting from proteolysis of the precursor. Tethered mucins contain a  
single transmembrane helix (TH) and a C-terminal cytoplasmic tail (CT) with numerous phosphorylation 
sites. Drawing adapted from [6] and [11].
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possibility of very specific pathogen-mucin interactions, which need to be varied depending on the 
mucin  catalog  presented  by each  tissue.  On  the  other  hand,  H.  pylori is  very  specific  in  just 
colonizing the antral mucosa and, very rarely, other regions of the stomach (Table 2.1)[4]. Closely 
related species, like  Campylobacter jejunii, do not share adhesin orthologes  with  H. pylori, and 
correspondingly  do  colonize  different  tissues  in  the  human  gastrointestinal  tract[28].  Tissue 
localization and glycosylation patterns of mucins seem therefore crucial in the elucidation of the 
adhesion  specificity  of  several  pathogens.  Conversely,  the  information  obtained  from adhesins 
specifically  targeting  certain  mucins  in  certain  tissues  might  provide  information  on  the 
glycosylation patterns of the human mucosal proteins.










Table 2.1: Sulfo-mucin positive tissues in Homo sapiens [7]. Sulfo-mucin mediated adhesion has 
been proven to be of great importance for H. pylori[29]
7
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Mucin Family Tissue specificity Possible 
target of
MUC1 both ubiquitous C. glabrata
H. pylori
MUC2 secreted Colon, middle ear epithelium
MUC3 tethered Gastrointestinal  and  middle  ear  epithelia,  male  urogenital 
epithelial
C. glabrata
MUC4 secreted Male urogenital and middle ear epithelia, cervix, vagina C. glabrata
MUC5 secreted Male urogenital and middle ear epithelia, cervix, saliva C. glabrata
MUC6 secreted Cervix, endometrium, uterus, male urogenital and middle ear 
epithelia,  parotid  glands,  heart,  fundic  neck  cells,  pyloric 
glands,  duodenum, jejunum,  ileum,  gall  bladder  glands, 
common bile duct, pancreas.
C. glabrata
H. pylori
MUC7 secreted middle ear epithelia, saliva C. glabrata
H. pylori
MUC8 secreted Sperm,  respiratory  tract,  endometrium,  cervix,  middle  ear 
epithelia.
C. glabrata
MUC9 secreted Oviduct  middle ear epithelium C. glabrata
MUC10 secreted Saliva C. glabrata
H. pylori
MUC11 secreted Middle ear epithelium, colon and stomach H. pylori
MUC12 tethered Middle ear epithelium, colon and stomach H. pylori




MUC14 secreted Heart, kidney and lung
MUC15 tethered Milk fat globules, lungs, gastrointestinal tract, mammary gland, 
hematopoietic tissues, gonads, middle ear epithelium
MUC16 secreted Middle ear epithelium
MUC17 tethered Gastrointestinal tract, male urogenital epithelia C. glabrata
H. pylori
MUC18 secreted Middle ear epithelium
MUC19 secreted Middle ear epithelium, saliva. C. glabrata
H. pylori
MUC20 tethered Proximal renal tubuli, male urogenital and middle ear epithelia. C. glabrata
Table 2.2:Tissue specific distribution of mucins. Historically, MUC has been used to denominate  
human mucins, while muc is the denomination of non-human, mammal mucins. All specificities  
have been compiled for Homo sapiens. According to the tissue specificity of the pathogen, the  
mucins have also been assigned as possible targets for C. glabrata (yellow), H. pylori (blue) or  




Mucins show very specific glycosylation 
patterns  in  the  VNTR region,  the  so 
called mucin type O-glycans[36]. Mucin-
type  O-glycans  are  always  bound  to 
either  a  serine  or  a  threonine  residue 
through an N-acetyl-galactosamine 
reductive end[11]. Mucin type O-glycans 
can  be  classified  via their  core,  which 
commonly corresponds  to  a  di-  or 
trisaccharide that  is  bound  by its first 
N-acetyl-galactosamine  (Fig.  2.2)[25]
[11].  Beyond the cores, several relevant 
antigens,  relating  to  blood  groups, 
amongst  others,  have been identified as 
forming part  of the branched O-glycans 
(Figure  2.7)[37][38][39][35].  Finally, 
some tethered mucins contain a few sites 
for  N-glycosylation  along  their 
C-terminal, extracellular domains (Figure 
2.2 f))[6][40]. 
Even though the glycosylation patterns  of  mucins  remain largely unknown, knowledge derived 
from the binding specificities of adhesins presented by pathogens might help in understanding what 
the crucial determinants are for tissue specific adhesion. For example, it has been shown that the 
Epa1 adhesin from  C. glabrata has a marked preference for  β1-3 galactosides[41], pointing at a 
preference for core 1 and core 3 O-glycans (Figure 2.2 a and c).  On the other hand,  H. pylori 
pathogenicity and the ultimate disease produced by the organism has been linked to the presence of 
several blood group antigens, especially the Lewis antigens (Figure 2.3). Polymorphisms  in the 
blood group antigen binding adhesin (BabA) are determinant in the successful colonization of  H. 
pylori in human populations where the O-blood type is more strongly presented[42]. The intimate 
co-evolution that is inferred from these observations indicates that the study of pathogenic adhesion 
molecules needs to be linked to the study of the glycosylation of mucins, but that the opposite is 
9
Figure  2.2:  Core  oligosaccharide  structures  present  in  
Mucins. a) – e) Examples of mucin-type O-glycan cores. f)  
Complex  N-glycan  core  common  to  all  N-glycans.  β1-3 
glycosydic bonds such as the ones presented in a) and c)  
are preferred by the C. glabrata adhesin Epa1. [11][35].
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also true, the study of pathogenic adhesion molecules may help in the mapping of the glycosylation 




Figure  2.3:  Blood  group  related  oligosaccharides  found  on  mucins  as  
branches  in  O-glycans.  Lewis  antigens  have  been  linked  to  H.  pylori  




C. glabrata  is a strict mammalian commensal fungus[43], which can act as a health care associated 
opportunistic pathogen, normally on immunocompromised patients, with severe results, related  to 
systemic infections and sepsis[44].  C. glabrata  can also be the causative agent of several less 
severe, mucosa related, oral or urogenital diseases[45][46]. Due to its relative resistance against 
traditional  antimycotics[27],  the  pathogen  is  considered  to  be  highly  emergent[45],  and  new 
therapeutic tools are being actively sought. One of these therapeutic targets is the epithelial adhesin 
(Epa) machinery, which is represented in C. glabrata by up to 23 different genes, of which the Epa1 
gene  is  considered   to  be  responsible  for  adhesion  of  fungal  cells  to  mammalian surfaces  in  
vitro[47].
2.2.1 The genetic background of C. glabrata
The C. glabrata genome is 12.3 Mbp long, and is divided into 13 chromosomes[48]. The genome 
shows a relatively high similarity to the baker's yeast S. cerevisiae, with paralogous genes sharing 
around 65% average sequence identity[48]. In reflection of its commensal life-style, C. glabrata has 
lost many metabolic genes.  Therefore  it  is auxotrophic for at least nicotinic acid, thiamine and 
pyridoxine[43].  Despite C.  glabrata being mainly  haploid,  mating  loci  have  been found in  its 
genome[49],  which  together  with  non-clonal  recombination,  point  to  the  possibility  of  seldom 
occurring sexual reproduction[50].
An interesting characteristic of the C. glabrata genome, which is shared with S. cerevisiae  but not 
with C. albicans, is the fact that a large part of the adhesion apparatus coding genes are located in 
sub-telomeric regions, where they are subject to regulation of expression by gene silencing[43][51]. 
It has been proposed that the proteins of the Sir silencing machinery, Rap1 and Rif1 are involved in 
the silencing of epithelial adhesin coding genes (Epa genes). In an analogous model to S. cerevisiae 
Rap1 and Hdf1 are telomere associated and recruit the proteins encoded by the genes SIR2, SIR3 
and  SIR4[52]. The  Sir2  protein  is  an NAD+-dependent  histone  deacetylase  that  increases  the 
positive  charge of  histones  H3 and H4 through deacetylation of  amine groups,  thus  increasing 
attraction between the nucleosomes and effectively compacting the chromatin[53][54](Fig. 2.4). An 
NAD+-dependent  Sir  silencing  model  for  the  regulation  of  expression  of  Epa  genes  is  further 
strengthened by the observed behavior  of  C. glabrata,  which,  under  limiting concentrations  of 
nicotinic  acid,  immediately increases  the expression of  Epa6[26].  As previously  mentioned,  C. 
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glabrata is  an  auxotroph  for  nicotinic  acid,  which  is  a  direct  precursor  of  NAD+.  At  limiting 
nicotinic acid concentrations,  insufficient  NAD+ would be directed to the Sir machinery, which 
would not be able to counteract background acetylation by acetylases like Sas2[55]. Predominant 
acetylation would then initiate a de-compaction of the subtelomeric chromatin, and an increased 
transcription rate of the Epa genes (Fig. 2.4). 
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Figure  2.4: Mechanism for the regulation of gene expression through silencing. Histones (light and dark  
blue drums) form octameres around which DNA coils, forming nucleosomes. Histones contain N-terminal  
tails which are lysine rich, and which interact either with DNA or with other histones, yielding very compact  
heterochromatine[54].  Sas2 is  a  histone acetylase,  which consumes Acetyl-CoA to acetylate  N-terminal  
lysines in histones. The result is euchromatine, which can be transcripted, as shown in the picture by the  
RNApol. On the other hand, the Sir trimer acts as a deacetylase, and is recruited to subtelomeric regions by  
hdf1  and  Rap1[52].  While   the  activity  of  Sas2  is  apparently  constitutive,  the  Sir  complex  is  highly  
dependent on the presence of NAD+, which it consumes during de-acetylation[55]. Since C. glabrata  is a  
nicotinic acid (NA) auxotroph, it depends on external sources of it to maintain NAD+  levels. If  insufficient 
quantities of NA  are supplied, NAD+ will become limiting in deactylation, and therefore Sas2 mediated  
acetylation will yield more euchromatine in subtelomeric regions. The result in C. glabrata would be an  
increased expression of Epa genes, as observed [26].
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2.2.2 The cell wall of C. glabrata
All yeasts have a cell wall, an outer shell composed of different polysaccharides, glycolipids and 
glycoproteins (Fig. 2.5), which protects and shapes the cell, and interacts with the environment[11]. 
In the case of C. glabrata,  the cell wall is around 100 – 200 nm in thickness, shows two electron 
dark  regions  sandwiching  an  electron  translucent  mid-section  in  electron  micrographs,  and 
corresponds to around 19% of the dry weight of the cell[56]. This layered arrangement is typical of 
ascomycetous  yeasts[57].  In  S.  cerevisiae,  the  outer,  dark  layers  are  composed  mainly  of 
mannoproteins  and  other  glycoproteins,  while  the  inner,  translucent  layer  corresponds  to  a 
polysaccharide rich region[58][59].
The cell wall of C. glabrata contains mainly β1-3- and β1-6-glucans with traces of chitin (Figure 
2.5 b, c and a, respectively) and an unusually high amount of mannoproteins ( Figure 2.5 d and e)
[56].  There  appears  to  be  less  cross-linking  between  the  glucans  and  chitin,  with  a  denser 
mannoprotein outer layer, than in C. albicans[56]. It has been suggested that such an arrangement 
might facilitate host-evasion by reducing recognizance via the dectin-1 host receptor, as is the case 
with C. albicans[60]. 
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Figure  2.5: Glycans found within the cell  wall of C. glabrata.  a)  Chitin b) β1-3-glucan c) β1-6-glucan  
d) O-mannan and e) N-mannan commonly found in fungal glycoproteins.
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The mannoprotein layer of the C. glabrata cell wall has proven to be highly dynamic, with proteins 
both GPI-anchored and cross-linked to the  β1-3-glucan[56].  Among these,  many are structural 
proteins that cross-link the cell wall,  as demonstrated for an orthologue of the Pir protein family 
found in  S. cerevisiae[57], but there are also many proteins that are crucial in pathogenicity and 
virulence,  which are  expressed  on  the  cell  surface,  especially  adhesins.  The  adhesin  Epa1  is 
presented on the surface of the cell wall at very early stages of cell growth, and is then cleaved by 
aspartic  proteases[61],  while  EPA6 is  expressed during the stationary phase  in  vitro[56]. Under 
limiting nicotinic acid conditions, EPA6 along with EPA7 and EPA1 is transcriptionally active[26]. 
In general, it has been shown that  EPA genes remain relatively silent under non-limiting growth 
conditions[51],  but  that  any  kind  of  danger  or  limiting  conditions,  including  the  presence  of 
antimycotics[27], can lead to their activation and presentation on the cell wall.
The cell wall of C. glabrata is therefore a highly dynamic structure, with the capacity to both adapt 
to a  commensal life-style or a pathogenic one, and even to regulate the probable binding specificity 
and hydrophobicity of the cell  surface according to the ecological niche occupied at  any given 
moment.
2.2.3 The adhesins of C. glabrata
Adhesion plays a fundamental role in the pathogenesis of both C. glabrata and C. albicans, as it is 
the first step in the colonization of the mucosal surface[8]. In both cases, adhesion is mediated by 
GPI-anchored mannoproteins called adhesins, of which the Als (agglutinin-like sequence) family in 
C. albicans and the Epa (epithelial adhesin) family in C. glabrata are some of the best characterized 
examples. Both protein families share a very similar modular structure  -with N-terminal domains 
responsible for the adhesive capabilities (A domain), central serine and threonine rich regions which 
are highly glycosylated  in vivo  (B domain)- and maintain an extended structure and a C-terminal 
GPI anchor which cross-links the protein to the cell wall (C domain)(Fig. 2.6 a))[47][62]. 
The Ser/Thr rich region (B domain) is not directly involved in adhesion, but is highly glycosylated 
and maintains the N-terminal adhesive domain well outside the cell wall, allowing it to interact with 
its ligands[63]. The N-terminal adhesive domain (A domain) of all members of the Epa family has 
been characterized as being a PA14 domain[64][65] involved in sugar binding in several adhesins 
and sharing a very similar domain architecture in S. cerevisiae, as typified by Flo1p[1][62].
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The A domain specificity has been described as being governed by a penta-peptide present within 
amino-acids 227 to 231 (Fig. 2.6 b))[41]. Variations within this region and a hyper-variable region 
spanning amino-acids 114 to 139 were shown to be responsible for the variations in specificity by 
Zupancic et. al.[41]. The penta-peptide coincides with the CBL2 loop in the S. cerevisiae flocculins 
Flo5 and Flo1[1].
There are  around 20 Epa genes  in any given  C. glabrata strain,  but  the number varies greatly 
depending on the strain, and the characterization is hampered due to the long, repeating B-domains. 
These domains show many repeats  at the DNA level, which makes  the  assembly of contigs very 
difficult in the sub-telomeric EPA clusters[56].
Functionally, Epa1 seems to be the most important adhesin in vitro, as it is responsible for almost all 
binding under standard laboratory conditions[43], while Epa6 has been linked to biofilm formation 
and  the  colonization  of  the  vaginal  epithelium[66].  Epa1,  Epa6  and  Epa7  are  also  important 
virulence factors, as the deactivation of the Sir-dependent silencing (Fig.  2.4)  by deletion of  sir3 
produced hyper-virulent strains,  which could colonize the kidney of murine models much more 
efficiently than the wild type strains[51]. This effect could at least be partially traced back to Epa1, 
Epa6 and Epa7.
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Figure 2.6: Some of the features of Epa proteins. a) Domain architecture of fungal adhesins as described by  
Verstrepen et.  al.  [62]. An adhesin is composed of an adhesive A domain, which can show a PA14 like  
architecture, a B domain and a C domain. The B domain is rich in serine and threonine, which are organized  
in repeats. The B domain is highly glycosylated in vivo and serves the purpose of a long  “stem” which 
allows the A domain to protrude outside of the cell-wall and interact with nearby ligands.  The C domain  
contains the GPI anchor, which may either bind directly to the membrane, or be further processed and  
interact with one of the cell-wall polysaccharides (fig 2.2). Either way, the C domain acts as an anchor for  
the entire structure. b)  The sequences of the Epa1, Epa6 and Epa7 A domains. Marked in red are two  
important  regions as described by Zupancic  et.  al.  in  2008[41].  The hyper-variable  region,  comprising  
amino-acid 114 to 139, contains 10 of the 27 amino-acids that differ between Epa6 and 7. On the other  
hand, the penta-peptide composed of E227Y228D229G230A231 was shown to be critical in determining the ligand  
specificity of each of these three proteins.
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Recent,  semiquantitative  functional  characterization  of  Epa1,  Epa6  and  Epa7  shows that  the 
specificity for these three proteins is similar, but not identical. While all three proteins require a 
terminal  galactose, Epa6 can bind to carbohydrates where the galactose is bonded either α or β over 
a 1-3 or 1-4 glycosydic bond to glucose or galactose or their N-acetylated derivates. In contrast,  
Epa1 shows a narrower specificity, mainly excluding the α-bonded carbohydrates. Finally, Epa7 is 
the  most  specific,  almost  exclusively  binding  galactoseβ1-3galactose  or  lactose 
(galactoseβ1-4glucose)[41].
The large number of epithelial adhesins present in the Candida genome, their differential expression 
and specificity point towards a specialization of Epa function. This specialization could be tissue or 
situation specific, or both.
2.2.4 Pathogenicity of C. glabrata
C. glabrata is responsible for around 15% of all infections caused by the Candida genus[43]. There 
have not been many comprehensive attempts to set all virulence factors of C. glabrata in a whole-
organism context.  Instead, many  isolated  pieces  of  evidence  point towards  a  generally  similar 
pathogenicity  mechanism  as  C. albicans[67].  Major  similarities  are  the  large  adhesin  array, 
composed of the Epa family and others in  C. glabrata[43], as well as the presence of secreted 
aspartic  proteases[61],  which  have been  described  as  very  important  for  C.  albicans  
pathogenicity[68]. The capacity for phenotype switching, which allows the Candida population to 
change its outward appearance without any major genotypic events, and is therefore crucial in host 
evasion, is also a feature present in both organisms[69][70].
Major  differences,  on  the  other  hand,  include  the  fact  that  pseudohyphal  forms,  although 
possible[71] in C. glabrata, could not to be isolated from clinical samples[43]. In C. albicans, the 
filamentous  form dramatically  increases  invasiveness,  and  is  considered  to  be  essential  during 
pathogenic  colonization[72].  C.  glabrata's tightly  regulated  adhesion  machinery[51] is  also  an 
important difference, as  C. albicans  has  basally  a much more adhesive cell wall[73].   Finally, it 
seems that secreted proteases and phospholipases, although genotypically present[61][74], are not 
as  important  in  C.  glabrata  as  in  C.  albicans,  as  no  significant  activities  could  be  found 
extracellularly[74].
The mannose rich cell wall of  C. glabrata  could also be an important difference, as it has been 
proposed to be more difficult to identify by the host immune system[60]. Finally,  C. glabrata has 
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been characterized as being naturally resistant to azole based antimycotics,  due to  an ABC efflux 
transporter[75].
A basally less adhesive cell wall might be responsible for the lower infection rate of  C. glabrata 
compared  to  C.  albicans.  On  the  other  hand,  the  mannoprotein-rich  cell  wall  and  the  natural 
antimycotic resistance might account for the more severe nature of C. glabrata infections, and the 
increased  difficulty  in  treating  them[67].  The importance  of  the  different  regulation of  adhesin 




H.  pylori is  a  flagellated  Gram-negative  eubacterium  with  helical  morphology,  which  was 
discovered in 1982 by Drs Marshall and Warren in Perth, Australia[76]. Their results challenged the 
then-established paradigm for the etiology of peptic ulcer, and were rewarded with the Nobel prize 
for medicine in 2005. It is the only bacterium to persistently colonize the human gastric mucus[77], 
and infects around 50% of the human population[78][79]. Even with such a large part of humanity 
infected by  H. pylori,  only ~15% of carriers will develop peptic ulceration (~80% of all peptic 
ulcers), and ~0.2 – 0.3% gastric adenocarcinoma[4]. Mucosa associated lymphoid tissue (MALT) 
can also develop from any ulcerous process, but if no malignancy is developed, it normally recedes 
with successful antibacterial treatment[4]. The reasons why some carriers develop a disease, while 
others do not, and whether the pathological process develops into either peptic ulcer or cancer is yet 
unclear, although it appears that one type of process protects from the other (i.e. H. pylori induced 
peptic ulcer patients do not suffer gastric adenocarcinoma)[80].
2.3.1 Colonization and pathogenesis of H. pylori
H. pylori  probably colonizes the human stomach during the host's early childhood[4]. In the rare 
cases of colonization during adulthood, gastritis accompanied with hypochlorhydria ensues[81][82]. 
It  is  not  known  whether  childhood  infection  carries  any  changes  in  gastric  homeostasis.  No 
colonization of  the esophagus or  the duodenum is possible  unless  they have undergone gastric 
metaplasia[4]. Accordingly, there only appears to be an active niche within the stomach and an oral 
reservoir. 
In a first step of colonization, H. pylori must chemotactically (Fig. 2.7) locate its target within the 
stomach. One CheA histidine kinase and two CheY regulator proteins have been isolated in  H. 
pylori, and they are essential for chemotaxis  and colonization of the gastric  mucosa[83]. 
While swimming in the gastric juices,  H. pylori  needs to be able to survive the extremely harsh 
environment,  specifically,  it  must  neutralize  the  low  pHs  of  its  surrounding.  As  proof  of  the 
importance of acid-dependent regulation of all H. pylori functions, it could be shown that more than 
300 genes  are  acid-regulated  or  acid-affected[84].  Among these,  the  gene  coding  for  the  most 
abundant protein within H. pylori can be found, namely, urease. Urease is an intracellular enzyme 
which hydrolyzes urea to ammonia and carbon dioxide. The ammonia raises the pH within the 
cytoplasm,  which  buffers  the  periplasm.  The  result  is  a  strong  buffering  system  surrounding 
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H. pylori, which encourages survival at extremely acidic pHs. Urea import is controlled by a pH-
gated urea channel (UreI), which allows non-genetic, direct coupling of pH and urease activity[85]
[86].
Once the mucus producing cells of the antral region are located,  H. pylori  will bind to the mucus 
directly above them, mainly to mucins MUC1 and MUC5A[87]. The largest part of the H. pylori  
population will grow within the mucus layer, and only a small part, if at all, will actually attach 
itself to the epithelial cells forming the antral mucosa[11][88][89]. Attachment and adhesion during 
the process of colonization and invasion of the mucous and epithelial layers of the mucosa is very 
complex, and requires very distinct modes of adhesion[90][91].
If the bacterium manages to colonize the epithelial surface, it is possible for a pathogenic process to  
be  initiated.  The  factors  involved  in  the  development  of  illness  and  the  corresponding 
symptomatology are very diverse, depend both on the bacterium and on the host, and are not yet 
fully understood. Amongst the better understood host factors are the  muc1  genotype, where short 
muc1 alleles  could  be  linked  to  Helicobacter-linked  gastritis  and  gastric  adenocarcinoma[92]. 
Murine muc1 knockouts showed a much higher propensity towards severe H. pylori infections and 
were  easier  to  colonize[93].  Another  important  host  factor  is  the  inflammation-dependent 
differential glycosylation of the gastric mucins. Upon contact with H. pylori, the epithelium releases 
an innate immune response. As part of the response, the glycosylation patterns of the gastric mucins 
change, with an increase in sialic acid-containing glycoconjugates. H. pylori is capable of adapting 
to such changes by differentially expressing different sets of adhesins[91][94].
The bacterial  factors  leading  to  virulence  and severe  disease  are  much  better  understood.  The 
cytotoxin associated gene pathogenicity island (cag PAI) is a large ensemble of approximately 30 
genes obtained by H. pylori through an unknown source and inserted within its glutamate racemase 
gene[95]. Different H. pylori strains may contain the entire PAI (cag+), none (cag-) or only part of 
it, which normally leads to a cag- phenotype[96]. 
The cag PAI is composed of genes that code for a secretory apparatus[95] that allows H. pylori to 
inject  the  cagA gene  product  (also  part  of  the  cag  PAI)  into  epithelial  cells[97].  Once  within 
epithelial cells, CagA acts as a target for host cell Src family tyrosine kinases[98]. Phosphorylated 
CagA then  activates several other regulatory proteins within the MAP-kinase pathway leading to 
cell  proliferation[99],  motility  and  cytoskeletal  changes[100].  The  most  potent  effect  of  CagA 
injection is  the elongation of the epithelial  cells  in  the so called hummingbird phenotype[100]. 
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Interestingly,  MAP-kinase  activation  has  been  linked  to  c-Fos,  c-Jun[99] and  the  c-Met 
receptor[101], which are all pro-oncogenes. CagA can also disrupt gap-junctions between epithelial 
cells, decreasing tissue cohesiveness and probably facilitating nutrient uptake[102]. The secretory 
apparatus itself also causes an increased production of interleukin IL8, recruiting a higher number 
of neutrophils and leading to an enhanced inflammatory response to any cag+ strain[103]. The cag 
PAI is necessary for disease, but not sufficient, as some cag+ strains are minimally pathogenic, as 
CagA is polymorphous and may contain no phosphorylation sites[103].
The other very important pathogenicity factor of  H. pylori is the vacuolating cytotoxin A (vacA). 
VacA  is  produced  in  H.  pylori as  a  pre-toxin,  which  is  secreted  by  an  autotransporter 
mechanism[104][105][106]. The toxin is then subjected to N- and C-terminal cleavage, generating a 
functional  heterodimer[107].  VacA's  toxicity  relies  on  it  binding  several  epithelial  factors,  the 
receptor protein tyrosine phosphatase (RPTP)  α and β[108], the epidermal growth factor receptor 
(EGFR)[109] and a (GPI)-anchored protein associated with lipid rafts[110]. Interaction of VacA 
with a receptor is followed by acid-dependent internalization through endocytosis[111]. In an acidic 
pH dependent manner[112], VacA is activated after internalization, and oligomerizes into hexameric 
pores[113]. The pore is selective to anions and small neutral molecules[114], and causes osmotic 
swelling of late endosomal compartments, which become large acidic vacuoles[115]. Vacuolation is 
only observed in vitro,  however, and it is not clear what the mechanism for toxicity is within the 
gastric mucosa, although it appears to affect both the epithelium and immune cells[92]. VacA is also 
highly polymorphic,  with so-called S2 variants yielding  minimally  pathogenic strains,  while S1 
variants vary in pathogenicity, but are always pathogenic to some extent[116].
Pathogenicity in  H. pylori is very complex, but also much better studied than in  C. glabrata.  H. 
pylori is extremely well adapted to an environment were pH ranges are extreme, going within a few 
microns from extremely acidic to neutral. Its virulence factors reflect such an adaptation, while they 




Figure  2.7:  CheA/CheY dependent  Chemotaxis.  a)  The flagellar  apparatus  (orange),  
intracellular regulatory cascade and corresponding receptors. The flagellar apparatus  
consists  of  a  cytoplasmic (CP) regulatory region,  an inner  (IM) and an outer  (OM)  
membrane regions, a periplasmic (PP) region,  the Hook (H) and the flagellum (F). Due  
to the orientation of the Hook, whenever the flagellum rotates counterclockwise (CCW),  
the bacterium swims straight. If the flagellum rotates clockwise (CW), then the flagella  
separate, and the bacterium initiates a tumble. Whenever CheY phosphate is bound to  
the regulatory region, the flagellum turns clockwise, causing a tumble. CheY phosphate  
is produced by transfer of a phosphate group from CheA phosphate, which is itself a  
autophosphorilating kinase, and depleted through CheZ. Chemotactic receptors act on  
the  transduction  cascade  depending  on  their  state.  When  free,  they  activate  CheA  
activity, yielding basal tumbling (b). When bound to an attractant (green), they inhibit  
CheA  activity,  increasing  straight  swimming  paths  with  increasing  attractant  
concentrations (c). If they bind a repellant (red), they up-regulate CheA activity beyond  
basal levels, causing more tumbling at higher concentration levels, and longer paths at  
lower  concentrations  (d).Upon  constant  activation,  chemotactic  receptors  become  
desensitized, and tumble frequency returns to basal levels.
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2.3.2 Adhesion in H. pylori
Adhesion in  Helicobacter pylori has been proven to be one of the key virulence factors,  but it 
appears that the adhesion machinery of  H. pylori  is very complex and polymorphic, with a high 
recombination and modification rate[117]. It seems that the binding to the Lewis b (Leb) antigen 
present on gastric mucins (section  2.1) is of special importance during colonization, as  H. pylori  
strains lacking Leb binding capacities are less prone to produce any of the described diseases[118]
[119].
The blood group antigen-binding adhesin (BabA) is mainly responsible for the binding of the Leb 
antigen[120]. The BabA protein is highly polymorphic, and has been shown to lose and reattain its 
Leb binding activity repeatedly during infection[120][121][122]. Even in certain human populations 
where Leb secretors are very rare, it has been shown that BabA has adapted to bind other, more 
common ligands[42]. The rapid and functional modification of BabA has been traced back, at least 
in part, to three gene loci babA1, babA2 and babB, of which only babA2 is expressed. babA2 can 
rapidly recombinate with babB and perhaps babA1 to lose or gain function[121].
BabA is ~80  kDa and  ~750 amino-acid long outer membrane protein (OMP) of the HP_OMP 
family[123], which is composed of a C-terminal  β-sheet rich region and an N-terminal globular 
domain, that is putatively considered to be responsible for adhesion. The C-terminal domain fulfills 
all prerequisites  of a typical transmembrane β-barrel like structure typical of OMPs[89][124]. The 
N-terminal domain is composed of a very conserved N-terminal sequence and a C-terminal region 
of high variability[42]. Insertion into the outer membrane of the C-terminal domain would leave the 
N-terminal domain within the periplasm, which further supports the claim that BabA works as an 
autotransporter[105][106][125][120].
Secondary to BabA-Leb mediated adhesion, the Lewis X (LeX) antigen has also been observed to be 
an important ligand to H. pylori[126]. Especially in its sialylated form, LeX  is bound by the sialic 
acid binding adhesin (SabA), which is very similar in biophysical characteristics to BabA. SabA is 
apparently most important after the unspecific immune response has started, as LeX expression is 
up-regulated in inflamed tissue[91]. Other putative adhesins, like AlpA and AlpB, might also be 
involved, but it is not quite clear what their cognate host ligands are[91].
Other modes of adhesion have been identified for  H. pylori,  including one  that is mediated by 
electrostatic interactions and which only happens at low pH[90] for which  no single protein has 
been identified, and one in which the LeX and LeY antigens are involved. These glycans must be 
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present both at the bacterial lipopolysaccharide  (LPS) and at the mucosal surface of the host[127]. 
Anti-LeX auto-antigens produced in response of H. pylori colonization have been implicated in this 
adhesin-independent adhesion, which is strong enough to reestablish wild-type infectivity in bab - 
mutants[127]. 
Adhesion of H. pylori has been shown to be highly pH dependent[87]. H. pylori almost exclusively 
colonizes slime producing cells of the gastric antrum[128], which is the least acidic region of the 
stomach. Also, ex vivo binding to pig gastric mucins was pH dependent[9]. Specifically for BabA, it 
could  be  demonstrated  that  BabA-dependent  activity  was  only  to  be  found at  mildly  acidic  to 
neutral  pHs,  and  not  at  extremely acidic  pHs[90][87].  Therefore,  BabA is  important  during 
epithelial  adhesion  in  gastroduodenal  disease[129] and  for  the  maintenance  of  an  oral 
reservoir[130], but not during travel of the bacterium within the gastric fluids[90].
The adhesion mechanisms of H. pylori are extremely complex, polymorphic and subject to strong 
variations, with apparently many rescue pathways to maintain adhesion to the host. Such a complex 
and tightly secured system indicates the extreme importance of adhesion in H. pylori infection.
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2.4 The Structural features of glycan binding proteins from pathogenic origin
The  surface  of  epithelial  cells  is  covered  by the  glycocalyx,  which  is  composed  of  different 
glycoproteins  and  oligosaccharides,  including  tethered  mucins.  The  glycocalyx  has  long  been 
proposed to be responsible for tissue specificity during pathogenic colonization, due to very specific 
recognition  of  glycan  determinants  by  the  invasive  organisms.  Genetic  and  functional  studies 
demonstrated  that  microbial  pathogens  present  several  surface  lectins,  which  were  deemed 
responsible  for  glycan  binding[131][132].   The  structural  characterization  of  the  lectin-glycan 
interactions soon followed in some cases, but current information is still limited.
Even though the folds are very diverse, all known structures are  β-strand rich, with  β-sandwiches, 
either straight or in jellyroll fold[133], lectin-like domains[134], β-propellers [135][136]and ricin-B 
trefoil domains  being the recurrent motifs[137](Fig. 2.8).  β-propeller type lectins are multivalent, 
with many binding sites to procure a high avidity,  and  follow a similar mode of action as  their 
animal and plant lectins  counterparts. Most of the other microbial  lectins are  monovalent.[136] 
Accordingly, lectins from pathogenic organisms have, as a rule, a much higher affinity for their 
ligands than their non-pathogenic counterparts[138]. 
Within each fold type, structural conservation is quite high, but sequence identity can be as low as 
~20%. Perhaps as a result, different lectins presenting the same fold do not necessarily bind their 
ligands in the same way. Even the position of the binding pocket within a single fold might not be  
well conserved, and can vary strongly from one protein to another[139].
Fungal flocculins, like Flo5, have a modular structure with an adhesive A domain at their apex (Fig.  
2.6). It has been determined that the Flo5A domain is folded into a PA14 domain[1], which contains 
a jellyroll fold. It has been proposed that the Epa1 A domain will share that  architecture  and a 
similar binding mode with Flo5A. On the other hand, not much is known on the structural features 
of the BabA adhesin,  besides it having an autotransporter modular architecture[106]. Secondary 
structure predictions indicate that the extracellular fragment is β-strand rich, in accordance  with 
other bacterial adhesins, which bind blood group antigens[140].
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2.4.1 The PA14 domain
The PA14 domain was first discovered in the crystal structure of the anthrax protective antigen 
toxin (PA) (PDB accession code 1ACC)[141], but was defined much later[64]. The PA14 domain is 
contained within the PA20 pro-peptide of immature PA (Fig. 2.9 a), and is called PA14 due to the 
fact that it weighs 14 kDa. In Bacillus anthracis, PA is part of the trimeric anthrax toxin, which is 
composed  by  the  protective  antigen,  the  edema factor  and  the  lethal  factor[142].  In  vivo,  PA 
associates with the eukaryotic membrane as a monomeric immature protein, from which the PA20 
pro-peptide is then cleaved. The resulting protein, PA63, oligomerizes into heptameres, which insert 
themselves into the eukaryotic membrane to produce a large pore, through which the edema and the 
lethal factors are translocated[141].
With  the  use  of  multiple  sequence  alignments  and  other  bioinformatic  methods[143][144],  a 
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Figure  2.8 a) Jellyroll fold from  E. coli FimH chaperone-usher adhesin[133]. (PDBID: 1QUN) b)  
Multivalent  β-propeller  lectin  from the  fungus  Aleuria  aurantia  (AAL)  [135](PDBID:  1OFZ). c)  
Trefoil  fold of the LSL adhesin from Laetiporus sulphureus  [137] (PDBID: 1W3F). d) the Invasin  
structure of Yersinia pseudotuberculosis, composed of 3 N-terminal Ig-like domains (left) and one C-
terminal Lectin-like domain (right)[134] (PDBID: 1CWV)
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minimum theoretical domain structure within PA20 was defined[64], composed of amino-acids 43 
to 179 from the PA (SWISS-PROT: P13423). This sequence corresponds to amino-acids 14-150 of 
the 1ACC PDB entry (shown in red in Fig. 2.9 a and c), and define the PA14 domain. The general 
fold  described  for  the  PA14  domain  is  a  β-sandwich  like  structure  with  jelly-roll  topology, 
composed of a total of 10 anti-parallel  β-strands. 
Although no carbohydrate binding capacity has been characterized for the original PA14 domain, 
there are many examples of glycan binding proteins which have been shown or are predicted to 
employ a PA14 domain for ligand binding[64]. All Epa proteins have been predicted to present 
PA14  domains  as  A domains[64]. There  are  several  glycan  binding  proteins  for  which  crystal 
structures are available  showing the PA14 domain, like the 3β-glucosidase from  Kluyveromyces  
marxianus[145] or,  more  importantly,  the  A domain  of  the  S.  cerevisiae  flocculin  (Flo5A) 
(Fig. 2.9 b)[1]. 
The Flo5A structure is extremely interesting for the characterization of the Epa A domains, as the 
PA14 domain has been shown to be structurally quite  well-conserved  between them despite their 
very low sequence identity[1]. The Flo5A core structure is quite similar to the PA14 structure from 
1ACC, as it is composed of 11anti-parallel  β-strands forming a β-sandwich. The main differences 
stem from the loops, the so-called subdomain and the calcium binding loops 1 and 2 (CBL1 and 
CBL2). The Flo5 sub-domain is composed of the loop spanning between β-strand 4 and β-strand 10 
of Flo5A. It contains 5 short β-strands that interact with each other and 4 cysteines, which generate 
two disulfide bridges within the sub-domain structure (Fig. 2.8). The CBL1 and CBL2 loops are 
located between β-sheets 11 and 12 and β-sheets 15 and 16 respectively. CBL1 contains the unique 
DcisD motif (Fig.  2.9),  which  presents an unusual cis peptide bond between to aspartates, which 
enables them to perfectly coordinate a calcium cation required for carbohydrate binding[1]. CBL2 is 
positioned  below  the  same  calcium  cation  and  interacts  with  it  through  the  loop's  peptide 
backbone[1]. It is within these four features (the subdomain, CBL1, CBL2 and the calcium cation), 
that the carbohydrate ligand binds. Flo5A has been shown to present affinity for α1-2mannobiose 
containing oligosaccharides in the mM range[1] (Fig. 2.9).
Interestingly,  no subdomain is  predicted to  be present  in Epa1A  (Fig.  2.9),  but  the specificity 
defining  penta-peptide  present  within  Epa1A[41] aligns  well  with  the  Flo5A  CBL2[1]. 
Additionally,  although no DcisD motif  can be  found in the  PA14 domain,  and indeed the  DN 
peptide substituting it is in a trans conformation in PA14 (Fig. 2.9),  the motif can be found and 
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Figure 2.9: PA14 domains in different proteins. a) The B. anthracis protective antigen. The PA is an 83 KDa  
protein divided into 4 different domains. Marked in red is the PA14 domain, which is part of the PA20  
propeptide, which is in turn part of domain 1 of the immature PA. The PA14 domain shows a β-sandwich 
like structure with jelly-roll topology, composed of a total of 10 anti-parallel  β-sheets[64]. b) The crystal  
structure of the S. cerevisiae flocculin Flo5 A domain (Flo5A). The structure of Flo5A is strikingly similar to  
that of the PA14 domain, despite  their poor sequence similarity (Fig. 2.8 c) and d)). It presents a Flo5A  
subdomain, which is marked in grey and the calcium binding loops 1 and 2 (CBL1 and CBL2). CBL1 and  
CBL2 bind calcium (shown in orange), CBL1 through two aspartates joined by a cis peptide bond (the  
DcisD motif) and CBL2 through its peptide backbone. The combination of the subdomain, CBL1, CBL2 and  
the calcium cation form the binding pocket. In the present structure, Flo5A is bound to  α1-2mannobiose,  
shown in blue. c) The PA14 domain from PA. The CBL2 loop follows a different path than in Flo5A, while in  
CBL1, one of the aspartates has been substituted by an asparagine, resulting in no interaction with calcium.  
This is probably also the reason why the peptide bond between the aspartate and the asparagine is in trans,  
and not cis.[1] d) Multiple alignment between Epa1A, Flo5A and PA14. No Flo5A subdomain is expected  
within Epa1A, but the DcisD motif is. Part of the Epa1A specificity defining penta-peptide[41] is aligned 
with CBL2.  The alignment  hints  therefore  at  the  possibility  of  a  similar  mechanism in  ligand binding  
between Epa1A and Flo5A. The alignment is based on the one presented by Veelders et. al. [1], and the  
secondary structure  elements are derived from the Flo5A structure.
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2.4.2 Type V protein secretion: autotransport.
In  order  to  secrete  proteins  into  the  extracellular  space,  Gram-negative  bacteria  have  various 
systems that allow for the secreted molecules to pass both the inner and the outer membranes (IM 
and OM, respectively). Secretion types I to IV need accessory proteins to traverse both the IM, the 
OM and the periplasm (PP). These systems are normally involved in export of soluble proteins, like 
toxins or constituents of pili or fimbria, which have no more contact with the OM after export. On 
the other hand, during type V secretion,  accessory proteins are only needed to traverse the inner 
membrane[146].  Transport  through  the  outer  membrane  is  accomplished  by  a  C-terminal 
autotransporter domain, which is composed of a porin-like β-barrel. After insertion of the β-barrel 
into the OM, an N-terminal passenger domain is exported to the extracellular space. The passenger 
domain may then either stay attached to the β-barrel (type Va secretion), or separate from it for full 
secretion (type Vb secretion)[5]. A third option is that the β-barrel is formed through the β-sheets of 
several molecules,  generating a membrane bound oligomere (type Vc secretion,  Fig.  2.10 a)[5]. 
Chaperones might be needed for passage through the periplasm, but are not  absolutely necessary in 
most cases.
Autotransporters are consistently composed of three regions; a signal peptide which is compatible 
either with the Sec or SRP translocation systems, an N-terminal passenger domain, and a C-terminal 
translocation unit domain (Fig. 2.10 b)[147]. 
During inner membrane transport, SecB has been postulated to associate with the autotransporter, 
and  to  bind to SecA, which translocates the autotransporter to the periplasm[148]. On the other 
hand, SRP dependent association with the translocon allows for co-translational translocation of the 
autotransporter[5] (Fig. 2.10 c). Once in the periplasm, it has been hypothesized that the  β-barrel of 
the translocation unit immediately starts insertion into the OM, which leaves the passenger domain 
in an extended conformation within the periplasm[5]. Evidence has been found for both, a pre-
folding  before  translocation[149] and  for  some  intramolecular  chaperones  which  maintain  the 
passenger  domain in an extended, yet stable  conformation[150].  It  is  therefore unclear  whether 
there is a universal mechanism for periplasmic transport, or whether some autotransporters behave 
in one fashion, and others in a different one.
Protein passage through the outer membrane is also a matter of discussion[125]. Although it was 
initially  proposed that  the   β-barrel  barrel  of  the  translocation  unit  would  autonomously  insert 
itself[146], it  could be shown that several factors at least facilitate such insertion. The bacterial 
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lipopolysaccharide  (LPS)[151] and  the  periplasmic  chaperone  Skp[152] seem  to  have  some 
function in the facilitation of membrane insertion of the  β-barrel. Also, the outer membrane β-
barrel assembly machinery (Bam complex or Omp85) seems to be associated with the translocation 
unit during insertion[153]. The Bam complex is essential for the export of OMPs, and it has been 
shown to interact directly with them during membrane insertion[154].
Finally, the passenger domain needs to cross the outer membrane, to be exposed to the medium. A 
hairpin  model  seems  to  be  the  most  prevalent  in  describing how  the  passenger  domain  is 
translocated  through  the  translocation  unit  domain[125].  In  it,  the  C-terminal  region  of  the 
passenger domain is first translocated through the β-barrel pore, yielding an extracellular hairpin. 
The rest  of the passenger domain is  'pulled out'  by this hairpin.  How this happens without the 
coupling of an energy carrier such as nucleotide triphosphates is still unclear(Fig  2.10 d)[105]. A 
weakness of this model is the fact that fully folded, disulfide bridge comprising passenger domains 
should not be exported, although such transport has been observed in vivo[149]. Other models have 




Figure  2.10:  Autotransporters  in  Gram-negative  procaryotes.  a)  Autotransport  is  also  known  as  type  V  
secretion.  There are three subclasses of  type V secretion. Type Va,  in which the passenger domain (blue)  
remains attached to the translocation unit  (green).  Type Vb,  where the passenger domain is  cleaved and  
released to the exterior. In type Vc two or more domains build the functional pore (in green and red gradient),  
yielding a multimeric autotransporter[5]. b) The domain architecture of an autotransporter is composed of a  
minimum of three regions, an N-terminal signal peptide (orange), the passenger domain (blue) and the C-
terminal translocation unit (green). An intramolecular chaperone domain (purple), might be present, but is  
not  necessary[125].  c)  Translocation  through  the  inner  membrane.  Two  pathways  are  available for 
autotransporter  translocation  through  the  inner  membrane,  either  post-translationally through  the  Sec  
system[148], or co-translational through the SRP-translocon system[5]. (Ribosome in green, mRNA in red). d)  
Possible  translocation mechanisms  of  the  passenger domain through the outer  membrane.  Left:  classical 
hairpin mode[105]. Center: the  β-barrel pre-forms in the periplasm and is inserted in a semi-folded state into  
the OM by the Bam system. This mode would allow for fully folded passenger domains to be passed through  
the membrane. Right: Several translocation units associate in the outer membrane, producing a large central  
hydrophilic pore. The pore would then allow for the semi-folded passenger domains to pass through[105].
Aim
3 Aim
The aim of this project was to characterize pathogenic adhesins, of microbial origin which interact 
with human mucins. C. glabrata adhesin Epa1 and H. pylori's BabA and SabA were chosen due to 
their  medical  relevance.  The A domain  of  Epa1A was  to  be  functionally  characterized  and  its 
structure  elucidated. Furthermore, variants of Epa1A were to be generated to shift its specificity 
along Epa1's nearest phylogenetic relatives within the Epa family. These variants were to be also 
functionally and structurally characterized as well. 
The recombinant  production of the passenger  domain of  the  H. pylori autotransporter  adhesins 
BabA and SabA was to be established. To obtain soluble protein, refolding methods and extensive 
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Plates Cover slides  Ø = 22 mm (Hampton Research),
24 well crystallization tool (Nextal/Qiagen),
24 well VDX (Hampton Research),
96 well InnovaplateTM SD-2 (Hampton Research),
SilverSeal (Greiner Bio-one),
VIEWsealTM adhesive sheets (Greiner Bio-one)
Screens NEXTAL crystallization kits (Qiagen)
Tools Cryotong, Crystal WandTM, Micro-Tools (Hampton Research)
Cryoloops Crystal CapTM  Colored (Hampton Research), 
CrystalCap HTTM (Hampton Research),
MicromountsTM (MiTeGen)
Dialysis cassettes Slide-A-Lyzer® Mini Dialysis Units 10000 MWCO (Pierce)
Dialysis membrane Pore size 0.025 µm, Ø = 25 mm (Millipore),
Snakeskin, MWCO 3.5 Kda (Thermo Scientific)
Disposable cuvettes Cuvettes REF 67.742 (Sardstedt)
Desalting columns PD-10 Desalting Columns (GE Healthcare)
Microspin G50 Desalting columns (GE Healthcare)
Protein concentrators Amicon-Ultra4 (Millipore)
Sterile filters Ultrafree®-MC (Millipore), Filtropur S 0.2 (Sarstedt),
Steritop bottletop filter, 22 µm express plus (Millipore)





Autoclave T-lineTM  (Fedegari)
CD spectrometer
Digital Camera Powershot A70 (Canon), D60 (Nikon)
Documentation systems
Agarose gels Computer E.A.S.Y with digital camera (UVP), 
UV-transilluminator  (Herolab),  thermal  printer  UP-D  895 
(Sony)
Crystallization Crystal Pro HT 110 (TriTek Corporation)
Fluidizer EmulsiFlex-C5 (Avestin)
Fluorescence spectrophotometer
French Press French-pressure cell-Version 5.1 (Sim Aminco)
French-pressure cell  (Philipps Universität  Marburg workshop 
for precision engineering) 
Gel electrophoresis
SDS-PAGE Mighty Small II SE250 (HoeferScientific Instruments), 
PerfectBlue two-gel system Twin M (PEQLAB)
Power boxes Model 453 (ISCO), EPS 300 (GE Health care)
Gel shaker Model 3013 (GFL), Köttermann 4010 (Köttermann)
Incubator Incubator (Heraeus), BFED-53 (WTB Binder)
Crystallization robot Cartesian MicrosysTM SQ4000 (Genomic Solutions)
LC-Systems ÄKTA primeTM P100 (GE Health care)
ÄKTA purifierTM 100 (GE Health care)
FPLC System 250 (GE Health care)
Liquid handling system Lissy (Zinsser Analytic)
pH-Meter Basic Meter PB-11 (Sartorius), Seven Easy (Mettler Toledo)
Photometer U-2000 (Hitachi), UltrospecTM 3100pro (Biochrom),
Uvikon spectrophotometer 930 (Kontron), 
Nicolet Evolution e100  (Thermo Electron Corporation)
Ultrapure water dispenser Seralpur Pro90CN  (Seral), Milli-Q (Millipore)
X-ray diffractometer Rotating anode AXS FR591 (Bruker),
MAR345dtb detector (MAR Research).
Oxford cryosystems (Oxford)
Peristaltic pump P1 (GE Health care)
Shakers Certomat®  IS (Sartorius), G25 (New Brunswick Scientific),
Multitron 2 (Infors), TH 25 (Edmund Bühler)
Dish washer Professional G7883 (Miele)





Scales DeltaRange® PC2200 (Mettler), Toledo Labstyle 54 (Mettler)
Centrifuges 2K15 (Sigma), Biofuge 13R (Heraeus), 
Biofuge fresco/pico (Heraeus),
Centrifuge 5417C/5910R (Eppendorf),
DiscoveryTM 90SE (Sorvall), EvolutionRC (Sorvall),
J2-HS / J2-21 M/E (Beckmann), Minifuge GL (Heraeus Christ)
X-Ray diffractometer Rotating anode AXS FR591 (Bruker)
MAR345dtb detector (Mar Research)
Oxford Cryosystems (Oxford)
Table 4.3: Technical equipment.
Products, chemicals and consumables mentioned in this work which are not  listed in these tables 
were ordered from either Merck, Sigma, Roth or Fluka with the highest possible purity.
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4.2 Vectors and Microorganisms
4.2.1 Vectors
4.2.1.1 The pET28a Vector
The pET28a  vector  system was employed in combination with  different  E.  coli strains  for  the 
cloning, mutagenesis and heterologous expression of all genes presented in this work. pET28a is a 
low copy plasmid  equipped  with  a  kanamycin  resistance  and an  expression  cassette  under  the 
control of the T7 promoter and the lac operator. These features ensure selection and tight control of 
the expression.
The  pET28a  Vector  formed  the  basis  for  the  two  constructs  upon  which  this  work  is  based 
(Figure 4.1).
4.2.1.2 The pCR 2.1-Topo plasmid
The  pCR  2.1-Topo  plasmid  is  a  commercially  available  plasmid  which  encodes  for  both  a 
kanamycin and an ampicillin resistance. The cloning site for the insert is found within the LacZα 
gene. If an insert is successfully cloned within the vector, the β-galactosidase activity of the gene 
product will be disrupted. A blue-white screening for fragment insertion can then be undertaken by 
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Figure  4.1:  Left: pET28a_BabA235 vector, which contained the putative passenger domain of BabA. It  
contains both a kanamycin resistance gene, the lactose repressor gene LacI and the BabA235 gene. Right :  
pET28a-Epa1_2. This vector contained the Epa1A gene plus the same features as pET28a_BabA235. The 
pET28a-Epa1_2 vector was adopted from [155], where it got its original denomination.
Materials
administering X-gal to the LB-agar plates where transformants are to be grown.
This  vector  was  used  primarily  in  combination  with  the  Invitrogen TOPO-TA cloning  kit  for 
purposes of subcloning.
4.2.2 E. coli strains
E. coli DH5α
Genotype: F-  Φ80lacZΔM15  Δ(lacZYA-argF)  U169  recA1  endA1  hsdR17  (rk-,  mk+)  phoA 
supE44 λ- thi-1 gyrA96 relA
The E. coli DH5α (Invitrogen) strain is especially well suited for the isolation and production of 
recombinant DNA, as it is not capable of recombinant expression of T7 promoter-controlled genes 
and can achieve very high plasmid replication rates.
E. coli BL21 (DE3) Gold:
Genotype: B F– ompT hsdS(rB– mB–) dcm+ Tetr gal λ(DE3) endA Hte
The BL21 (DE3) Gold strain is equipped with a λ pro-phage containing the T7 RNA polymerase 
gene, which works together with the lac operator, to allow for IPTG mediated gene expression. The 
system is under the control of the lac promoter[156].
E. coli Origami2 (DE3):
Genotype:  Δ( ara–leu)7697 ΔlacX74 ΔphoA PvuII phoR araD139 ahpC galE galK rpsL
F’[lac+ lacIq pro] (DE3) gor522::Tn10 trxB (StrR, TetR)
E. coli Origami 2 (DE3) cells are a K12 derived strain containing the DE3 element and mutations in 
both the thioredoxin reductase (TrxB) and the  glutathione oxidoreductase (Gor).  The mutations 
within  trxB and  gor raise  the  oxidation  potential  of  the  cytoplasm  enough  to  allow  for  the 
generation of disulfide bonds[157]. E. coli Origami 2 (DE3) cells are therefore well suited for the 
T7-regulated synthesis of proteins containing disulfide bonds.
E. coli Shuffle T7:
Genotype: F´  lac, pro, lacIQ /  Δ(ara-leu)7697 araD139 fhuA2 lacZ::T7 gene1 Δ(phoA)PvuII  




 The E. coli Shuffle T7 (New England Biolabs) strain contains deletions within the  gor  and  trxB 
genes which, as in the case of the Origami 2 cells, grants it the capability  to synthesize disulfide 
bonds intracellularly. Furthermore, it contains the  DsbC gene, which codes for a disulfide bridge 
isomerase[158]. DsbC acts  by  rearranging  energetically  suboptimal  disulfide  bridges,  thus 
increasing in most cases the soluble yield of the produced recombinant protein, as compared with 




Primers were designed for both de novo cloning and mutagenesis of cloned genes.
4.3.1 Primers for de novo cloning:
Gene/fragment Primer (orientation/Restriction enzyme)  TM (°C)
SabA uni gtgtgCCATGGGGgtgagcgccggctatc (Fwd/NcoI) 70.05
SabA 180 gttgtgCTCGAGgtttgatgttgagtctgttg (Rev/XhoI) 62.3
SabA 260 gttgtgCTCGAGagatagggtgtggttgc (Rev/XhoI) 63.8
SabA 325 gttgtcCTCGAGcgttgaacccgcattggg (Rev/XhoI) 67.4
Table 4.4: de novo cloning primers. Uni: universal forward primer, to be used in all amplifications.  
Fwd: forward orientation, Rev: reverse orientation, TM: melting temperature. Fragment sizes are  
given in number of amino-acids. Restriction sites are highlighted in uppercase.
4.3.2 Mutagenesis primers:




























Table 4.5: Mutagenesis primers. Mutations are marked in red, mutations accumulated from 




4.4 Media, buffers and Stock solutions
4.4.1 Media:
Both Luria Bertani (LB) and Terrific Broth (TB) media were employed for heterologous expression; 
only LB medium was used during molecular biology experiments, both in liquid  cultures  and in 
agar plates All media were autoclaved immediately after preparation (30 min, 121 °C, 1.5 bar) and 
were kept under sterile conditions until inoculation. Kanamycin (35 µg/ml en concentration) was 
added  prior  to  inoculation  in  order  to  select  for  the  pET28a  vector.  Any  further  selection 
requirements imposed by the corresponding strain were also fulfilled.





24 g/L Bacto-Yeast Extract
4 mL Glycerol (87%)








5 g/L Bacto Yeast Extract
10 g/L NaCl





Protein buffers were used to purify and store native or refolded proteins.
AM buffer (pH 8) AMI buffer
20 mM Tris/HCl AM buffer
200 mM NaCl 500 mM imidazole
AME buffer AML buffer
AM buffer AM buffer
10 mM EDTA 50 mM lactose
Phosphate buffer pH 5.8 Phosphate buffer pH 2.5
50 mM KH2PO4/K2HPO4  pH 5.8 50 mM KH2PO4/HCl pH 2.5
200 mM NaCl 200 mM NaCl
Table 4.8: protein buffers.
4.4.2.2 Washing buffers:
Washing buffers were used for the isolation and enrichment of inclusion bodies.
Washing buffer  1




0.75 % (v/v) LDAO
Washing buffer 2








Denaturing buffers were used to solubilize and purify protein from inclusion bodies.
Denaturing buffer 1
AM buffer
6 M guanidinium chloride
Denaturing buffer 2
AM buffer
6 M guanidinium chloride
500 mM imidazole
Table 4.10: Denaturing buffers.
4.4.2.4 Analytical buffers:
Analytical  buffers  were  used  during  experiments  to  increase  stability  under  experimental 
conditions, or to provide the corresponding ligands or metal ions necessary for binding experiments.
Fluorescence buffer
0.1 M K2HPO4/KH2PO4 pH 5.2
5 mM CaCl2
1 mM EDTA
Transition buffer (pH 8 – 2.5)
50 mM K2HPO4/KH2PO4/HCl




The refolding buffer provided adequate conditions for preparative folding of denatured protein by 
rapid dilution.
Refolding buffer
50 mM HEPES pH 7.5
0.5 mM Arginine
6 mM Glutathione (GSH)
4 mM Di-glutathione (GSSG)
Table 4.12: Refolding buffer.
4.4.2.6 Buffers for the preparation of chemically competent cells
TFB I TFB II
100 mM RbCl 10 mM MOPS
50 mM MnCl2·2H2O 10 mM RbCl
30 mM KOAc 75 mM CaCl2·2H2O
10 mM CaCl2·2H2O 15 % (v/v) Glycerol
15 % (v/v) Glycerol
Table 4.13: Buffers for preparation of chemically competent cells.
4.4.3 Stock solutions:
4.4.3.1 Agarose gel electrophoresis stock solutions:
Agarose gel 6x DNA Loading buffer
1 % (w/v) Agarose 0.25 % (w/v) Xylencyanol FF
TBE buffer 1.5 % Ficoll Type 400
10x TBE buffer Ethidium bromide bath
1 M Tris 200 ml distilled H2O
1 M Boric acid 200 µg Ethidium bromide
20 mM EDTA
Table 4.14: Solutions for agarose gels.
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0.625 M Tris/HCl pH8
Resolving gel buffer
1.125 Tris/HCl pH 8.0




1 % (w/v) SDS
Protein loading buffer
62.5 mM Tris/HCl pH6.8
15 % (w/v) Glycerol
4 % (w/v) SDS
0.001 % (w/v) Bromophenol blue
4 % (v/v) β-Mercaptoethanol
Staining solution
0.25 % (w/v) Coomasie brilliant blue R250
5 % (v/v) Acetic acid
50 % (v/v) Ethanol
De-staining solution
5 % (v/v) Acetic acid
28 % (v/v) Isopropanol
Table 4.15: Stock solutions used during SDS PAGE
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4.4.3.3 Buffers for western blotting
Blotting buffer Blocking liquid
25 mM Tris/Hcl pH 8 5 g/l Blocking reagent 
150 mM Glycine 1 X Blocking buffer 
10 % (v/v)Methanol 0.1 % (v/v) Tween-20 
Fixing reagent Ink staining solution
20 g/l K2S2O5 2 % (w/v) Ink (blue) 
100 g/l Na2S2O3·5H2O 1% (v/v) Acetic acid 
TBS buffer TBS-T buffer
50 mM Tris/HCl 20 mM Tris/HCl pH 7.5 
138 mM NaCl 150 mM NaCl 
2.7 mM KCl 0.1 % (v/v) Tween-20 
Table 4.16: Buffers for western blotting.  
The blocking buffer was commercially obtained  




12.5 mg/mL Tetracycline in isopropanol
50 mg/mL Streptomycin 
Other stocks
1 M IPTG





All methods employed to manipulate, modify and obtain DNA will be described in the following 
sections.
5.1.1 DNA synthesis methods
5.1.1.1 Polymerase chain reaction (PCR)
The  PCR  method  is  based  on  the  temperature-dependent  activity  of  DNA polymerases  from 
thermophilic  organisms, and their dependence on specific primers for initiation of replication[159]. 
By repeating several cycles of DNA melting, primer annealing and elongation, the desired DNA 
fragment is exponentially amplified from a template, such as genomic DNA or a cDNA library.
In order to calculate the proper temperatures and times for the reaction, the following factors were 
taken into account, as described in the Phusion-polymerase user manual (Invitrogen). 
1. The  melting  temperature  for  the  primers  was  calculated  by  the  nearest  neighbor 
method[160].
2. The annealing temperature was calculated as the lowest melting temperature of the two 
primers plus 3 °C.
3. The elongation times were calculated by  providing 15-30 seconds per kilobase of desired 
amplified product. 
In table 5.1 a sample mix is given, while in table 5.2 a cycling program is described.
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N° of cycles Step Temperature (°C) Time (sec)









1 Elongation 72 600
Table 5.2:Example of a PCR program. Two sets of cycles provide initially relaxed conditions to  
obtain large amounts of template and final stringency for increased specificity.
5.1.1.2 Site-directed mutagenesis
Site-directed  mutagenesis  was  performed  in  a  Biometra  T  personal  thermal  cycler.  in  which 
complementary primers were used to  amplify an entire  circular  DNA molecule[161].  The PCR 
protocol was analogous to the one described in section 5.1.1.1, with the exception that the melting 
temperature of the primer was taken as annealing temperature, and the elongation time was always 
kept at 30 seconds per kilobase. The PCR was immediately followed by a DpnI restriction, which 
digests methylated, i.e. parental, DNA, but leaves unmethylated DNA intact. The digestion took 
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Component Volume (µl) Final concentration
5X Phussion HF-Buffer 10 1 X
10 mM dNTPs 1 0.2 mM
10 µM Fwd.-Primer 1.25 250 nM
10 µM Rev. Primer 1.25 250 nM
~0.3 g/l Template 1 µl 6 mg/l
2 U/µl  Phusion Polymerase 0.5 µL 0.02 U/µl
Double distilled H2O ad 50 µl 
Table 5.1: Sample composition of a PCR mix.
Methods
place by adding 1 µl DpnI at 37 °C for 1 h. The digestion mix was then desalted by dialysis at RT 
for 1 hour against  double distilled water and finally used to transform electrocompetent  E. coli 
DH5α cells.
5.1.2 Cloning
5.1.2.1 Digestion with restriction enzymes
Type II restriction enzymes are widely  used at preparative scales to produce sticky ends in DNA 
fragments, which facilitate directional ligations between inserts and vectors. Analytical digestions 
are also common for quick identification of unsequenced DNA molecules.
Preparative digest mixtures (Table 5.3) were incubated at 37 °C for 4 hours and were either  PCR 
purified or loaded onto a preparative 1 % agarose gel. Analytical digestions were only allowed to 
proceed for one hour before agarose gel electrophoresis.
Component (concentration of stock) Preparative (µl) Analytical (µl)
DNA fragment (53 ng/µl) 30 4
NcoI 2 0.25
XhoI 2 0.25
10 X NEB4 5 1
100 X BSA solution 0.5 0.1
Double distilled H2O ad to 50 3.4
Table 5.3: Exemplary digestion of DNA.
5.1.2.2 Ligation
The active enzyme catalyzing DNA ligation was the ATP-dependent  T4-DNA-ligase.  Reactions 




Digested vector 25 fmol
Digested insert 125 fmol
T4-DNA-ligase 1 µl
Double distilled H2O Add to 9 µl
10 X T4-ligase buffer 1 µl
Table 5.4: Composition of a ligation sample.
5.1.2.3 Transformation
During electro-transformation, cells are electroshocked using a very short pulse with high potential,  
which permeabilizes the cells and allows for DNA to enter the cytoplasm. 10 µl of the ligation assay 
were dialyzed against double distilled water for 1 hour to avoid salt derived short-circuits during 
transformation. Two transformations were performed, one with 1 µl of the sample, and one with the 
rest.  The  desired  volume  of  the  ligation  assay  was  pipetted  into  a  50  µl  aliquot  of  chilled 
electrocompetent E. coli DH5α and transferred into a 0.2 cm electroporation cell. The sample was 
then pulsed in an electroporator for 4.5 – 6 ms, 950 µl LB-Medium were swiftly added and the cells  
were finally incubated for 1 h at 200 rpm in  a 37 °C shaker. Subsequently, cells were plated on LB-
agar plates containing the necessary selection markers.
For chemical transformation, either E. coli DH5α, BL21(DE3)Gold, Origami 2 or Shuffle T7 cells 
were used. 50 µl aliquots of these were incubated with 1 µl DNA solution for 0.5 h on ice, then  
heat-shocked for 90 s at 42 °C, resuspended in 950 µl LB -medium and subjected to the same 
growth conditions as the electroporated cells.
5.1.3 DNA Isolation methods
5.1.3.1 Qiagen methods
PCR purification, gel extraction and plasmid preparation kits were purchased from  Qiagen,  and 
their protocols were followed as described in the manufacturer's manual. 
5.1.3.2 Plasmid preparation by the “quick & dirty” method
The quick & dirty method is based on the selective alkaline lysis[162].
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A pelleted  5  ml  LB medium overnight  cell  culture  was  treated  with  250  µl  P1 buffer,  which 
destabilizes cell walls and brakes down RNA molecules. Subsequently, 250 µl P2 buffer were added 
to disrupt the cell membrane and lyse the cells. This step was followed by careful inversion of the 
vial, so as to ensure maximum mixture and avoid fragmentation of genomic DNA. 300 µl P3 buffer 
were added, which produces insoluble potassium complexes of dodecyl-sulfate with large DNA 
molecules,  while  the  small  ones  remain  in  solution.  The  suspension  was  then  centrifuged  at 
~17000g for 30 min. 
The supernatant was removed and mixed with 600 µl isopropanol. A second 17000g centrifugation 
step for 30 min followed, the supernatant was discarded and the small pellet kept. The pellet was 
washed with 70 % ethanol and centrifuged again at 17000g for 10 minutes. The supernatant was 
carefully removed, and the remaining pellets were dried further at 37 °C for ~30 min. Finally, the 
dried pellets were redissolved into EB buffer and stored at -20 °C.
5.1.4 Agarose gel electrophoresis
DNA fragments were separated by the method of gel electrophoresis (1 % agarose gels in TBE 
buffer)  performed at 100 - 120 V, 300 mA for 1 h. Bands were subsequently visualized by soaking 
in the ethidium bromide bath and exposure to UV light (254 nm). 
5.1.5 Cell preparation methods
5.1.5.1 Preparation of chemically competent E. coli cells
The following method was successfully performed with all strains discussed in this work. 
50  ml liquid LB medium was inoculated with a single fresh colony from a new LB-agar plate. Cells 
were left to grow overnight at 37 °C and 200 rpm. 100 ml liquid LB medium were  subsequently 
inoculated with 1 ml of the overnight culture. The culture was grown at 37 °C and 200 rpm until 
densitometric measurements showed OD600=0.5 – 0.6.
The cells were then immediately cooled on ice and centrifuged (12300g, 10 min, 4 °C). The pellet  
was resuspended in 30 ml TFB I buffer. After 2 h incubation time on ice, the cells were again 
centrifuged (12300g, 5 min, 4 °C) and resuspended in 4 ml chilled TFBII. The suspension was then 
divided into 50 µl aliquots in Eppendorf cups, shock frozen in liquid nitrogen and stored at -80 °C.
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5.1.5.2 Preparation of electrocompetent DH5α cells
1 l liquid LB medium was inoculated with 1 ml of an overnight culture and incubated at 37 °C and 
200 rpm until an OD600=0.7 – 0.9 was reached. The culture was chilled for 20 min on ice and 
centrifuged (12300g, 10 min, 4 °C). The pellet was resuspended in 450 ml chilled, sterile, double 
distilled water and centrifuged again as described, after which the process was repeated. The pellet 
was then resuspended in 450 ml sterile and chilled 10 % (v/v) glycerol and pelleted as above. 
Finally, the cells were resuspended in 2.5 ml sterile and chilled 10 %  (v/v) glycerol and divided in  




5.2.1 Recombinant gene expression
Expression  cultures  were  used  to  produce  recombinant  protein  for  structural,  biophysical  and 
functional characterization.
5.2.1.1 Analytical expression
Analytical expression was used to determine optimal expression conditions for each of the de novo 
cloned expression cassettes. Table  5.5 shows all conditions tested for each new construct. In all 
cases, culture volume was 50 ml in 250 ml Erlenmeyer flasks with an inoculation volume of 0.5 ml 
overnight pre-culture. All samples where shaken at 225 rpm.
Construct;  expression 
strain




E. coli BL21 (DE3) Gold
LB IPTG 0.1 / 1 4 h/37 °C; 36 h/18 °C; 
16 h/25 °C
TB autoinduction 0 24 h /37 °C; 36 h/18 °C
pET28a_Epa1→6A/2A/3A; 
E. coli Shuffle T7
LB IPTG 0.01 / 0.1 / 1 72 h/12 °C
TB autoinduction 0 72 h/ 12 °C; 24 h/ 37 °C
pET28a_Epa1→6A/2A/3A;
E. coli Origami 2
LB IPTG 0.01 / 0.1 / 1 72 h/ 12 °C
TB autoinduction 0 72 h/ 12 °C; 24 h/ 37 °C
Table 5.5: Overview of performed analytical expressions. All expressions were shaken at 225 rpm.
Cells were harvested by centrifugation at 4220g for 20 minutes at 4°C in falcon tubes. Supernatant 
was discarded, while the pellets were frozen at -20 °C.
5.2.1.2 Preparative expression
Preparative expressions were either directly upscaled from the best analytical expression conditions, 
or taken as such from previous work. All expressions were scaled in 5 L Erlenmeyer flasks shaken 
at 160 rpm. Table 5.6 shows the chosen expression conditions for all constructs.
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Construct; Strain Medium Type  of 
induction




Volume of culture 
per flask (l)
pET28a_SabA260; 
E. coli BL21 (DE3) Gold
LB IPTG 36 h/ 18 °C 1 1
pET28a_BabA210;
E. coli BL21 (DE3) Gold
TB IPTG 36 h/ 37 °C 1 3
pET28a_BabA235
E. coli BL21 (DE3) Gold
TB IPTG 36 h/ 37 °C 1 3
pET28a_BabA 255;
E. coli BL21 (DE3) Gold
TB IPTG 36 h/ 37 °C 1 3
BabA2.2_5;
E. coli BL21 (DE3) Gold
TB IPTG 36 h/ 37 °C 1 3[164]
pET28a_Epa1_2wt;
 E. coli Origami 2
LB IPTG 72 h/ 12 °C 0.01 2[155]
pET28a_Epa1_2wt;
E. coli T7 Shuffle
LB IPTG 72 h/ 12 °C 0.01 2
pET28a_Epa1→2A;
E. coli T7 Shuffle
LB IPTG 72 h/ 12 °C 0.01 2
pET28a_Epa1→3A;
E. coli T7 Shuffle
LB IPTG 72 h/ 12 °C 0.01 2
pET28a_Epa1→6A;
E. coli T7 Shuffle
LB IPTG 72 h/ 12 °C 0.01 2
Table 5.6: Overview of performed preparative expressions. Shaker speeds were set to 160 rpm.
After expression was complete, cells were pelleted for 10 minutes at 4 °C and 8000 rpm in a JA-10 
rotor.  Pellets  were resuspended in 20 ml AM-buffer per liter  of culture,  shock frozen in liquid 
nitrogen and stored either at -20 °C for short term or at -80 °C for long term storage.
5.2.2 Cell lysis
Depending on the intended use of the cell extract, different methods of cell lysis were employed.
5.2.2.1 Analytical cell lysis through sonication
Analytical expressions had to be tested not only for protein production, but also for proper protein 
folding.  Unfolded  or  mis-folded  proteins  usually form  insoluble  inclusion  bodies,  therefore, 
separating and analyzing the soluble and insoluble fractions of cell extracts is a good criterion for 
the identification of conditions leading to the expression of correctly folded proteins.
Pelleted cells were thawed and resuspended in 3 ml cold AM-Buffer. 1 ml of the suspension and 2 
55
Methods
µl 50 mg/ml lysozyme were then pipetted into a 1.5 ml Eppendorf cup and incubated for 10 minutes 
on ice.   Cells  were  lysed  by sonication  for  a  total  of  90  pulses  divided evenly  into  3  rounds 
separated by ~30 seconds pauses. Soluble and insoluble fractions were separated by centrifugation 
(17000g, 30 minutes, 4 °C). The supernatant was then decanted into a new Eppendorf cup, while the 
pellet was resuspended in 1 ml AM-buffer. 10 µl of each were mixed with 10 µl protein loading 
buffer and incubated at 95 °C for 5 minutes. 5 to 10 µl of each were then loaded on a 12 % SDS-
PAGE-gel.
5.2.2.2 Preparative cell lysis to obtain inclusion bodies 
20 ml of a thawed aliquot from a preparative culture (5.2.1.2) were treated with 200 µl 0.1 M EDTA 
(1 mM final concentration), 120 µl 0.1 M PMSF (0.6 mM final concentration) and 480 µl of a 100 
mg/ml  lysozyme  solution  (1.2  mg/ml  final  concentration).  The  assay  was  incubated  at  room 
temperature for 20 minutes with occasional shaking. 
Then 2 ml 30 % LDAO (3 % final concentration) were added, and the sample was incubated for 
further 30 minutes at 37 °C with mixing at 225 rpm. Finally a spatula tip of freeze dried DNAseI 
was dissolved in the cell extract, followed by a further 30 minutes incubation at RT. This last step 
was  repeated  for  as  long  as  no  DNA  (identifiable  by  its  high  viscosity  and  its  milky  and 
mucilaginous consistency) was observable in the sample. Once the suspension had been properly 
clarified, a centrifugation step followed for 30 minutes (15000 rpm, 4 °C, JA-20), after which the 
supernatant was discarded and the pellet was either stored at -20 °C or further processed to isolate 
inclusion bodies.
5.2.2.3 Preparative cell lysis to obtain soluble protein using the French press
The heat sensitivity of soluble proteins often makes their cellular extraction challenging. The use of 
the French press (Sim Amico) offers a fast and efficient alternative for cell wall disruption, since the 
pre-cooling of the steel cell provides protection against heat denaturation to the cytoplasmic lysate. 
An aliquot of the cell suspension was thawed and treated with 50 µl 50 mg/ml lysozyme and a 
spatula tip of freeze dried DNAseI. The suspension was loaded on the pre-cooled pressure cell  
immediately afterwards, and the cell was operated at a maximum pressure of 6895 kPa (1000 psi). 
After two rounds,  the cell  lysate was centrifuged for 1 h in  a JA-20 rotor  (18000 rpm, 4 °C),  
supernatant was kept for purification, while the pellet was discarded.
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5.2.2.4 Preparative cell lysis to obtain soluble protein using the emulsifier C5 
The emulsifier C5 (Avestin) works similarly to the French press, but allows for  the processing of 
much  larger  volumes.  However,  it  is  more  prone  to  clotting,  and  requires  much  more  diluted 
suspensions. As such, it was mainly used to lyse cell extracts containing SabA gene products from 
long auto-inductions, which had to be diluted to ~300 ml with AM buffer before effective cell lysis 
could take place. The sample was treated analogously as with the  French press, with maximum 
pressures between 50000 and 100000 kPa (7252 – 14503 psi) and a centrifugation step which lasted 
for 3 h.
5.2.3 Protein purification
5.2.3.1 Isolation of inclusion bodies
To isolate inclusion bodies, the insoluble fraction of the cell extracts were homogenized with a  
potter homogenizer using 6 wash steps.
Wash step Composition Final concentration 
1 to 3 20 ml AM buffer
200 µl 0.1 M EDTA 1 mM
60 µl 0.1 M PMSF 0.3 mM
500 µl 30% (w/v) LDAO 0.75%
4 20 ml AM buffer
200 µl 0.1 M EDTA 1 mM
60 µl 0.1 M PMSF 0.3 mM
5 and 6 20 ml double distilled H2O
Table 5.7: Composition of washing buffers for the isolation of inclusion bodies
After wash steps 1 to 5 the suspension was centrifuged for 20 minutes (4 °C, JA-20, 18000 rpm) 
and re-homogenized for 5 minutes in the next buffer. After the sixth wash-step, the suspension was 
divided into 10 2 ml Eppendorf cups and pelleted for 30 minutes at 13000 rpm. The supernatant was 
discarded and the pellets were kept at -20 °C for further use.
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5.2.3.2 Immobilized metal affinity chromatography: NiNTA 
Cloning of  adhesin-encoding inserts  into the pET28a vector  allowed for  the fusion of all  gene 
products with either a C- or N-terminal His-Tag compatible with affinity purification by means of 
NiNTA chromatography[165]. Soluble proteins were purified under native conditions and insoluble 
proteins had to be purified under denaturing conditions; a  3 ml  Ni-NTA column was used in all 
cases. Elution was monitored with a UV absorption detector (280 nm detection).
For native proteins, the column was equilibrated with 5 column volumes (CV) of water and 5 CV of 
AM buffer. The cell extract was then sterile-filtered and loaded onto the column via a  peristaltic 
pump, operating overnight with a speed of 0.5 ml/min. Next day, the column was attached to either 
the Äkta Prime or the Äkta Purifier FPLC systems and first washed with a minimum of 10 CV of 
AM-buffer. Washing continued with AM buffer containing 5 % AMI buffer. In case any impurities 
eluted from the column, the washing procedure was continued until impurities were completely 
eliminated. Finally, a 5 CV gradient to 100 % AMI buffer was used to elute the purified protein,  
which was fractioned in 1 – 2 ml fractions. The column was rinsed with 5 CV AMI buffer, 5 CV 
water and 5 CV 20 % EtOH (v/v) for storage. All steps took place at 4 °C.
For protein  stabilization from inclusion bodies cell pellets were thawed and resuspended with a 
potter homogenizer in 35 ml  denaturing buffer 1. The suspension was then heated to 75 °C for 20 
minutes in a water bath, then left to cool down and sterile filtered. 6 ml 50 % (w/v) NiNTA material  
suspension in 20 % (v/v) ethanol was centrifuged for 5 minutes at 750g and RT with the supernatant 
being discarded. The pelleted NiNTA material was centrifuged twice after being washed first with 
15 ml water, and then 15 ml denaturing buffer 1. The NiNTA material was then mixed in the protein 
solution. The mixture was incubated with light shaking overnight at RT. The next day, the material 
was packed into a chromatographic column, attached to an FPLC system at RT and purified in the 
same way as described for native proteins, replacing AMI buffer with denaturing buffer 2.
5.2.3.3 Size exclusion chromatography
Size exclusion chromatography was the method of choice to polish pre-purified protein after the 
NiNTA step. The gel filtration system was composed of Superdex 200 material, which is composed 
of a dextran and  cross-linked agarose matrix (figure  5.1)[166], packed in an XK 16/70 130 ml 
column.  Using either the Äkta prime, Äkta purifier (GE) or an FPLC (Pharmacia Biotech),  the 
column was equilibrated first with 1.5 CV water and then with 1.5 CV of the corresponding buffer. 
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Elution was detected by absorption at 280 nm. 
Desalting columns are a  special  form of  gel  filtration in  which the 
matrix is very tightly packed, only allowing small molecules to enter 
the beads,  thus proteins are eluted in the exclusion volume. Buffers 
could  be  exchanged  by  using  PD-10  desalting  columns  (GE 
Healthcare)  and  illustra  MicroSpin  G50  columns  (Amersham 
biosciences).  PD-10  columns  were  equilibrated  as  described  in  the 
manual  [167], but were then loaded with 500 µl protein solution and 
eluted in fractions of 500 µl. Protein rich fractions were detected at the 
nano-drop  spectrophotometer  and  pooled.  Illustra  MicroSpin  G50 
colums were equilibrated with 2 times 200 µl of the target buffer and 
then packed, loaded and eluted as described in the manual [168].
5.2.4 Protein concentration
Amicon  Ultra-4  (Millipore)  concentrators  were  used  to  concentrate  pooled  fractions  from  the 
purification and refolding steps. The concentrators were chosen to have at least a 10 kDa smaller 
MWCO than the target protein to be concentrated. Concentrators were first rinsed for 5 minutes at 
4220 g and 4 °C for native or refolded proteins  and at RT for denatured proteins, with the same 
buffer in which the protein had been pooled. The protein solution was then loaded and concentrated 
to the desired concentration by the same procedure. Concentration was measured by absorption at 
280 nm.
5.2.5 Protein refolding
Protein refolding is always a two component system, comprising on the one hand the solubilized, 
denatured  and purified protein in denaturing buffer, on the other, the refolding buffer which forces 
the protein to undergo proper folding. The two components can be mixed in two ways: 1)  either 
through  dialysis,  which  consists  of  two  separate  compartments  joined  by  a  semipermeable 
membrane with a MWCO that only allows for small molecules to pass  through, and 2) by rapid 
dilution, where a small amount of concentrated protein solution is mixed with a large volume of 
refolding  buffer  and incubated  for  a  certain  amount  of  time. Refolding buffers  are  not  always 
optimal for further biochemical  and or biophysical  characterization,  as  they may interfere with 
analytical measurements or crystallization, therefore it is sometimes necessary to introduce a third 
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Figure  5.1:  Structures  of  
dextran  (a)  and  agarose  
(b). Source: [166]
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step in which the protein is loaded onto a desalting column.
5.2.5.1 Analytical protein refolding by microdialysis
Different refolding  and  storage  buffers were  screened  for  optimal  conditions   by  analytical 
microdialysis.  The  setup  for  microdialysis  consisted  of  a  microdialysis  unit  with  a  sample 
compartment filled with 10 µl of 5 mg/ml protein solution in denaturing buffer 1 sealed with a small 
piece  of  snakeskin  dialysis  membrane 
(Thermo  Scientific)  with  a  MWCO  of  3.5 
kDa  The  loaded  microdialysis  units  were 
sunk into VDX 24 well crystallization plates 
filled  with 1.5 ml  refolding  buffer  in  each 
well. The setup is depicted in figure 5.2. 
All assays were tested at 4 °C and incubated 
for  at  least  12  hours, before the  unit  was 
removed  from  the  well.  The  dialysis 
membrane  was  carefully  set  aside  and  the 
solution or suspension, depending on the amount of precipitate, was transferred into an Eppendorf 
cup.  The samples were then centrifuged at 17000g for 1 hour, the supernatant was transferred to a 
fresh Eppendorf cup and mixed with 10 µl of protein loading buffer. The pellets were resuspended 
in 20 µl protein loading buffer, with both samples loaded on the large PerfectBlue two-gel system 
Twin  M  (PEQLAB).  Alternatively,  protein  concentrations of  the  supernatant  and  pellet  were 
spectrophotometrically determined  by the BCA test, and  refolding  yields were determined from 
those.
Table 5.8 shows the tested storage buffers. Refolding buffers tested by this method were based on 
the original BabA full length refolding protocol and all comprised the same buffer system: 200 mM 
NaCl and 10 mM phosphate buffer with pHs ranging from 7.8 to 3.8.
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Figure 5.2: Microdialysis setup  
(Source: www.hamptonresearch.com)
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Buffer system pH Additives tested
50 mM Tris/HCl 6, 7 200 mM NaCl 
5 % Glycerol 
5 % PEG 400 
50 mM CHES 8, 9 200 mM NaCl 
5 % Glycerol 
5 % PEG 400 
50  mM  Acetate 
buffer, 200 mM NaCl
3.4.5  20 mM CaCl2
20 mM MgCl2 
 20 mM MnCl2
5 % Glycerol
Table 5.8: Tested storage buffer conditions for refolding trials of BabA fragments. All conditions  
were tested with and without 1 mM β-mercaptoethanol as a reducing agent.
Promising  conditions  were  upscaled  to  1  ml  by  using  Slide-A-Lyzer  cassettes.  Supernatant 
concentrations were tested via absorption measurements and sample quality via circular dichroism 
(CD) spectroscopy.
5.2.5.2 Analytical protein refolding by rapid dilution
Analytical rapid dilution took place at the micro-scale through the commercially available iFold 
screen (Merck), as depicted in Figure 5.3.
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Figure 5.3: Ifold Protein refolding system 2.  
(Source:www.merck-chemicals.de)
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Folding  efficiency  was  controlled  as  described  [169],  but  it  was  also  further  confirmed  by 
reproducing folding  conditions  in  a  1  ml  scale  followed by analytical  desalting  either  through 
microdialysis or PD-10 (GE Healthcare) desalting columns. Effects from the addition of RedOx 
buffers were also tested, by reproducing promising conditions with either 6 mM GSH to 4 mM 
GSSG or 9 mM GSH to 1 mM GSSG.
5.2.5.3 Preparative protein refolding through dialysis
The BabA full length gene product was refolded by dialyzing a sample of purified protein at ~1.5 
mg/ml against 10 mM phosphate buffer pH 7.8, 300 mM NaCl, 0.05 % LDAO at a 1:300 ratio 
overnight.  The  resulting  suspension  was  centrifuged  at  100000g  for  30  minutes,  concentrated, 
sterile filtered and kept at 4 °C for further analysis[164].
5.2.5.4 Preparative protein refolding through rapid dilution
BabA fragments 210, 235 and 255 where refolded by adding a 5 to 8 mg/ml aliquot of purified 
protein in denaturing buffer 1 to refolding buffer in a 1:25 ratio and incubating for at least 24 h. The 
sample was then concentrated to ~0.5 ml, desalted with PD-10 columns to phosphate buffer pH 2.5, 
sterile filtered and kept at 4 °C for further analysis.
5.2.6 Estimation of protein concentration
Protein  concentration  was  calculated  by  absorption  at  280 nm and  usage  of  the  Lambert-Beer 
equation (eq. 5.1).
Using the appropriate protein sequence, the theoretical molar extinction coefficient was calculated 
by the expasy prot-param server[170], and used for protein concentration estimation.
Alternatively, protein concentrations were measured by the BCA test as described in [171].
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Proteins in denaturing buffers could not be loaded directly onto SDS gels, as the guanidinium ions 
formed insoluble complexes with SDS, co-precipitating the proteins in-situ. Samples from refolding 
assays and purification under denaturing conditions had to be precipitated and re-solubilized in a 
compatible buffer prior to SDS-PAGE analysis. 
One tenth of the sample volume of 72 % (v/v) trichloroacetic acid (TCA) was pipetted into the 
sample to a final concentration of 6.5 %. Samples were kept on ice for 1 hour, then centrifuged at  
17000g for another hour. Supernatant was discarded, pellets resuspended in protein loading buffer 
and  heated  for  5  minutes  at  95  °C.  If  the  buffer  turned  yellow upon  contact  with  the  pellet, 
indicating excessive acidification,  drops  of 1  M Tris/HCl pH 8 solution were pipetted into the 




The standard methods of SDS-PAGE and subsequent staining with Coomasie  Brilliant Blue  were 
used as described by Laemmli[172] and Bennett[173]. 
5.3.1 Western blotting
Western  blotting  is  an  analytical  method  by  which  proteins  immobilized  on  a  nitrocellulose 
membrane are immunostained with enzyme-coupled antibodies[174]. The advent of protein tagging 
facilitated enormously the usage of monoclonal antibodies, as they could be synthesized in large 
scale to react against common tags,  such as the His-tag.  As all investigated proteins in this work 
were  his-tagged,  commercially  available  monoclonal  anti-histag  antibodies  conjugated  with 
horseradish peroxidase could be used to detect them. 
Protein concentration was either estimated by absorption at 280 nm or via a previous Coomassie 
stained SDS-gel. In both cases, around 5 µg of total protein for each sample were loaded on an 
SDS-gel,  and  an  SDS-PAGE  was  run.  The  gel  was  not  stained,  but  set  in  contact  with  a 
nitrocellulose membrane in a sandwich setup with four Whattman papers in a semi-dry western 
transfer  system  (PEQLAB).  The  membrane  and  the  papers  had  been  previously  activated  by 
incubating for 30 minutes in blotting buffer at RT. Transfer took place for 1 h and 15 minutes at 5 V 
and 62 mA per  gel.  The membrane was then  stained with ink;  protein  marker  and lanes  were 
carefully noted, and the membrane was destained with 0.1 M NaOH and water. 
Two washes with TBS and once with TBS-T each for at least  10 minutes followed, before the 
membrane was immersed in blocking liquid (overnight at 4 °C or for 1 h at RT). The next day, the 
membrane underwent three further washing steps, before addition of blocking liquid, supplemented 
with  1:3000  anti-PENTA-His-HRP-conjugate  antibody  (Qiagen). The  membrane  was  then 
incubated in the antibody solution for 1 h at RT. Antibody solution was kept for further Western 
blots,  while  the membrane was slightly dried and prepared for  detection by carefully  pipetting 
luminol solution on it and incubating for 2 minutes at RT.
The luminescent membrane was encased in a chamber in which auto-radiographic film was exposed 
to it for different times, ranging from 1 to 10 min. The exposed films were then developed in a dark 
room using  Kodak developer  solution  D19,  diluted  acetic  acid and fixing solution,  and  finally 




CD spectroscopy is based on the optical isomers'  property of interacting differentially with light. 
When  an  enantiomeric  chromophore  interacts  with  linearly  polarized  light,  the  two  circularly 
polarized components of the wavelength will be differently absorbed,  thus giving rise to circular 
dichroism. Although optical activity is normally given by the configuration of asymmetrical carbon 
centers, polymers composed of optically active monomers, such as proteins,  also show distinct 
polarized-light-interaction  behaviors  that  can  be  correlated  with  structural,  i.e.  conformational, 
features. The chromophores responsible for protein circular dichroism are the peptide bonds, which 
interact mainly with far UV light (180 – 260 nm), and aromatic side chains, which are responsible 
for absorption in the near UV range (260 – 320 nm). The asymmetric environment of peptide bonds 
is  provided  mainly  by  secondary  structures,  while  the  tertiary  structure  is  responsible  for  the 
differential absorption of aromatic amino acids. Structural information derived from far UV spectra, 
as  the  ones  presented  in  this  work,  are  especially useful in determining the  overall  secondary 
structure of a protein, while near UV spectra offer more information on the general folding of  the 
protein[175]. 
So called melting curves are able to provide information about the stability and dynamics of a 
protein fold. Melting curves are executed by measuring ellipticity, the traditional signal of circular 
dichroism, at a single wavelength versus temperature. As protein folding is temperature-dependent, 
and  absorption  behavior  is  fold-dependent,  it  is  possible  to  track  protein  denaturation by  this 
method. A melting curve provides then both information on the stability of the protein, through the 
melting point, and on the quality of folding, due to its curve shape[176]. 
Both, far UV spectra and melting curves, were measured on a JA-18 CD spectrometer (Jasco) for 
the assessment  of  fold quality  under  different  conditions, and to  assess environment-dependent 
conformational  changes undergone by sample proteins.  To assess folding quality,  proteins were 
diluted into double distilled water to a final concentration of between 0.1 to 1 mg/ml, while for the 
evaluation of buffer dependent conformational changes, different methods were employed. Either 
the  proteins  in  storage  buffer  were  desalted  over  illustra  MicroSpin  G50  desalting  columns 
(Amersham) into transition buffer, or they were first diluted to 2 mg/ml into the transition buffer 
and  then  incubated for at least 2 h. In either case they were finally diluted to 0.1 - 0.3 mg/ml in 
double distilled water. Spectra were measured with settings as shown in table 5.9. Melting curves 
were  measured  directly  afterward (table  5.10),  finally  a  spectrum was  taken  after  the  cooling 
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procedure at both the initial and final temperature.
For data processing, observed ellipticities were converted to mean residue ellipticities :
 
5.3.3 Analytical gel filtration
Gel  filtration  can  provide  information  about  large  conformational  changes  within  a  protein, 
specially  differences  in  oligomerization  in  response  to  buffer  changes.  Analytical  gel  filtration 
differed from the preparative one mainly in bed and sample volume. The Superdex 200 150/10GL 
(GE  Healthcare) employed for these experiments has a total volume of ~3 ml, while the sample 
volume was kept at  50 µl.   50 µl of 1 – 3 mg/ml protein solutions where loaded into the pre-
equilibrated  column and  run  at  0.3  ml/min (table  5.11).  All  runs  were  performed  at  the  Äkta 
purifier, as it was the only system compatible with the analytical column. Elution was  followed by 
absorption measurements at 280 nm.
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Parameter Value
Wavelength range 190 – 260 nm
Data pitch 0.2 nm
Band width 1 nm
Response 1 sec
Sensitivity Standard
Scanning speed 50 nm/min
Accumulation 3
Temperature 10 °C / 95 °C
Table 5.9: Settings for far UV CD spectrum 
measurement
Parameter Value
Range 10 – 95 °C 
Data pitch 0.1 °C
Band width 2 nm
Response 1 sec
Sensitivity Standard
Temperature slope 2 °C/min
Monitored wavelength 208 nm
Table 5.10: Settings for melting curve analyses,  
both heating and cooling
eq. 5.2: []mrw ,=
MRW⋅
10⋅d⋅c













BabA fragments Phosphate buffer pH 5.8
Phosphate buffer pH 2.5
Table 5.11: Buffer employed for analytical gel filtrations for each protein.
5.3.4 High throughput glycan binding studies at the Consortium for Functional Glycomics.
The Consortium for Functional Glycomics (The Scripps Research Institute, La Jolla, USA) provides 
extensive  glycan  array  technologies  which  permit  high  throughput  qualitative  screening  of 
protein-carbohydrate interactions for a wide variety of carbohydrates (Appendix I). 
The arrays are printed on N-hydroxysuccinimide (NHS) activated glass slides by dripping ~0.6 nl 
amine coupled glycan solution in printing buffer (300 mM phosphate pH 8.5, 0.005% Tween-20) 
using automated equipment (Figure 5.4 shows the NHS amine coupling reaction). After 30 minutes 
reaction  time  under  an  80%  humidity  atmosphere,  a  blocking  step  of  1  hour  with  50  mM 
ethanolamine in 50 mM borate buffer pH 9.2 ended the reaction. Slides are then thoroughly rinsed 
with water, dried and stored in desiccators at room temperature before use[177].
BabA 235 was sent  to the CFG  for pH-dependent carbohydrate-binding screening in phosphate 
buffer, pH 2.5, at a concentration of 6 mg/ml. The protein was diluted directly before the assay to a 
final concentration of 200 µg/ml either in phosphate buffer pH 2.5 or phosphate buffer pH 5.8 and 
incubated for 2 hours. Binding experiments were performed on the cfg glycan array chip V 3.2 and 
monitored using fluorescently labeled anti-6xHis antibodies.
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Figure  5.4: NHS activated glass surface reacts with amine coupled carbohydrate. N-hydroxysuccinimide  
(NHS) is shown coupled to a blue block of glass. A primary amine coupled to a carbohydrate R acts as a  
nucleophile, substituting NHS, and producing an amide bond to the glass surface.
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Epa1A and variants where marked with the fluorescent dye Alexafluor 488 SPD (Invitrogen)[178] 
(Figure 5.5). 4 mg/ml protein solutions in 0.1 M sodium bicarbonate buffer pH 8.3 were mixed with 
7 µl  of  10  mg/ml  Alexafluor  488 SPD solution  in  DMF for  2  hours  at  RT.  Residual  dye  was 
eliminated with MicroSpin G50 desalting columns (Amersham biosciences) pre-equilibrated with 
AME buffer. Measurements were performed on the cfg glycan array chip V4.1 at concentrations of 
200 µg/ml for all  proteins and 50 µg/ml and 1 µg/ml additionally for Epa1A. Relative binding 
strength was measured directly over the signal from the  fluorescent dye. 
The experiment was performed by adding ~50 µl of  protein solution on the slide directly and 
covering  it  with  a  microscope  cover  slip.  Samples  were  incubated  for  30  to  60  minutes  in  a 
humidified chamber, after which they were washed frequently with the corresponding buffer, PBS 
buffer and PBS buffer containing 0.05% Tween-20 and deionized water. If the sample was to be set  
in contact with a labeled antibody.  The antibody was given at this point and the procedure was 
repeated[177]. Detection of Alexafluor 488 took place at 495 nm excitation wavelength and 519 nm 
emission wavelength.
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Figure 5.5: Reaction of Alexa fluor 488 Sulphodichlorophenyl (SPD) ester with a sample protein. The SPD  
group acts as a good salient group in a reaction at RT in basic aqueous medium in which the primary amines  
of a protein (red) attack nucleophilically the carbonyl group of the ester. The result is a coupling of the Alexa  
Fluor fluorophore on lysins and the N-terminus of almost any protein[178].
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5.3.5 Fluorescence spectroscopy 
Intrinsic fluorescence occurs in proteins lacking a cofactor when aromatic amino acids are excited 
by UV light (280 nm for tyrosines, 295 nm for tryptophanes) with emission maxima at around 320 - 
345 nm. Whenever an aromatic molecule absorbs a photon, it may relax either radiantly or non-
radiantly.  The  ratio  of  emitted  photons  per  absorbed  photon  is  the  quantum  yield  (Q)  of  the 
fluorophore. When a molecule interacts with the excited fluorophore, the molecule may relax it 
non-radiantly, thus decreasing the quantum yield; this phenomenon is known as quenching, and 
such a molecule is called a quencher. [179]
Ligands are in general good quenchers of protein fluorescence, and since the quench intensity is 
proportional to the concentration of the protein ligand complex, it is possible to calculate affinity 
constants by fluorescence titration. Usually, fluorescence titration is monitored by changes in the 
quenching percentage displayed by the selected protein (equation 5.3).
The quench is normally calculated for the wavelength with maximum emission, which is usually 
between 343 and 347 nm.
In order to perform a titration assay, two  protein solutions were prepared in fluorescence buffer. 
While one of them was carbohydrate free, the other contained the carbohydrate against which the 






q c : percentage of quench for ligand concentration c
FI c: fluorescence intensity for concentration c
FI 0 : fluorescence intensity at concentration 0
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Lactose titration
Component Protein solution Ligand solution
Protein 0.3 mg/ml 0.3 mg/ml
Glycan 0 mM 0.5/5/50 mM
CaCl2 5 mM 5 mM
EDTA 1 mM 1 mM
Table 5.12: Typical composition of the solutions necessary for lactose titration
T-antigen titration
Component Protein solution Ligand solution
Protein 0.01 mg/ml 0.01 mg/ml
Glycan 0 mM 0.1/1/10 mM
CaCl2 5 mM 5 mM
EDTA 1 mM 1 mM
Table 5.13: Typical composition of the solutions necessary for T-antigen titration
The titrations took place at an FP-6500 fluorescence spectrometer (Jasco) with settings as per table 
5.14.  500 µl  of carbohydrate-free protein solution were pipetted into a  round fluorescence cell 
(Hellma) containing a magnetic stirrer.  Carbohydrate containing solutions were kept on ice, and 
pipetted into the round cell (table 5.15). The stirrer was activated for a total of 90 sec, followed by 
30 sec incubation and the spectrum measurement.
Dissociation  constants  (Kd)  where calculated  by  ploting carbohydrate  concentration  against 
percentage of quench with either the total binding equation (equation 5.4).
The total binding equation accounts for specific binding, but also for non-specific, linear binding 









: Dissociation constant NS: non-specific binding constant.
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measure of non-specific binding strength.  High standard errors for the NS constant  may indicate 
that the non-specific binding is negligible.
Scatchard plots were performed as a quality control for the fitting systems. A Scatchard plot is 
performed by opposing quench on the x-axis against quench divided by concentration on the y-axis. 
The  resulting  representation  has  been  demonstrated  to  present  a  straight  line  defined  by  a 
-1/Kd slope  and  the  value  qmax/Kd   at  the  X-axis  intersection.  Non-linear  Scatchard  plots  are 
indicative either of cooperativity,  or of the presence of different types of binding events in the 
solution. Although it is theoretically possible to perform a proper fit of a non-linear Scatchard plot 
by  approximating  it  to  two  separate  linear  plots  and  some  relatively  sophisticated   manual 
adjustments[180], a non-linear regression of the raw data is more reliable, and statistically sound. In 
order to perform a non-linear regression for a data series that produced a non linear Scatchard plot,  
equation 5.5 is used.
Equation 5.5 assumes that the system presents two different kinds of binding sites, which could 
either  represent  a  monodisperse  protein  solution  where  the  protein  presents  a  primary  and  a 
secondary binding site, or a non-monodisperse solution, where a protein with a single binding site is 
in  two different  states[181].  The results  is  that  a  single  system is  defined by two dissociation 
constants, Kd1 and Kd2. The challenge while using such an equation for non-linear regressions is that 
there are many possible solutions, most of which do not have any biological relevance. In order to 
improve  the  fitting  process,  it  is  important  to  obtain  good  starting  values  for  all  unknown 
parameters.  Such  values  where  calculated  using the  preliminary  constants  derived  from linear 
regressions of the data as presented in the Scatchard plot.
During the process of evaluating the experimental data, the simpler model offered by equation 5.4 































Table 5.14: Sample titration of epa1A against  
lactose. Protein concentration was kept  
constant, while the carbohydrate ligand was  
varied.
Parameter Value
Excitation wavelength 295 nm
Emission range 300 – 400 nm
Band width excitation 3 nm
Band width emission 5 nm
Response 0.5 sec
Sensitivity Medium  or 
high
Data pitch 0.5 nm
Scanning speed 500 nm/min
Accumulation 3
Temperature 10 °C





Reproducibility  of  crystals  and  diffraction quality can  be  important  limiting  factors  when 
determining the crystal  structure of a  protein.  Initial  screening conditions were purchased from 
Qiagen, and utilized  the sparse matrix screening strategy[182], each of the screens tested (see 
reference [183]) contained 96 different conditions. The sparse matrix methodology demands the use 
of aqueous solutions of different buffers, precipitants and salts that have been empirically shown to 
lead to successful crystal growth. This method has proven i's usefulness time and again, as most 
commercial  and  initial  screens  follow  the  sparse  matrix  strategy  nowadays,  but  they  can  be 
fundamentally  flawed.  Similar  proteins  might  crystallize  in  similar  yet  markedly  different 
conditions, it  is therefore possible to miss crystallization conditions when using a sparse matrix 
strategy,  because no systematic approach is  taken to explore changes  in pH, precipitant and or 
additive concentration, within a certain condition. Initial crystallization trials took place under a 
sitting  drop,  vapor  diffusion  setup  and  were  pipetted  with  a  MicrosysTM SQ4000  (Genomic 
Solutions) crystallization robot. 
80 µl  of  each  of  the 96 crystallization  conditions  composing a  screen  were  pipetted  into  their 
corresponding reservoir  of  an  Innova Plate  (Hampton Research)  with  an  Eppendorf multipette, 
which was then loaded on the crystallization robot. The device pipetted 300 nl drops of the reservoir 
into each of the two respective wells on the plate. Finally, the robot pipetted 300 nl of either protein  
or buffer solution into the freshly pipetted drops. The setup was then isolated by sealing the plate 
with VIEWsealTM (Greiner Bio-one) adhesive transparent plastic sheets. The finished plate was then 
stored at either 18 °C or 4 °C, as temperature does affect crystal growth. Table  5.16 shows the 
standard setups for the different proteins tested for crystallization during this work.
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Parameter Epa1 A domain and variants SabA 260 BabA fragments
Upper drop Protein Protein Protein
Lower drop Protein (half concentrated) Buffer Buffer
Concentration (mg/ml) 12 20 3; 15*
Protein buffer AML, AME or AM AM buffer Phosphate  buffer 
pH 5.8 and 2.5
Additives 20  mM  lactoNbiose  I  for 
co-crystallization  and  20 
mM  CaCl2 if  AME  was 
used.
Screens tested Classic,  Classic  Lite,  Cryos,   JCSG+,  PACT,  MBCI,  MBCII,  Anions, 
Ammonium sulfate.
Table 5.16: Screens and setups tested for crystallization of the different proteins. *BabA had a 
maximum solubility at pH 5.8 of 3 mg/ml, thus crystallization at pH 2.5 was tested at  15 mg/ml and  
at 3 mg/ml for pH 5.8.
Prior  to  storage,  plates  were  documented  by  microscopic  observation  for  crystals,  and  then  at 
exponentially increasing times for up to 2 years after dispensing.
5.4.2 Optimizing and reproducing crystallization
Conditions that lead to crystals during initial screening were firstly reproduced and then optimized. 
To reproduce the crystals, 0.75 – 1 ml of  the  same screen solutions from, if possible, the same 
production batch, were dispensed in 24 well VDX plates (Hampton Research or Nextal). Different 
drop sizes and protein-to-buffer-to-reservoir solution ratios were tested, as these can vastly improve 
crystal  quality.  Drops of protein-reservoir  mix where then produced on cover-slides,  table  5.17 
shows the different types of drops prepared during reproduction.  




Table 5.17: Drop sizes and ratios used during reproduction.
The conditions  yielding  the  most  promising  initial  crystals  within  1 week after  pipetting  were 
optimized. Optimization consists  of performing a screen surrounding the initial hit in which such 
parameters as pH, precipitant, salt concentration or additive composition are tested. Tables 5.18 and 
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5.19 show the two main optimizations performed for the Epa1 A domain and variants. 
Composition Original Optimization steps
0.1 M Mes (pH) 6.5 5.5/6/6.5/6.8
Ammonium sulfate concentration (M) 0.2 0.1/0.2/0.3/0.4
PEG 5000 MME (% in v/v) 30 22.5/25/27.5/30/32.5
Table 5.18: Optimization based on condition 92 from the EasyXtal Classics suite (Qiagen). 
Composition Original Optimization steps
0.1 M Sodium acetate (pH) 4.6 4.3/4.6/4.9/5.2
Ammonium sulfate concentration (M) 0.2 0.1/0.2/0.3/0.4
PEG 4000 (% in v/v) 25 17.5/20/22.5/25/27.5/30
Table 5.19: Optimization based on condition 85 from the EasyXtal Classics suite (Qiagen).
5.4.3 Diffractometric measurements and sample preparation.
Protein crystals are measured at very low temperatures (~100 K) to avoid radiation damage during 
the diffraction experiment. If ice crystals are formed during the freezing step, the structural integrity 
of the protein crystal might be compromised. It is therefore necessary to cryoprotect the crystals 
with the help of either such anti-freezing agents as glycerol or PEG 400, or high salt concentrations. 
Table 5.20 shows all the cryoprotectant solutions employed for diffraction experiments.
In order to prepare the sample, the crystals were first fished out of the mother liquor in either Cryo-
Loops or MicroMounts (Hampton) and then soaked for no more than 30 seconds in cryoprotectant 
solution. Finally, the samples were frozen in liquid nitrogen and stored in such for measurement.
Cryoprotectant concentration
Glycerol 15 – 30 % (v/v)





Table 5.20: Cryoprotectants and corresponding concentrations. All cryoprotectants were dissolved  
into solutions with as similar a composition to the original mother liquor of the crystal native  
condition as possible . The given concentration of ammonium sulfate is the final concentration. 
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The  measurement  of  protein  crystals  took  place  either  at  the  European  Synchrotron  Radiation 
Facility (ESRF, Grenoble,  France) at  beamlines  ID14-2 or  ID23-2, or in-house using the X-ray 
diffractometer. The crystal containing Cryo-Loop was transferred from the dewar container to the 
device's  goniometer  head and kept  refrigerated with a  100 K nitrogen stream. The crystal  was 
centered in both cases in such a way that its center remained within the incident radiation path for at 
least a 180 ° rotation of the goniometer head. Test images were taken either with the MXCubE 
contained DNA[184] (ESRF) or the in-house Mar-provided software at 90 ° from each other, and a 
strategy was developed using mosflm [185]. The crystal was centered for the corresponding angle 
range as indicated by the strategy, and images were collected with the recommended exposure time 
(Table 5.21). 
Parameter Epa1A Epa1→6A Epa1→3A Epa1→2A
Δφ (deg) 0.3 0.2 0.5 0.3
φ range (deg) 110 120 98 85
Exposure  time 
(sec)
20 0.5 5 480
Resolution (Å) 1.467 – 23.602 1.487 – 39.698 1.666 – 27.920 1.927 – 49.355
Location ESRF/ID14-2 ESRF/ID14-4 ESRF/ID14-2 In House/Rotating 
anode
Table 5.21: Data collection parameters for all datasets. 
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5.5 Computer assisted methods
A wide variety of computer assisted methods were used for very different purposes. For purposes of 
clarity,  they  will  be  divided  into  homology  model  building  methods,  structure  elucidation  and 
evaluation methods, and methods for calculating protein properties.
5.5.1 Homology model building methods
Homology  modeling  is  a  very  useful  tool  in  both  the  solution  of  the  phase  problem,  and  in 
generating in silico models of proteins for which no experimental structure information is available. 
In  both  cases,  a  protein  of  similar  sequence  (at  least  30% identity  in  most  cases)  and known 
structure is used as a template for the generation of model of the target protein. The resulting model 
can be used to determine initial phases for phase solution, or for the study of variants or paralogues 
for  which  there  is no  structural  information.  For  the  Epa1A project,  homology  models  were 
fundamental in both aspects.
A homology model was built using the program Chainsaw from the ccp4 suite[186] to obtain initial 
phases for molecular replacement. Homology models of several paralogues of the Epa family were 
developed based on Ep1A using the program modeller[187] in order to study the plasticity and 
specificity of the Epa A domain carbohydrate binding pocket.
In any homology modeling effort work is divided into 5 steps[188][189];
1. Identification of homologue(s) that can be used as template(s) for modeling
2. Generating of a sequence alignment between target and template.
3. Building of the initial model
4. Evaluation of the model
5. Using the model in a research environment, either to interpret previous data, or to devise 
new experiments. 
5.5.1.1 Identification of homologues and choosing a template for modeling
In order to produce an accurate model that will deliver reliable predictions, choosing the correct 
template is of capital importance. Assessing the correctness of a template is a difficult task, as no 
single  clear  criterion  can  be  used  [190]. The main  consideration  when choosing  a  template  is 
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normally sequence identity, with at least 70% sequence identity needed between template and target 
for very accurate homology modeling, and at least 30% for a low confidence structure[190]. Other 
factors  can  also  be  taken  into  account,  like  biochemical  information  or  secondary  structure 
predictions. In this way, distant homologues within a family or a superfamily can also be used for 
successful homology building with the proper alignment[191], although with considerably greater 
effort. 
In the case of the phase solution of Epa1A, the A domain of the Flo5  Saccharomyces cerevisiae 
flocculin[1] was chosen as template  (Figure 5.6 PDB accession code 2XJP). Even though sequence 
identity  was  below  30%,  both  proteins  had  been  characterized  as  PA14  domains[65][64],  had 
similar far UV-CD spectra and showed only predicted β secondary elements in their structures[155]
[192]. The structure of Flo5A was known, as well as the one for the  B. anthracis  PA14 domain 
(PDB ID 1ACC)[141].  The   core  structures  of  Flo5A and  the  PA14  domain  are  quite  similar 
(RMSD=2.98Å² over 67 common Cα atoms),  even though the sequence identity is so low that 
BLAST is not capable of finding any significant similarity. Finally, both Flo5 and Epa1 had been 
characterized as C-type lectins and contained the very characteristic DcisD motif[65][192][1]. The 
Epa1A and Flo5A modeling pair is one of the cases where, even with a very low sequence identity, 
structural and functional evidence overwhelmingly points to a common, conserved core structure 
upon which a homology model could be based.
The aim of the Epa1A variants project was to generate mutations within the Epa1A binding pocket 
to  study  the  diversification  of  carbohydrate  specificity  within  the  Epa  family.  Since  no  prior 
structural information was available for any of the members of the Epa family, building homology 
models was the best tool with which to obtain reliable information on the specificity determinants 
within the Epa binding pocket. Under conditions where the template is already given, the next step 
is to obtain a set  of target sequences for which reliable structure models can be calculated.  As 
sequence identity is  the most important  criterion for assessing the feasibility  of template based 




The Basic Local Alignment Search Tool (BLAST) from NCBI [143][144] was employed using the 
blastp algorithm and Epa1 A domain as query to search for suitable candidates within the protein 
sequences  of  Candida  glabrata in  the  non-redundant  (nr)  protein  sequence  database.  The  nr 
database is composed of all non-redundant GenBank CDS translations, RefSeq Proteins database, 
the Protein Data Bank, SwissProt database, the Protein Information Resource (PIR) data-bank and 
the Protein Research Foundation data-bank[144].
The  blastp  algorithm  is  based  on  the  original  Basic  Local  Alignment  Tool  as  applied  to 
proteins[193][143].  BLAST  employs  a  heuristic  method  to  simulate  dynamic  programing 
algorithms[194] at a vastly diminished processing cost. In the first step of a search, blastp compares 
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Figure  5.6: Structural  alignment of Flo5A[1] and the B. anthracis PA14 domain[141]. The core of the  
Flo5A domain is shown in green, while the core of the B. anthracis PA14 domain is shown in red. Features  
of both structures that do not align well with each other, and that were therfore left out of the alignment, are  
shown in blue.  β sheets nomenclature is based on Flo5A multiple alignments[1], as well as loops CBL1 and 
CBL1, that compose the calcium binding pocket and the Flo5 subdomain. Alignment was performed under  
pymol  with  the  super  command,  which  minimizes  root  mean  square  distances  (RMSD)  between  the  
structures to be aligned without previously performing a sequence alignment, as the align command does.  
The core (represented respectively in green and red for Flo5A and B. anthracis PA14), composed of sheets 4  
and 11 to 19 is structurally well conserved, with an RMSD of 2.98Å² over 67 common Cα atoms, the Flo5A 
subdomain is a  specific feature of this protein and is not predicted to be in any other PA14 containing  
structure except for Flo1A[1].
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all possible 3 amino acid long peptides with the query and produces list of homologous peptides. 
Each  peptide  is  scored  according  to  PAM120[195] or  BLOSUM  62  [196]based  substitution 
matrices. Each peptide obtains a score t, which is highest for peptides found within the sequence, 
and decreases proportionally to similarity. The t score is then compared with a T cutoff of 11, if the t 
score is 11 or more, the peptide is considered to be homologous to the query, if it is below, it is  
discarded. Homologous peptides are then used as queries within the chosen data-bank for subjects. 
Whenever an exact peptide is found within a subject, it is considered a hit. Blastp then determines 
whether it is at most within 40 amino acids of a second hit. If it is, it compares the amino acids  
surrounding the hits in the query and the subject sequentially, trying to maximize the sequence score 
through elongation. The scoring parameters are the same as for the generation of the initial peptide 
list, with the exception that gaps within the compared sequence are allowed, but penalized by the 
scoring matrix with -11 for opening and -1 for extension by one amino acid Each of the regions 
where query and subject align is called a maximal segment pair (MSP) and receives an MSP score, 
as previously described. If MSP scores are  equal or greater than a cutoff value S (55 as default), the 
maximal segment pair is considered significantly homologous, and therefore a part of a correct 
alignment. 
Four scores are then assigned to each query to subject pair:
1. Bit Score: the bit score is the addition of all MSP scores within the alignment that surpass 
the cutoff value S.
2. Identity score: the number of identical amino acids in the alignment divided by the number 
of total amino acids This value is given either as a quotient, or as a percentage.
3. Positives score: the number of homologous and identical amino acids divided by the number 
of total amino acids This value is also given either as a quotient, or as a percentage.
4. Gap score:  the number of gaps introduced in the shorter chain of an alignment divided 
between the length of the longer chain. This value is also given either as a quotient, or as a  
percentage.
Although the bit score is the internal score employed for performing the pairwise alignment, it is 
difficult  to  compare  this  value  between different  alignments  without  a  deep knowledge of  the 
mathematical processing of the scoring matrix. The identity or positive percentages are much more 
widely used scores to give the degree of goodness of an alignment performed with BLAST.
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Blast  works extremely well  under these parameters when the objective of the search is  to  find 
sequences where conserved amino acids are spread evenly, even if they are few. Due to the nature of 
the  scoring  process,  however,  if  the  conserved  amino  acids  between  query  and  subject  are 
concentrated in short regions within the entire sequence, many of these regions can be passed over 
(up to 11% of the total search), and some real targets can be missed[143].
For the purposes of choosing homology candidates, a 45% identity cutoff in the A domain was 
adopted for any molecule of C. glabrata within the Epa family, as this is an average value for high 
quality homology structures[197].
5.5.1.2 Generating of a sequence alignment and a phylogenetic tree between target(s) and  
template(s)
Once Flo5A was selected as template, sequence alignment was the starting point in generating a 
homology model. The sequence alignment is key to the reliability of the entire process, as small 
differences within the alignment can lead to shifts within the overall structure.
The program Chainsaw[186] does not provide a built-in alignment system, therefore, an external 
program had to be used. CLUSTALW[198][199] was the program of choice, as it is widely used 
and presents a very user-friendly GUI in he form of CLUSTALX[200]. The CLUSTALW algorithm 
is  similar  to  the  blastp  algorithm[190],  but  the scoring matrix  is  more sophisticated.  The most 
important  difference  in  a  pairwise  alignment,  where  two  sequences  or  alignments  are  aligned 
against each other, is that gap penalties are not only dependent on whether the gap is being opened 
or extended, but also on the amino acids involved in opening the gap and those which will pair with 
the gap[201]. The amino acid dependent gap penalty modulation reduces the penalty for amino 
acids frequently found on loops, while it increases the penalty for  amino acids frequently found on 
secondary structures (equation 5.6). The modulation factors were originally calculated from known 
structures, and they cluster hydrophilic amino acids as those more prone to allow the opening and 
extension of gaps, while the hydrophobic ones tend to prevent it. 
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CLUSTALW is capable of doing multiple alignments, 
where up to thousands of molecules can be paired to 
increase  reliability.  CLUSTALW  aligns  multiple 
sequences  by  performing  exhaustive  pairwise 
alignments.  It  determines  the  most  similar  pairs,  and 
orders  them  in  a  guide  tree  (Fig.  5.7)  in  order  of 
similarity,  then  performs  pairwise  alignments  of  the 
paired  sequences  (step  1 Fig.  5.7)  and  recursively 
performs pairwise  alignments  with  the  alignments  of 
the previous step (steps 2 to n, Fig. 5.7). In this manner, 
redundant  evaluation  of  sequences  is  averted,  and 
model  bias  towards  the  most  similar  molecules 
prevented[190].
Both  features  increase  the  reliability  of  the 
CLUSTALW method above the BLAST method, at the 
cost  of  increased  CPU  time.  CLUSTALW is  a  very 
good algorithm for  performing alignments of already 
handpicked sequences, but it cannot perform data-bank 
searches as quickly as BLAST can. Another important 
advantage  of  CLUSTALW above BLAST is  that  the 




P: penalty asigned for a given gap at position i of sequence A corresponding 
to position j in sequence B. 
Ag[i]: gap opening penalty on position i of sequence A. 
Bg[j+1]: gap opening penalty on position j+1 on sequence B. 
Bh[l]: gap extension penalty  for all positions of sequence B within the gap.
M= last position of sequence A.
Figure  5.7:  Guide  tree  as  employed by  
CLUSTALW  during  multiple  alignment.  
Sequences  A,  B,  C,  D  and  E  are  first  
ordered  in  pairs  by  overall  similitude.  
Then, a pairwise alignment is performed  
for  each  pair  (step 1).  The  resulting  
aligments  of  step  1  are  then  aligned  
against  each  other  or  against  other  
sequences in order of similitude (steps 2  
and  3)  until  the  multiple  alignment  is  
complete. Diagram based on [190]
P={
0 if i=0, i=M
Ag [i]Bg [ j1 ] ∑
l= j1
l= jk
Bh[l ] if 0iM }
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alignment generation phase, which allows the user to introduce chemical, biochemical or structural 
information that would otherwise be missed in a fully automated setup.
The A Domain sequences of all Epa paralogues were also processed in this manner, so as to obtain 
an Epa family multiple alignment.
At his point, the desired alignment of Epa1A and Flo5A for CHAINSAW was finished, but the 
evaluation of the paralogues of the Epa family was not. The reason was that, to obtain a full model 
of the evolutionary relationship within the selected members of the Epa family, it was necessary to 
perform a phylogenetic tree. 
The CLUSTALX interface is also implemented with the capacity to build phylogenetic trees based 
on the multiple alignments generated in previous steps. The first step in generating a phylogenetic 
tree is to obtain a distance matrix of the sequences. CLUSTALX uses the percent  of divergence 
between all sequences in the multiple alignment as the values within the distant matrix. The percent  
of divergence is calculated as the number of substitutions and deletions between a pair of sequences 
divided by the length of the longest sequence. Next, the phylogenetic tree is built with the Neighbor 
Joining (NJ) method[202][203]. The NJ method is an algorithm designed to select two sequences or 
groups of sequences (taxon) within a distance matrix, build a new subtree  u and agglomerate the 
two selected taxa within the new subtree  u, thus reducing the taxon set by 1 (Fig. 5.8)[203]. NJ 
selects the two taxa that minimize the Q criterion (equation  5.7) which takes its minimum value 
when two taxa are very near each other, and very distant from all other taxa within the taxon set.
After a taxon pair is selected and agglomerated within a new subtree u, the new distances between 
the  joined taxa i and j and subtree u, and between subtree u and all other taxa, d(i,u), d(j,u) and 
d(u,k) need to be calculated (equations 5.8 and 5.9).
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eq. 5.7
Q(i,j): Q score for taxa i and j. r:current size of the taxon set.
d(i,j): distance between taxa i and j. 
d(i,k): distance between taxon i and any one taxon k from the taxon set of size r.
d(j,k): distance between taxon I and any one taxon k from the taxon set of size r.
Q i , j =r−2d i , j −∑
k=1
r
d i , k −∑
k=1
r
d  j , k 
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As can be seen in equation  5.8, distance between the new subtree and one of the taxa within it 
depends on the former distance between the joined taxa and the difference of their corresponding 
distances to all the rest of taxa within the taxon set. This is a good measure of the joint difference  
between the two taxa. The distance d(j,u) is calculated symmetrically.
The distance d(u,k) is simply calculated as the average of the difference between the distances of 
the joined taxa towards the new subtree u and towards all other taxa within the taxon set.
Although it is not stated within the algorithm explicitly, it  could be shown that the NJ method 
minimizes whole tree length l, as computed using the generalized Pauplin formula (equation 5.10)
[204]. An example of the calculation of the generalized Pauplin formula weighting term w(i,j) can 
be seen in Fig. 5.8. The biological relevance of the principle of whole tree length minimization  has  
been partly corroborated [205], but as with every phylogeny method, there is no guarantee that the 
generated tree is the actual best tree.
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eq. 5.8 
d(i,u) distance between new subtree u and taxon i
eq. 5.10 
w(i,j): weighting term for the distance between two 
taxa i and j within a phylogenetic tree.
{ij}: all possible combinations of taxa within the 
taxon set
eq. 5.9
d i , u=
1
2
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k=1
r
d  j , k ]
d u ,k =
1
2
[ d i , k −d i , u ]
1
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Generalized  Pauplin  weighting  
term
Distance Weighting formula Numerical result
d(i'j')
d(e''j'')
Table 5.22: Calculation of the generalized Pauplin weighting term. The term w(i'j') is calculated as  
one over the multiplication of the number of branches n in each of the nodes within the distance.  
Two examples are given, as shown in green and red dotted lines on figure 5.8.
5.5.1.3 Building a model for molecular replacement
A multiple  alignment of  several  PA14 domain  containing  sequences,  including the  Epa1A and 
Flo5A pair,  and  generated with CLUSTALW was used to  produce a Chainsaw model.  Only the 
aforementioned pair was used as a sequence guide for the Chainsaw program. Chainsaw uses a very 




Figure 5.8: The neighbor joining method. a) The NJ algorithm selects the two taxa i and j that minimize the Q  
criterion (equation 5.7) by being near each other and distant to the rest of the taxon set a-e. It then joins the  
two into subtree u and calculates resulting distances according to equations 5.8 and 5.9. b) the generalized 
Pauplin weighting term is calculated for distance i'j'  (red dotted line) and e''J''  (green dotted line).  The  
weighting term is calculated by counting the number of branches at each of the nodes along the distance,  
multiplying them together and dividing 1 by that number (equation 5.11). 
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as input, and crop the template structure to eliminate features that will probably not be found within  
the target[186]. In its default mode, also called Mixed S mode, chainsaw eliminates any residues 
within the template structure,  which are represented by gaps in the target.  Any gaps within the 
template sequence are edited as gaps within the target structure. Amino acids that are not identical 
in  the alignment  are  cropped to their  γ-atom, which is  then changed to either  carbon,  oxygen, 
nitrogen  or  sulfur  to  match  the  targets  sequence.  The  resulting  model  is  a  so-called  'mixed 
model'[206] and can be considered as a hybrid between two limiting cases, an all-conserved model 
as the limit of high sequence identity and a polyserine model as the limit of low sequence identity.  
Precisely because the method of generating the structural model is so simple, the success of the 
structural model as a key to obtain a molecular replacement solution is even more dependent of a 
proper alignment. 
Even with a structurally highly conserved central PA14 domain, it is possible for such structures to 
vary strongly within the loop regions, as was the case between Flo5A and the  B. anthracis PA14 
domain (Fig. 5.6). Therefore, after the Epa1A chainsaw model had been generated, several steps of 
manual retouching were performed to reduce the structure to its essential core. 
5.5.1.4 Building models for selected homologues.
Once the final candidates had been chosen with he help of the phylogenetic tree, models of the Epa 
variants were generated with the program modeller[207], which uses comparative protein structure 
modeling by satisfaction of spatial restraints[187] to produce models based on sequence alignment 
of the desired protein against an experimentally obtained template model structure. For this, the 
putative A domain regions of the Epa variants, plus a 30 amino acid long C-terminal margin, were 
employed as target sequences.  Modeller was used with the free modeller GUI, programmed by 
Kuntal Bushan[208], which simplifies the modeling process to 3 steps. First, an internal pairwise 
alignment is generated by methods similar to the CLUSTALW algorithm, with the difference that 
the gap penalty scores are not only dependent on statistical considerations, but on empirical data as 
represented  by the template  structure itself[207].  The resulting  alignment  was inspected for  all 
alignments, and at no time could differences be seen between this alignment and the one performed 
by CLUSTALW. 
Subsequentially,  modeller  extracts  spatial  restrains  from  both  an  internal  database  on  protein 
features and from the template structure as aligned on the target sequence (Table 3.21 gives an 
exhaustive list on spatial restraints used by modeller). From the spatial restraints, basic probability 
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density  functions  are  calculated  (pdf).  A pdf  is  a  function  that  gives  the  range  and  value  of 
probability for the different states a system can adopt. For example, a peptide bond pdf will show 
one very large peak at the trans state for almost all amino acids, while proline will have two peaks, 
one in the cis and one in the trans state. As all probability functions, a pdf cannot adopt negative 
values, and, when integrated from -∞ to +∞, it will always be 1. The basic pdfs are then combined 
to describe features. A feature is defined as a certain aspect within a structure that affects more than 
one atom. For example, the angle formed by three atoms, or the distance between two given atoms. 
A feature can be described as a weighted multiplication of several basic pdfs. Finally, a molecular 
pdf is defined as the multiplication of all feature pdfs[206]. 
Finally, the molecular pdf P is converted to the target function F (equation  5.12), which has the 
computational advantage of being less floating coma intensive and substituting multiplications for 
additions,  making cpu overflow less likely[187].  The entire molecular  pdf,  and therefore target 
function,  is  not  generated  immediately,  but  iteratively.  After  each  round  of  minimization,  new 
feature pdfs are added to the P function. The addition of new features is governed by a growing 
amino acid window, which means that the sequence is read N to C terminally and incrementally 
minimized in this direction. Size of the window, and size of initial standard deviations for the basic 
pdfs can change strongly the initial conditions for folding. It is therefore recommended to generate 
an ensemble of models for difficult candidates. 
The program then tries to minimize the value of F iteratively. It is to be noted that the value of F is 
not an absolute value, and can only be used to compare different models performed with the exact 
same alignment.  To asses  model  quality,  modeller  calculates  discrete  optimized  protein  energy 
(DOPE) potentials[209] for each position of the sequence as an average of a 15 amino acid window. 
DOPE potentials  are essentially  a normalized score per amino acid which shows the degree of 
chemical instability of the amino acid in its current environment. It mimics true potential energy in 
having highly positive scores for unstable locations,  which are therefore poorly modeled, while 
showing negative scores for amino acids with stable states. 




P: molecular probability density function (pdf)
F=−LnP
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order to observe the relative position of the ligand-binding motif and the actual binding pocket and 
decide the mutagenesis strategy. 
5.5.2 Structure elucidation methods
5.5.2.1 Data reduction
All steps in crystallographic data reduction were performed with the xds_par and xscale programs 
of the XDS program package[211], and the SCALA program of the ccp4 suite[212]. The first step 
after obtaining diffraction images from a well diffracting crystal is to integrate the reflexes. During 
this process, the intensity  Ihkl for each hkl reflex is derived from the images, furthermore, XDS 
divides each image in resolution shells,  and calculates the quotient of the mean intensities Ihkl and 
their standard deviation  σIhkl  for each shell. The quotient represents the signal to noise ratio, and 
maximum resolutions were chosen for values of  Ihkl/σIhkl of 2 or higher. 
After the data had been integrated, it needed to be scaled with the program xscale. During data 
scaling, intensities are normed to a common scale so that systematic errors and uncertainties like 
radiation damage or absorption effects are accounted for. Evaluation of the integration and scaling 
process took place through the parameters of completeness, Rmerge, Rmeas and  Ihkl/σIhkl.
Completeness is defined as the percentage of the expected unique reflections that are found within 
the dataset. Rmerge  is a quality parameter that measures the divergence of all symmetrically related 
reflexes, it is given by equation 5.13 and is normally expressed in a percentage. 
Rmeas is another quality factor which is multiplicity independent, and therefore does not increase with 
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The absolute values of these parameters were used to evaluate the quality of the dataset, and the 
qualitative weighing of all parameters against each other lead to decide the maximum resolution at 
which the dataset would be further processed.
Unmerged data  in .hkl  format  were loaded into the ccp4 package by converting them with the 
combat program into an .mtz file. In the case of Epa1A, the SCALA[212] task was used to merge 
the dataset and to set the FreeR flag, for use during phase solution and data refinement (see section 
5.5.2.3), to ~1000 reflections. For the variants, the FreeR flag was imported using the import task 
from the Epa1A model structure during merging with SCALA.  
5.5.2.2 Phase solution via molecular replacement
The solution of the phase problem is the central task in protein crystallography. Due to the nature of 
the data collection, only amplitudes can be directly integrated from the images, while the initial 
phases need to be determined by indirect methods and then refined.
In principle,  there are four methods to solve the phase problem[214], of which only molecular 
replacement was needed to solve the structures of the Epa A domain. The molecular replacement 
method is based on the use of either a previously known structure or a model of the protein of 
interest based on an experimentally determined structure, which is then processed through reverse 
Fourier transform to determine initial phases, which are subsequently refined.
Phase  solution  by  molecular  replacement  is  a  six-dimensional  problem.  The  orientation  of  the 
searched molecule along the unit cell depends on both rotation along 3 angles (α, β and γ) and 
translation along three axes (x, y and z) (Fig  5.9). Traditionally,  cross-Patterson function based 
methods have been widely employed for phase solving[215], but recent developments in maximum 
likelihood probability algorithms have delivered better results[216]. The underlying assumption in 
maximum likelihood inferences is that  'the best model on the evidence of the data is the one that  
explains what has in fact been observed with the highest probability'[217]. For crystallography, the 
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data are the individual reflection intensities,  while the model  is  the calculated output including 
orientation, packing and the corresponding phases. Although not strictly true, it has been shown that 
the individual reflection intensities can be treated as independent  variables without large errors 
being introduced into the system.[216]
The program Phaser[216] of the ccp4 package[212] is capable of producing maximum likelihood 
based rotation and translation  functions.  In  these,  the  Logarithmic  Likelihood  Gain (LLG),  the 
Z-score  and the  Clash  Test  are  the  fundamental  quality  parameters  based  on which  the  output 
solutions are evaluated. The LLG score is defined as the difference between the likelihood of the 
model and the likelihood calculated from a Wilson distribution, which is a random distribution of 
the  atoms  composing  the  model.  Therefore,  LLG  measures  how  much  better  the  model  is  as 
compared with random atoms. The Z-score is defined by equation 5.15, and it gives the number of 
standard deviations above the mean for a particular LLG score. A Z-score above 5 usually indicates 
a correct model, although a value as low as 4 can still indicate a correct solution. 
During the clash test, accepted models are tested for molecular overlap of the Cα atoms within the 
unit  cell;  some  overlap  is  acceptable  for  initial 
phases, and in this work the threshold was set at a 
maximum  of  10  clashes.  A  high  number  of 
overlaps  tends  to  indicate  either  a  false  positive 
model,  or  that  the  wrong  space-group  has  been 
used. A clash is defined as any symmetry-related 
molecule  or  components  of  the  asymmetric  unit 
that are found within less than 3 Å of any  Cα of a 
given model.
The  Epa1A dataset  was  solved  using  the  phaser 
program and a model of the Flo5 A domain (kindly 
provided  by  Maik  Veelders)  processed  with 
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Chainsaw [186] and coot [218] (section 5.5.1). Maximum resolution was set to 3 Å and space group 
to C2221. The mutants presented >99% identity with the solved Epa1A, they were all processed 
directly using refmac5[219] and the Epa1A model stripped of water and ligands (see section 5.5.2.3 
for more information on both programs). Relevant mutations where generated with coot[218] after 
the first refinement cycle, so as to see that the electron density showed the mutated amino acids  
without them having been introduced. The Epa1Ato3 structure could only be solved through phaser, 
as, although the unit cell seemed to be the same, the orientation of the protein model within was not. 
5.5.2.3 Model building  and data refinement
During the model building process, the amino-acid sequence of the target protein is modeled into 
the  calculated  electron  density.  Models  for  high  resolution  datasets  can  be  quickly  built  by 
automated algorithms. Model building was accomplished automatically for the Epa1A domain with 
the program ARP/wARP and its integrated warpNtrace[220] function. Before running ARP/wARP, 
Model building was not necessary for the Epa1A variants, as the structures had >99% sequence 
identity with the Epa1A model. The sequence still applied except for the mutations, which were 
generated later with coot[218]. 
Models were then refined using a combination of automated maximum likelihood methods and 
manual refinement. For the automated methods, refmac5[219][212] was employed, while  for  the 
manual steps the program coot was used.[218] During automated refinement, the R and Rfree  (eq. 
5.16 and 3.17)factors were minimized, while the root mean square deviations (RMSD) for the bond 
length and angle were kept at all times below 0.01Å and 1.5°, respectively. Both R and Rfree use the 
same equation,  but while R compares all the calculated data against  all  the observed data, Rfree 
compares the subset of the calculated structure factors corresponding to the FreeR flag, against the 
actual observed reflections marked by the FreeR flag, which are left out by refmac5 and phaser 
during  model  refinement  and  phase  solution.  Therefore,  the  Rfree factor  is  an  internal  quality 
parameter impervious to model bias, since it compares  calculated reflections against the observed 







The automated  refinement  of  Epa1A was started  by loading the  scaled,  integrated and merged 
dataset with FreeR flags and the  best  output model of the ARP/wARP program into the ccp4i 
refmac5 interface. Parameters of the GUI were set to perform a restrained refinement with no prior 
phase information, isotropic B factors and 10 maximum likelihood refinement cycles. 
After automated refinement, the output electron densities and structure models were loaded into 
coot, where the standard settings were 1-2σ for the electron density and 3.5σ for the difference 
electron density. The main chain of the protein model underwent both real space refinement and 
regularization. Both waters and ligands were added and saved.
The saved output  from manual  refinement  was  loaded again  for  a  second round of  automated 
refinement cycles with refmac5. The process was repeated until the R and R free factors could not be 
lowered any further. Different strategies were employed during advanced automated refinement, 
like  TLS  refinement[221],  rigid  body  refinement,  Babinet  scaling[222],  adding  computed 
hydrogens, and changing the geometric weighting factor[219]. These strategies were only pursued 
if, after the refinement job, the Rfree   had been reduced by at least 1 point. TLS groups for TLS 
refinement  were  calculated  using  the  TLS  Motion  Determination  (TLSMD) server  [223][224], 
which produces different ensembles of TLS groups that may be selected.
5.5.3 Protein properties calculation methods
5.5.3.1 Isolectric point (pI), extinction coefficient (ε) and molecular weight (MW)
The program  ProtParam[225] from the ExPASy server calculated the theoretical values of the pI,  ε 
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5.5.3.2 Unit conversion, melting curve fitting and deconvolution of spectra for CD  
measurements
A simple macro for the OpenOffice.org Calc converted ellipticity in mean molar ellipticity  per 
residue using eq. 5.2. Data had to be converted from the Jasco proprietary format to ASCII .txt files 
using the in-built Jasco File ConverterTM.
Melting curves were fitted using the QtiPlot[226] and equation 5.18 as described in [227].
Equation  5.18 is the simplest conceivable model for the fitting of a  two state  melting curve. One 
must assume that the heat capacity of the system does not change with temperature, and that no 
linear denaturation occurs before or after the sigmoidal one[227]. An adapted model for a three state 
melting curve is  given with  equation 5.19,  but  the  assumptions  made are  the same ones.  It  is 
important to note that initial values for all constants are of extreme importance when fitting melting 
curves.  The  suggested  values  for  initial  enthalpies  given  by  Greenfield  in  [227] have  proven 
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Deconvolution  of  spectra  was  performed  using  the  K2d server[228].  The  K2d  server  employs 
Kohonen's  self-organizing  map  (SOM)[229] neural  network  algorithm.  Briefly,  the  K2d  server 
emulates the growth of sensory neurons, where only the fastest converging neuron survives upon 
connection with the growth factor emitting region, while all other neurons enter  apoptosis. In the 
case of K2d, 41 input parameters, corresponding to each whole-number wavelength between 200 
and 240 nm, are confronted by a set of 100 “neurons”. Each neuron is represented by a random set 
of 41 values for each wavelength derived from a weighted combination of the training set,  i.e.  
although the values are random, it is known what amount of α-helix, β-sheet and random coil would 
produce such a spectrum. The neuron which most closely resembles the experimental spectrum 
“survives” while all others “die”. The process is iterated with new neurons whose values are near 
the  surviving  neuron  from  last  cycle.  The  final  surviving  neuron  in  the  last  cycle  is  a  good 
approximation of the average secondary structure quantities that would produce the spectrum.
The neural network produces then 2 quality parameters, the secondary structure proportions and a 
corresponding calculated spectrum as output.  The first  quality  parameter  is  the square distance 
between the calculated spectrum and the experimental spectrum. It is a value which holds the same 
significance  as  the  RMSD  between  a  set  of  points  and  a  corresponding  function  in  a  linear 
regression, for example.  The square distance is calculated as the euclidean distance between two 
vectors. A square distance value of 0 would mean that the calculated and experimental values fully 
overlap, and are therefore identical. The second quality parameter is the estimated error, which is an 
estimation performed by comparing the actual calculated and experimental data with the calculated 
and experimental data employed during training of the neural network, for which real errors could 
be calculated,  as  secondary structure percentages  were known.  The estimated error  is  given in 
percentage,  and the program has an in-built  cutoff  of 22.7% after  which it  determines that  the 
calculated and experimental spectra are too different, and therefore the deconvolution failed.
5.5.3.3 Imaging and exploring structural models
Structural models where studied using pymol v1.2r1[210]. Estimations of secondary structure on 
the model where performed with the stride plug-in as distributed with the VMD package[230], 
while  structural  alignments  were  performed  using  the  CEAlign  plug-in  [231].  All  snapshots 
presented in this work were performed with pymol, unless otherwise stated.
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5.5.3.4 Secondary structure predictions
Secondary structure predictions were performed using the Jpred3 server[232]. The Jpred server uses 
the Jnet[233] neural network algorithm to predict the secondary structure of the query. As the first 
step, Jnet generates a multiple alignment using PSIBLAST[193], which is a similar algorithm to 
BLASTp as described in section 3.5.1.1,  but less stringent,  therefore allowing for more distant 
homologues to be identified. It then removes any gaps within the query sequence, and with it the 
corresponding portions of the subjects.  Next,  Jnet compares the resulting array with its  trained 





6.1 Epithelial Adhesins from Candida glabrata (Epa)
C. glabrata is, with C. albicans, the most common fungal pathogen in Homo sapiens. Even though 
most  cases  of  candidiasis  are  mild  and  occur  on  a  mucosal  level,  systemic  infections  in 
immunocompromised  patients[44] can  have  up  to  52% median  mortality  rates[234],  inducting 
C. glabrata into the category of hospital pathogens with such other, mainly bacterial, pathogens as 
Staphylococcus  aureus.  The  challenges  faced  when  treating  a  systemic  candidiasis  are  quite 
different than a multiresistant bacterial infection. The eukaryotic nature of the pathogen implies a 
much more similar cellular structure between host and pathogen,  which in most cases in strong 
adverse reactions to drugs and difficult and long-winded therapies[235]. It is therefore of capital 
importance to develop alternative therapies based on differential characteristics between host and 
pathogen, which will improve both survival rate and living quality of the patient. One of the most 
interesting targets in  C. glabrata is the adhesion mechanism, which allows it to colonize both the 
external  mucosas  and  the  internal  epi-  and  endothelia  during  pathogenesis[234].  The  adhesion 
system, as especially exemplified by the epithelial adhesin family (Epa), is completely different to 
the way the human organism interacts with its own carbohydrates, and is absolutely necessary for 
primary colonization. Even though this system has been shown to be necessary for infection,  in  
vitro and biochemical characterization have yet to be undertaken, barring some semi-quantitative 
binding assays[41].  Especially structural knowledge of the glycan binding domain of members of 
the  Epa  family  and their  specificity  would  be  of  tremendous  use  in  the  development  of  new, 
alternative therapies against candidiasis.
For  the  study  of  the  Epa1  adhesive  domain  (Epa1A),  several  constructs  had  been  previously 
generated  by  producing  fragments  from  the  Epa1  full  length  gene  from  C.  glabrata  (gene 
ID 34809538)[155]. Out of these, the pET28a Epa1_2 construct was the one adopted for this work. 
The gene product Epa1_2 (Epa1A from now on) was 262 amino acids long, from which amino 
acids 32 to 259 correspond to the sequence fragment 40 to 267 of full  length Epa1. The short 
N-terminal fragment in Epa1A contained a His-tag, which was used during protein purification. 
Epa1A has a molecular weight of 29.4 kDa and a predicted pI of 6.20.
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6.1.1 Purification of the Epa1A domain
Epa1A could be readily purified from raw cell  lysates  following expression  and  using NiNTA-
affinity colums.  However subsequent gel filtrations yielded very poor results (Fig. 6.1 a))[155]. 
When purified in AM buffer, Epa1A tended to either aggregate in the size exclusion column, eluting 
near the exclusion volume (Fig.  6.1, Peak I),  or interacted with the Superdex 200 material,  i.e. 
eluting far behind the theoretical maximal column volume (Fig 6.1 Peak III). Only a small fraction 
would  appear approximately at the calculated elution volume for the protein (Fig. 6.1 Peak II).  It 
was  from  this  fraction  that  preliminary  crystals  could  be  obtained[155].  As  the  Superdex  200 
material is a polysaccharide matrix (Fig. 5.1), it was proposed that specific protein-carbohydrate 
interactions might be causing the separation problems observed for this column. Lactose and EDTA 
were  both  tested  as  binding  inhibitors  on  an  analytical  scale  with  a  pre-packed  analytical  gel 
filtration  column  (Superdex  200  150/10GL,  GE  Healthcare)(Fig.6.1  b)).  Both  lactose,  at  a 
concentration of 50  mM, and EDTA, at 10 mM, were effective inhibitors of the interactions with 
the column,  and large quantities of the Peak II  fraction could be obtained.  The procedure was 
successfully upscaled to the preparative level, and high yields could be obtained (~7 mg purified 
protein per liter of culture).
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Figure 6.1:  a) Sample size exclusion chromatography as run in [155]. Peaks I, II and III correspond all to  
Epa1A, but only peak II yielded preliminary crystals.  b)  Analytical gel filtration for Epa1A. Purification  
under standard conditions using AM buffer [155] in black. Purification with AML as running buffer in blue  
and with AME in red. The main peak under standard conditions is to be found after one column volume  
(CV) has run through the column and is analogous to peak III in a), while the main peaks with AML and  
AME are within 0.6 and 0.8 of the total column volume, and correlate  well with peak II in a). SDS-PAGE 
shows pure protein after gel filtration. Although there appears  to be a contamination or degradation of the  
protein in  the  form of  a  double  band,  it  could be shown through mass  spectrometry  that  both bands  
correspond to Epa1A and that it was not a product of limited proteolysis[155]. Molecular weight marker  
weights are given in kDa. 
Results
6.1.1.1  Crystallization of Epa1A under optimized conditions
Reproduction trials  started with protein purified in AML at a   concentration of 12 mg/ml.  The 
classic and MBC screens were tested, but also optimizations based on the preliminary hits presented 
in [155] were planned and employed (section 5.4.2 and [183]). Finally, crystals could be obtained in 
the optimization screens (Table  5.16) although, interestingly, there was no crystal growth in  the 
original  conditions themselves, showing the importance of combining the sparse matrix strategy 
with a systematic screening of promising hits. The optimizations considerably increased crystal size 
and quality (Fig. 6.2).
6.1.2 Structure determination  of the Epa1A domain.
Epa1A structure solution took place via molecular replacement using the Flo5A structure (PDBID: 
2XJP)[1] as template for a chainsaw model, even though sequence identity was at ~20%. Fig. 6.3 
shows the alignment used to generate a successful chainsaw model.
Table 6.1 gives an overview of the entire structure solution process and statistics.
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Figure  6.2 Epa1A crystals.  a)  Preliminary crystals  
produced under condition 92 of the Qiagen Classic  
screen (0.1 M MES pH 6.5, 0.2 M ammonium sulfate,  
30% (w/v) PEG 5000 MME) plus 0.2 M lactose.. b)  
Optimized crystals based on condition 92.
Figure 6.3: Alignment between Flo5 A domain sequence and Epa1 A domain sequence for the purpose of  
developing a Chainsaw model. Even though sequence identity is very low, key features such as the Flo5A  
subdomain, supposed to be absent in Epa1A, is predicted as a large gap in the alignment, and the CBL2  
loop of Flo5A[1] corresponds with the specificity determining region of Epa1A[41].
Results
6.1.2.1 Data collection, processing and phase solution.
The Epa1A crystal  was  measured  at  the  ESRF  (Grenoble,  France)  at  beamline  ID14-4  at  a 
maximum resolution of 1.467 Å,  Δφ of 0.3° and a φ range of 110°. Data was processed with the 
XDS suite[211],  giving  a  final  Rmerge   of  7.0%,  completeness  of  98.8% and  I/σ  of  14.6  for  a 
resolution cutoff of 1.5  Å.
The Bravais  lattice  of  the  crystal  was  characterized  as  centered  orthorhombic.  Initially,  it  was 
assumed that the space group was C222 (number 21) but only datasets assigned to space group 20 
(C2221) delivered significant molecular replacement solutions. Phase solution was achieved  with 
the ccp4 program Phaser[216] by searching the dataset up to a resolution of 3 Å with  a manually 
trimmed chainsaw[212] model (Fig  6.4) based on the weakly homologous Flo5A structure[1] for 
one monomer.  The content of  one molecule per asymmetric unit was indicated by the Matthews 
coefficient  of  2.31 Å³/Da and an  estimated  solvent  content  of  46.75%. .  The selected  solution 
presented final Z-scores of 5.2 for rotation and 6.5 for translation, an LLG score of 41.45  and no 
clashes.
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Figure  6.4:  Models  of  Epa1_wt  used  for  phase  solution  of  the  
Epa1_2wt  dataset.  Grey:  final  model  used  for  structure  solution.  
Green:  pruned regions  of  the  original  automated  chainsaw model.  
Region A  (amino acids 35 – 48 and 259 – 270) contains the C and N-
terminal extensions, while B (amino acids 114 – 130) corresponds to  
the region modeled on base of the Flo5 sub-domain. The DcisD motif  
of calcium-binding site is included for orientation.
Results
6.1.2.2 Model building and refinement
Rigid body refinement followed by 20 cycles of automated ARP/wARP model building yielded a 
model with 4 partial chains for which 209 amino acids of the total 262 of the Epa1A gene product 
had been assigned. The process improved Rfree from initial 50% to a final value of 25%. The model 
correctness was estimated to be of 99.8% and the R factor after ARP/wARP had a value of 20.6%. 
During  refinement,  both  the  Ca2+ and  carbohydrate  could  be  found and built  into the  electron 
density (Fig 6.5 c)). As expected, Epa1A is an all-β protein composed of a β-sandwich motif in 
which 13 out of 15 β-strands are involved (Figures 6.5 and 6.6). Carbohydrate and calcium binding 
occurs mainly on the CBL1 and CBL2 loops, while lid loops L1, L2 and L3 act as an outer shell 
isolating the binding pocket from solvent (Figure  6.5 a) and b)). L3 also interacts directly with the 
sugar  over  the galactose moiety and Trp197 (Fig.  6.5 b)),  while  L1 and L2 are quite  rigid  by 
covalent binding over a disulfide bridge between C77 in L1 and C118 in L2 (Fig. 6.6).
Interestingly, lactose could be modeled within the carbohydrate electron density, but a disaccharide 
composed of galactose and glucose bound over a β1 → 3 glycosydic bond, this was surprising, as 
the protein had been co-crystallized  in 100 mM lactose which had a purity of 98% according to the 
manufacturer's data (Fluka, lot code: 397309).
The final model could be refined to an R factor of 16.7 % and an R free of 19.1 %. The asymmetric 
unit contains a total of 226 out of the 262 amino acids of the Epa1A gene product (amino acids D43 
to S267 of the Epa1 sequence),  244 water  molecules,  two glycerol  molecules,  one Ca2+ ion,  a 
Gal β1 → 3Glc disaccharide and one MES molecule. Fig. 6.5 shows the general fold of the Epa1 A 





Figure  6.5:  The  Epa1A structure.  a)  General  fold  of  the  Epa1  A  domain,  showing  the  typical  PA14  
β-sandwich fold[64]comprised by β-strands 2 to 4 and 7 to 13. Carbohydrate is portrayed in blue, MES in  
cyan, glycerol and Ca2+ in orange. Lid loops L1, L2 and L3 further isolate the binding pocket from the  
solvent, while loops CBL1 and CBL2 form the binding pocket itself. b) Detail on the binding pocket. The  
Ca2+ ion is coordinated by the peptide backbone of CBL2 and the DcisD motif  [1] of CBL1 and Asn 227,  
while the carbohydrate interacts with the side-chains of the CBL2 amino acids, W198 and W97. c) Omit  
map  showing  the  electron  density  at   a  contouring  level  of  1.2σ  and  1.6   Å  resolution  of  both  the  
carbohydrate and the calcium ion. Only a β1 → 3 glycosydic bond could be modeled in the electron density.  
The D-cis-D motive formed by D165 and D166 is shown for orientation.  d)Secondary structure elements  
present in the Epa1A structure. β  strands are marked in green from 1 to 15.  Disulfide bridges between 
cysteins are marked in yellow dashed lines. The calcium binding loops 1 and 2 (CBL1, CBL2) are marked as 
an asterisk (*) and CBL2, respectively, while the lid loops are marked as L1, L2 and L3.
Results
Data collection Refinement
Space group C2221 Resolution (Å) 1.5
Cell parameters Reflections (F>0) 41751
a (Å) 74.64 R (%) 16.7 (28.0)
b (Å) 104.33 Rfree (%) 19.1 (33.0)
c (Å) 69.79 Protein atoms 1955
Wavelength (Å) 0.933 Water molecules 244
Resolution (Å) 1.47– 19.89 Metal atoms 1
Completeness (%) 98.8 (98.7) Average  B-factor 
(Å2)
7.34
Total reflections 174640 RMSD
Unique reflections 43249 Bond length (Å) 0.01
Multiplicity 4 Bond angle (°) 1.38
Rmerge/Rmeas (%) 7.0 (65.5)/ 7.9 (74.8)
I/σ 14.6 (2.6)
Phase solution
Translation Z score 6.5
Rotation Z score 5.2
LLG 41.45
Clashes 0
Table 6.1: Overview of the statistics in data collection, phase solving and refinement of the Epa1A 
structure model.
6.1.3 Generation of Epa1A variants.
In  order  to  explore  possible  changes  in  specificity  within  the  Epa  family,  the  amino  acids 
responsible for the binding specificity in Epa1A had to be mutated. To define the key amino acids, 
the task was approached hierarchically. First, a BLAST[143] search was performed within the  C. 
glabrata genome to find Epa1 homologues sharing at least 45% identity with the Epa1 A domain. 
Secondly, a multiple  sequence  alignment and a phylogenetic tree were generated with the chosen 




Next,  the ligand-binding motif[41] was examined for each of the clusters  and compared to the 
Epa1A binding pocket  by homology modeling (Fig 6.7) as performed with modeller  v9.7[207]. 
Finally, mutagenesis for conversion of Epa1A into the derived Epa subclasses was undertaken and 
confirmed through sequencing (Appendix II). 
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Figure  6.6 Phylogenetic tree analysis of the seven A domains from the Epa  
Family with at least 45% identity to Epa1. Three branches or clusters are  
clearly  differentiated  within  the  tree.  Grey:  Epa1A cluster.  Green:  Epa2A  
cluster. Blue: Epa3A cluster. Even though it is not recognized as a separate  
cluster,  Epa6A (in  red)  shows  a  different  CBL2  region.  Therefore,  it  was  
considered  to  be  a  parallel  subclass  for  variant  selection.  Evolutionary 
distance scale is given on the bottom left (section 5.5.1.2).
Results
6.1.4 Expression of Epa variants
Conditions around the optimal expression conditions for 
Epa1A [155] were tested as described in section 5.2.1 for 
all variants shown in Fig. 6.8 and optimized expression 
conditions could be promptly attained. Figure  6.8 shows 
an example of a solubility test for the Epa1→6A variant. 
Preparative expressions were performed and E. coli cells 
were harvested as described in section 5.2.1.
6.1.5 Purification of Epa variants.
The Epa1 A domain variants were analogously purified using the optimized purification protocol for 
the Epa1A gene product. Interaction with the analytical Superdex 200 column varied among the 
different Epa1A variants (Fig. 6.9). Preparative purifications of the mutants in either AML or AME 
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Figure 6.8: Example of solubility test. M:  
molecular weight marker, with molecular  
weights  in  KDa.  P:  Pellet.  SN:  
Supernatant. 
Figure 6.7: Binding pockets of the homology models of the members of the Epa family suclasses represented  
in Fig. 6.6. superimposed on the X-ray structure of Epa1A. Grey: Epa1A X-ray structure. a) red: Epa6A  
model, b) Blue: Epa3A model, c) Green: Epa2A model. d) Table showing the different binding-site motif  
sequences for each cluster and the undertaken mutations. Although Epa1, 6 and 7 pertained to the same  
cluster, Epa6 showed a deviant binding-site motif for CBL2, and therefore was also taken into account for  
the mutagenesis strategy.
Results
buffers yielded large quantities of pure protein (~10 mg per litre of culture).
6.1.6 Structural analyses of subclass-converted Epa1A variants
6.1.6.1 Crystallization of the Epa1A variants
Crystallization  conditions  as  described  in  sections  5.4.1  and  5.4.2  were  set  up  for  the  Epa1A 
mutants at 18 and 4 °C in Innova plates (Hampton Research).  Crystals grew at similar rates as the 
original Epa1A, with 4 to 7 days as an average. There was a general tendency to produce better  
diffracting crystals using the optimization of condition 92 of the classics screen, but no crystals 
could be produced in the original solution of condition 92. Crystals of Epa1A variants could only be 
grown  in  the  presence  of  carbohydrate.  Although  it  was  possible  to  produce  co-crystals  of 
Epa1→6A and lactoNbiose I (Fig. 6.10), they diffracted poorly. Crystals grown by the sitting drop 
method grew out of a thick, transparent precipitate that hampered picking. Reproduction of target 
conditions in hanging drop format with a total volume of 2 µl generally solved this problem and 
increased crystal quality. 
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Figure 6.9: a) Epa1→3A b) Epa1→6A c) Epa1→2A. SDS-PAGEs show the corresponding samples prior to  
analytical gel filtration. Analytical gel filtrations of the Epa1 A domain mutants. Black: gel filtration under  
standard conditions. Blue: gel filtration with AML buffer. Red: gel filtration with AME buffer. Although the  
different buffers do not seem to have any effect on Epa1→6A, it could be shown by fluorescence titrations  
that only the purification with AME buffer supplemented with calcium yielded active protein (section 4.7.1).  
All  main  peaks  are  between 0.6  and 0.8 CV,  corresponding to  the  crystallizing  fraction II  of  Epa1wt.  
Interstignly, Epa1→3A does show a different ratio in the typical double band that both Epa1A and all other  
variants present. 
Results
6.1.6.2 Data collection and improvement of diffraction quality of the variant crystals
Datasets could be collected for all 3 
mutants, but the diffraction qualities 
of  Epa1→3A·lactose and 
Epa1→6A·lactoNbioseI  crystals 
were initially poor (8 – 10 Å highest 
resolution  shell).  At  that  point, 
crystals  had  been  frozen  in  cryo-
buffer  composed  of  the  original 
condition with 30 % (v/v) Glycerol 
added. 
Since  some  of  the  crystals  looked 
damaged after the freezing process, 
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Figure 6.11: Improving diffraction quality. Sample diffraction  
images from Epa1→6A lactoNbiose I co-crystals (upper row)  
and Epa1→3A crystals (lower row). Using Ammonium sulfate  
as  a  cryo-protectant  dramatically  improved  Epa1→3A  
diffraction  quality.  Maximum  resolutions  were  visually  
estimated using imosflm[185].
Figure 6.10: Diffracting crystals of the Epa1 A domain mutant.  
a) Crystals from Epa1→3A·lactose grown in 0.1 M MES pH 6.5,  
200 mM ammonium sulfate,  25  % (w/v)  PEG 5000  MME.  b)  
Crystals of Epa1→2A·lactose grown in 0.1 M MES pH 6, 200  
mM  ammonium  sulfate,  22.5  %  (w/v)  PEG  5000  MME.  c)  
Crystals of Epa1→6A·lactose grown in 0.1 M MES pH 6, 100  
mM  ammonium  sulfate,  32.5 %  (w/v)  PEG  5000  MME.  d)  
Crystals of Epa1→6A·lactoNbioseI grown in AME buffer + 10 
mM lactoNbiose I + 20 mM CaCl2, 0.1 M MES pH 6.8, 100 mM 
ammonium sulfate, 22.5 % (w/v) PEG 5000 MME.
Results
different cryo-conditions were tested (Fig  6.11). 1.5 M ammonium sulfate significantly improved 
the diffraction quality of Epa1→3A·lactose crystals, but no such effect could be achieved for the 




















Epa1→3A·lactose 98 0.5 4.5 5.3 16.3 98.9 C2221 1.63
Epa1→6A·lactose 120 0.2 4.1 4.6 26 99.6 C2221 1.50
Epa1→2A·lactose 85 0.3 7.9 10.7 8.59 97.7 C2221 2.00
Table 6.2: Summary of the collection strategies for the Epa1 A domain variants. Epa1→3A·lactose 
and Epa1→6A·lactose datasets where collected at ESRF beamlines ID23-2 and ID14-2,  
respectively. Epa1→2A·lactose dataset was collected using an in-house X-ray diffractometer.  
Maximum resolutions were obtained as an output of Scala[212].
6.1.6.3 Phase solution and refinement
Phase solution and refinement took place concurrently for the variants by molecular substitution, 
using the wild type Epa1A model structure without water molecules or ligands as starting point for 
refinement  in  refmac5[219].  In  the  case  of  Epa1→3A,  indexing  differences  within  the  crystal 
seemed to prevent refmac5 to accept the model.  Accordingly, molecular replacement was done with 
phaser using the Epa1A structure as template and gave Z scores of 27.2 and 40.1 for the rotation and 
translation functions,  respectively.  The mutated  amino acids  were  rebuilt  with coot[218],  when 
preliminary electron densities had been obtained, along with ligands and water molecules. Although 
50 mM lactose had been used for co-crystallization in all cases, Epa1→6A and Epa1→2A seem to 
have bound the β1→3 disaccharide that was also found for the Epa1A structure. Even though there 
seems to be a definite preference for the  β1→3 disaccharide above lactose, the definition of the 
electron density for the glucose molecule varied widely a) amongst the variants (Fig. 6.12), and b) 
with the orientation of the pyranose ring of the glucose being either planar or perpendicular to the 
galactose  (diagrams  performed  with  Avogadro[237]).  The  main  statistics  and  specifics  of  the 




Figure 6.12: Structural details of the Epa1 A domain variants. Red, blue and green polypeptides stand for  
Epa1→6A, Epa1→3A and Epa1→2A, respectively. Calcium shown in orange, disaccharide in blue. a), b),  
c)  top  view of  the  electron  density  corresponding  to  the  disaccharide  for  each  of  the  mutants.  The  
galactose maintains a constant orientation, while the glucose was rotated along the glycosydic bond in the  
different  variants.  In  the  case  of  Epa1→6A,  shown in  a),  two  conformations  were  available  for  the  
glucose,  shown in blue and in dark green.  Glucose orientation in  comparison with galactose can be  
appreciated  in  the  top  right  diagrams.  d),  e),  f)  detail  of  the  binding  pocket  of  the  mutants  (color)  
compared to the wild type structure (gray), all  changes are concentrated on the CBL2 loop.  Electron  
densities  were  calculated  by  refmac  5  as  omit  maps  and  are  presented  at  σ=0.8  and carve = 1.6 Å.  
Occupancies were always 1.0 for the galactose except  for Epa1→2A  in c), where it was 0.7. Glucose  
occupancies where 0.3 (average B-factor: 24.62 Å2 ) for blue and 0.5 (average B-factor: 32.32 Å2 )for 
green conformations in Epa1→6A in a). For the Epa1→3A the occupancy of glucose was 0.5 (average B-
factor: 18.78 Å2 ) in b) and  in the case  of Epa1→2A it was  0.5 (average B-factor: 21.00 Å2 ) in c).  
Orientation diagrams calculated with Avogadro[237].
Results
Data collection Epa1→3A Epa1→6A Epa1→2A
Space group C2221 C2221 C2221
Cell parameters
A (Å) 74.88 74.43 74.56
B (Å) 102.7 103.9 104
C (Å) 69.05 69.28 69.15
Wavelength (Å) 0.933 0.94 1.54
Resolution (Å) 1.63 1.55 2.00
Completeness (%) 98.9 (94.4) 99.6 (99.9) 97.7(99.7)
Total reflections 124967 186996 55079
Unique reflections 33171 39090 18024
Multiplicity 3.8 4.8 3.1
Rmerge/Rmeas (%) 4.5 (59.5)/ 5.3(70.4) 3.8 (47.4)/4.3(52.9) 12.3(51.9)/14.9(63.9)
I/σ 16.3(2.0) 26(3.5) 7.4(2.2)
Phase solution
Translation Z score 27.2 n.d. n.d.
Rotation Z score 40.1 n.d. n.d.
LLG 2174 n.d. n.d.
Clashes 0 n.d. n.d.
Refinement
Resolution (Å) 1.63 1.55 2
Reflections (F>0) 31967 37731 17402
R (%) 19.49 15.28 (24) 22.05(26)
Rfree (%) 20.8 17.52 (29) 25.17(27)
Protein atoms 1804 1924 1896
Water molecules 117 195 138
Metal atoms 1 1 1
Average B-factor (Å2) 11.2 11.6 14.4
RMSD
Bond length (Å) 0.01 0.01 0.01
Bond angle (°) 1.37 1.37 1.34
Table 6.3: Overview of the data collection and refinement statistics for the Epa1 A domain mutants.
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Results
6.1.7 Carbohydrate binding of Epa A domains
Carbohydrate specificity and affinity of Epa1A for and variants was quantitatively characterized by 
fluorescence titration and semi-quantitatively  by high-throughput binding assays to glycan arrays. 
These  arrays  were  provided  by  the  consortium  for  functional  glycomics  (CFG, 
www.functionalglycomics.org) at La Jolla, Ca, USA.
6.1.7.1 High-throughput semi-quantitative binding assays of Epa1 and mutants.
The CFG glycan arrays provide a very powerful tool to determine the preferred ligands for all 
manner of glycan binding proteins (GBPs). By testing 465 different immobilized carbohydrates in 
its last iteration (glycan chip V4.1), it is possible to obtain very fast, semi-quantitative information 
on GBP binding preferences. In the case of Epa1A and variants, the information provided could be 
partially compared with previous experiments[41], in which some of the Epa family members had 
been tested for binding against  CFG glycan arrays.  The study of Epa1A and its  variants  could 
expand the information offered there and clarify whether carbohydrate binding was only affected by 
short range interactions within the binding pocket, or whether long range effects on other regions of  
the protein may play an important role in ligand recognition. 
In order to characterize the binding specificity of Epa1A, binding experiments were performed at 
three different concentrations, 1 µg/ml, 50 µg/ml and 200 µg/ml (Fig. 6.13 a,  6.13 b and  6.14 a, 
respectively). Binding to the 4.1 CFG printed glycan array chip showed similar binding profiles for 
Epa1A, and Epa1→6A (Fig. 6.14 a, b). Epa1→2A and Epa1→3A showed also similar profiles, but 
Epa1→3A was much less active (Fig. 6.15 a and b). 
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A clear preference for mucin-type O-glycan core motifs could be attested for Epa1A (Figures 6.14 
a) and b) and  6.16 a)), especially the core 1 Galβ1→3GalNAc motif  or T-antigen[11][25]. This 
preference was also present for Epa1→6A, but the specificity was somewhat reduced, with many 
other glycans within the range of best binders (Fig 6.16 b)). In the case of Epa1→2A a preference 
for sulfogalactose containing carbohydrates is predominant (Fig. 6.16 c)). 
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Figure  6.13:  Binding  of  epithelial  adhesin  Epa1A  to  CFG  glycan  array  V4.1  at  different  protein  
concentrations. a) Binding of Epa1A at 1μg/ml. b) Binding of Epa1A at 50 μg/ml. Each carbohydrate has a  
unique identification number (carbohydrate number) which can be consulted in Appendix I Fluorescence 
intensities are given in arbitrary units. As binding conditions become more stringent due to limiting amounts  
of protein, the carbohydrates with the highest affinity are the ones sequestering most of it. As a result, at 1  
μg/ml  binding  occurs  almost  only  at  the  galactoseβ1-3  oligosaccharide  containing  region.  Secondary  
specificities can be observed at higher concentrations, as is apparent at 50 μg/ml, where some binding can  
be seen at the galactose α region and especially at the Galβ1-4 regions. 
Results
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Figure  6.14: Binding of Epithelial adhesin to CFG glycan array V4.1 at a protein concentration of 200  
µg/ml.  a) Binding  of  Epa1A.  b)  Binding  of  Epa1→6A.  Each  carbohydrate  has  a  unique  identification  
number (carbohydrate number) which can be consulted in Appenidx I Fluorescence intensities are given in  
arbitrary  units.  Both  proteins  show a  clear  preference  for  oligosaccharides  containing  non-reducing  
galactose. Epa1wt has a higher specificity for β1-3 bound galactose with a secondary specificity for β1-4  
carbohydrates. In the case of Epa1→6A, no clear specificity between α1-3,  α1-4,  β1-3 and  β1-4 can be  
differentiated, with the highest peaks evenly distributed amongst them, and a clearly lower general binding  
strength than Epa1A. * marks an especially prominent differential peak in Epa1A, which corresponds to a  
branched core 3 O-GalNac oligosaccharide (Fig. 6.16).
Results
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Figure  6.15: Binding of Epithelial adhesin to CFG glycan array V4.1 at a protein concentration of 200  
µg/ml. a) Binding of Epa1→2A. b) Binding of Epa1→3A. Each carbohydrate has a unique identification  
number (carbohydrate number) which can be consulted in Appendix I. Fluorescence intensities are given in  
arbitrary units. Epa1→2A shows relatively weak binding, with a ten fold decrease in maximum fluorescence  
intensity  compared  to Epa1A.  It  does  present  a  different  specificity  to  Epa1A and  Epa1→6A,  with  a  
preference for  α-Galactose containing carbohydrates and a secondary preference for  Galβ1-3 and Galβ1-4  
oligosaccharides. Epa1→3A is an even weaker binder, with 100 times less maximal binding intensity than  




Figure 6.16: Distribution of carbohydrate ligands by type. a) Pie charts showing the distribution of  
ligands with fluorescence intensities  up to  20% of  maximum  (top) or  showing the distribution of  
ligands up to 50% of maximum (bottom).  b)  Structural formulas of the top binding carbohydrates,  
giving  color  codes  for the  pie  charts.   Carbohydrates  present  on  mucins  are  accounted  for  
individually, all other carbohydrates are collectively referred as “other”.  The proportion of mucin 
related glycans decreases in both Epa1to6 and Epa1to2, while the proportion of other carbohydrates  
increases,  showing an increasing promiscuity in the mutants.  In  the  case of  Epa1A, ~75% of  all  
ligands with at least 20% of maximum fluorescence intensity are carbohydrates present on the surface  
of mucins,  which correlates well with the ecological niche of  C. glabrata, i.e.  the colonization of  








In order to further characterize the binding specificities of Epa1A and its variants, a closer look was  
taken  at the binding data for the mono- and disaccharides present within the CFG glycan array 
(Figures  6.17 –  19). Monosaccharide affinity is informative about the binding specificity of the 
calcium – CBL1 – W197 sub-pocket (Fig. 6.4), while disaccharide binding can  show the binding 
preference of the entire pocket in a much more defined way than the entire array. On the other hand, 
the array delivers a much more thorough profile and sets the glycan binding protein in a more  
biologically relevant context, as most oligosaccharides found within human tissues are larger than 
disaccharides, as figure 6.16 b shows. Another important point about the disaccharide representation 
is that both during the fluorescence titrations presented in this work and in previous ones  [155] 
lactose (Galactose-β1-4Glucose)  was chosen as a putative ligand. The disaccharide array shows 
very  clearly  that  lactose  is  bound with  very  low affinity  when compared to  other  sugars,  and 
therefore cannot be a primary ligand of Epa1A.
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Table 6.4: Distribution of carbohydrate ligands per type. Numerical values.
     O-glycan, core 1;        O-glycan, core 2;      O-glycan, core 3;      O-glycan, core 8;  
Blood group I  containing oligosaccharides;       Complex N-glycans;       Sulfo-
Galactose containing carbohydrates;      Other carbohydrates.
For each of the proteins, the left column represents the distribution of ligands that  
bind with at least 20% of the fluorescence intensity of the top binder for that protein.  




Figure 6.17: Array of all monosaccharides present in the CFG glycan array V4.1 with binding intensities  
for Epa1A and variants. Monosaccharides were ordered in decreasing binding intensity for  Epa1A at  
1 µg/ml, and all others were maintained in the same order for comparison purposes. The preference of  




Figure  6.18: Array of all  disaccharides present on the CFG glycan array V4.1 with binding  
intensities for Epa1A at different concentrations. Glycans were ordered  by  increasing binding 
intensity at 1 µg/ml, and kept like that at all other concentrations for comparison purposes. The  
high affinity for the T-antigen  (boxed in red)  is clear in this array, as represented by the two  
highest peaks. When protein availability becomes critical, at 1 µg/ml, Epa1A appears to prefer  
the  T antigen which is  β-o-linked to  the  surface rather  than the  α linked.  However, at  less  
limiting concentrations it does not show any strong preference. Lactose and its corresponding  
binding intensities are framed in blue, evidencing the weakness of Epa1A binding to lactose. 
Results
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Figure 6.19: Array of all disaccharides present on the CFG glycan array V4.1 with binding intensities  
for  Epa1A variants  at  200µg/ml.   Glycans  were  arranged  in  the  same  order  as  in  Fig.  6.19 for  
comparison  purposes.  In  all  cases,  it  can  be  clearly  seen  that  through  the  change  in  CBL2,  the  
preference for the T-antigen has been diminished (red box). Epa1→6A shows a high promiscuity with  
any  disaccharide  with  a  galactose  at  the  non-reducing  end,  while  in  the  case  of   Epa1→2A the  
preference has been reverted, and the T-antigen is not within the strongest binders anymore.  There is  
also a marked increase for the affinity towards   galactose-α1-3 containing disaccharides (green boxes). 
Epa1→3A shows very weak binding in all cases. Lactose (blue box), is very weakly bound, as was the  
case for Epa1A.
Results
6.1.8 Quantitative carbohydrate binding assays via fluorescence titration
Titrations were performed with the putative ligand of Epa1A, lactose (galactoseβ1-4glucose)[155], 
and  the  T-antigen  (galactoseβ1-3N-acetyl-galactosamine). The  T-antigen  was  one  of  the  best 
binding disaccharides for Epa1A and variants (figures 6.18 and 6.19), and was very similar to the 
β1-3 disaccharide found in the Epa1A and Epa1→6A co-crystal structures (Fig. 6.5).
All titrations  were  repeated  three  times,  averaged and processed  as described in  section  5.3.5, 
yielding the titration curves as exemplified in Figure 6.20 (see Appendix III for a full list). 
Fits were performed using equation 5.5 for total (specific and non-specific) binding. Quality control 
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Figure  6.20:  Examples of fluorescence titration curves against lactose and the T-antigen. Up: titrations  
against  lactose  for  Epa1A  and  Epa1→2A.  Bottom:  titrations  against  the  T-antigen  for  Epa1A  and  
Epa1→3A.  The ligands are illustrated under the corresponding Epa1A titration curves. All fits (red) where  
performed with equation 5.4.
Results
for the data by Scatchard plots[238] showed that some of the measurements presented apparently 
two different binding sites (Fig. 6.21). Fitting with equation 5.6 gave slightly better R² values, but at 
least one of the two dissociation constants had very high standard errors (see Annex II). Since the 
total binding regressions did not present significantly worse fits and less error prone constants, the 
simplest possible model, as represented by equation 5.5, was adopted.
Protein
Lactose
Kd (µM) Qmax (%) NS (10-3/µM) R2
Epa1A 24.9±5.1 17.1±0.9 1.9±0.8 0.97
Epa1→2A 200±43 23.1±1.1 -0.03±0.54 0.97
Epa1→3A 6850±3670 12.8±3.3 0.14±0.04 0.97
Epa1→6A 23.5±5.2 16.6±0.9 2.1±0.9 0.96
Table 6.5 Summary of the constants obtained by fluorescence titration for Epa1A and its variants.  
Kd: dissociation constant. Qmax: maximum quench. NS: non specific binding constant.  
R2: correlation coefficient.
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Figure 6.21: Examples of scatchard plots. Left: lactose titration against Epa1→6A. The fits show that there  
were two different binding processes during titration. Right: in the case of the T-antigen's titrations against  





Kd (µM) Qmax (%) NS (10-2/µM) R2
Epa1A 1.4±0.1 23.8±0.6 6.8±0.8 0.99
Epa1→2A                                                                 
Epa1→3A 17.9±5.2 12.9±1.3 8.1*10-4±3.0*10-4 0.97
Epa1→6A 0.8±0.1 22.5±0.7 9.6±1.1 0.99
Table 6.6 Summary of the constants obtained by fluorescence titration of Epa1A and variants  
against th T-antigen. At conditions where T-antigen dissociation constants could be measured,  
Epa1→2A was not stable, and measurements presented strong dispersion of data, which made  
analysis impossible. Qmax: maximum quench. NS: non specific binding constant. R2: correlation 
coefficient.
When comparing the dissociation constants for lactose and the T-antigen, it becomes immediately 
apparent that the T-antigen is a much better binder than lactose. Epa1A and Epa1→6A  displays at 
least 20-fold higher affinities for the T-antigen than for lactose. The case of Epa1→3A is especially 
interesting, since the binding of lactose can be considered marginal, while the binding for the T-




6.2 Lewis antigen binding adhesins from H. pylori
The Lewis antigen binding adhesins of Helicobacter pylori, mainly the blood group antigen binding 
adhesin  (BabA)  and the  sialic  acid  binding  adhesin  (SabA),  are  important  determinants  in  the 
colonization  of  the  human  gastric  mucosa[79].  BabA has  been  proposed to  be  responsible  for 
primary binding to fucosylated blood groups, while SabA acts as a secondary binder to sialylated 
Lewis antigens upon activation of the host's inflammatory response[92].  Both proteins are therefore 
crucial  in  the  understanding  of  H.  pylori colonization  of  the  stomach,  and  represent  for  the 
development  of  bactericidal  drugs  targets  alternative  to  the  transpeptidases  and  the  bacterial 
ribosome.  Interestingly,  though,  almost  no  in  vitro work  has  been  performed  on  these  two 
proteins[239]. Currently, there is no information on the bio- and physicochemical characteristics of 
these proteins, nor of their interactions with possible ligands, only information derived from genetic 
experiments  or  patient  isolates.  In  this  work,  extracellular  fragments  of  BabA  (gene  ID: 
AAC38081.1) could be expressed, refolded and characterized by CD and semi-quantitative glycan 
affinity measurements, while SabA could be recombinantly expressed for the first time.  Table 6.7 
gives a short summary of the employed fragments. And their nomenclature.
Name Length Relative length Molecular weight (kDa) pI
BabA full length 741 1 - 741 80.3 9.03
BabA 144 158 21-163 16.9 6.72
BabA 210 224 21-229 24.1 6.73
BabA 235 249 21-254 26.7 7.68
Table 6.7: BabA full length characteristics and derived extracellular fragments. The relative  
lengths refer always to the region within BabA full length represented within the fragments.  
Fragments are 15 amino acids longer than the relative sequence length since they needed a start  
codon for translation and a C-terminal His-tag with a linker for affinity purification. All values  




Since  much  of  the  biophysical  characterization  of  BabA relied  on  the  correct  interpretation  of 
changes in secondary and tertiary structure, a Jpred[232] in silico analysis of the BabA235 fragment 
was  undertaken  (Fig.  6.22).  The  resulting  secondary  structure  prediction  yielded  preliminary 
information (Table 6.8) that could be used to calculate a theoretical CD-spectrum using the K2d 
server and the poly-Lys method[240] (Fig. 6.23).
Jpred3 prediction of secondary 
structure
α- Helical portion (%) 34.1
β- Sheet portion (%) 15.7
Random portion (%) 50.2
Table 6.8: Predicted secondary structure 
portions for the BabA235 fragment using the 
Jpred secondary structure prediction of Fig.  
6.24.
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Figure 6.22: BabA235 jpred secondary structure prediction. The prediction is the output of a Jpred3  
job[232].
Figure 6.23:  K2d prediction of a spectrum  
with  secondary  structure  as  per  table  4.6  
(black)  versus  BabA235  CD  native  
spectrum at pH6 (red).
Results
6.2.2 Refolding of BabA fragments
BabA extracellular  fragments  could  only  be  produced  in  large  quantities  as  inclusion  bodies. 
Therefore, it was necessary to establish reproducible refolding methods. BabA fragments were first 
tested for refolding by dialysis. Concentrations of soluble BabA fragments measured by BCA test of 
pellet  and supernatant  fractions showed promising analytical  results,  with up to 92 % refolded 
protein.  However,  upscaling  proved  very  challenging,  and  alternatives  were  tested.  The  iFold 
system 2  refolding  screen  (Merck)  permitted  high-throughput  screening for  effective  and cheap 
refolding conditions (figure 6.24). 
Condition E4 (0.1M HEPES pH 7.5, 0.5 M Arginine) was selected for further optimization, due to 
its good results in the screen and simple composition. Low reproducibility for condition E4 was 
counter-acted by supplementing it with 6 mM GSH and 4 mM GSSG. All other fragments of BabA 
could be maintained in solution under the same conditions. In order to characterize the refolded 
proteins, the high concentrations of arginine had to be reduced, as they are deleterious for analytical 
methods.  A  microdialysis  screen  against  different  buffers  provided  information  on  the  best 
conditions for storage and characterization (Figure 6.25). Based on this, 50 mM Tris/HCl pH 6, 200 
mM NaCl and 50 mM CHES pH 9, 200 mM NaCl were chosen as candidates. Although the pH 6 
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Figure 6.24: Graphical view of the iFold system 2 protein refolding screen  
for BabA 210.  The lower the dispersion at  340 nm, the less  particulate  
could be found in the condition, which was interpreted as BabA insoluble  
aggregates. Condition E4 was selected for refolding, as it had a very low  
signal, and had an inexpensive composition.
Results
condition did not yield optimal results, it was considered to best represent  in vivo  conditions for 
BabA. On the other hand, conditions 7 and 8 in Fig. 6.22 initially seemed to be very promising, but 
presented poor reproducibility during upscaling for further tests.
Upscaling yielded maximal concentrations of ~15 mg/ml for BabA 210 and 235 at pH 9, while only 
3 mg/ml could be achieved under  pH 6.  As for BabA 144,  the protein was almost  completely 
insoluble at pH 6, while maximal concentrations at pH 9 where around 5 mg/ml (Data not shown).
6.2.3 CD spectroscopy of BabA 235
Initial CD measurements at conditions obtained from 6.2.1 showed a marked pH dependency of the 
overall folding characteristics (Figure 6.26 b) and d)). To further characterize the dependency, the 
Tris/HCl and CHES buffers were substituted for the more broadly buffering potassium phosphate 
buffer, and an entire screen ranging from pH 2 until pH 10 was performed (Fig. 6.26). Interestingly, 
mildly acidic pHs seemed to induce a compact fold, which denatured cooperatively and irreversibly, 
while  strongly  acidic  or  basic  pHs  produced  reversible  denaturation  with  very  little  or  no 
cooperativity when melting (Table  6.10). Neutral pHs were not tested, as protein solubility was 
negligible at or around pH 7. The behavior of BabA 210 was consistent with the one observed for  
BabA 235, but this was not the case for BabA 144, which could not be folded at  all (data not 
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Figure  6.25: Microdialysis results of BabA 235 against different storage buffers. After at least 12 hour  
dialysis,  samples  were  centrifuged,  pellet  and  supernatant  were  separated  and  loaded  on  SDS-
polyacrylamide gels. On the lower right side, samples are correlated to the screen. Protein is accumulated  
in the supernatant under  very basic pHs (13 – 24), while it is mostly insoluble at neutral pHs (9 – 18).  
P: Pellet. SN: Supernatant. An asterisc (*) marks selected supernatants for CD quality control. 
Results
shown).
Another interesting feature of the pH dependent spectra is that, regardless of the program employed, 
spectra within the mildly acidic range could be much better and more reliably deconvoluted than the 
ones in strongly acidic or basic range (Fig. 6.26 illustrates K2d[228] deconvolution results in green 
and Table 6.9 gives the results of these deconvolutions), up to the point where the deconvolutions at 
pH 10, 9, 4, 3 and 2 were considered unreliable by the software (Table 6.9). 
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Figure 6.26: pH dependency of BabA 235 fragment as followed by CD spectroscopy. Spectra (left) and  
melting curves (right) under each epigraph show the unfolding process under different  pHs. Spectra:  
black for native spectrum, red for spectrum after melting curve, blue for spectrum at 95 °C, green for  
deconvolution result with K2d[228] . Melting curves: black for melting, red for cooling. Protein thermal  
denturation was followed at 220 nm.
Results
pH 10 pH 5
α- Helical portion (%) 63 α- Helical portion (%) 34
β- Sheet portion (%) 6 β- Sheet portion (%) 16
Random portion (%) 31 Random portion (%) 50
Square distance (θ) 786 Square distance (θ) 90
Maximum error (%) >22.7 Maximum error (%) 18.2
pH 9 pH 4
α- Helical portion (%) 23 α- Helical portion (%) 32
β- Sheet portion (%) 23 β- Sheet portion (%) 19
Random portion (%) 55 Random portion (%) 49
Square distance (θ) 99.47 Square distance (θ) 134.1
Maximum error (%) >22.7 Maximum error (%) >22.7
pH 8 pH 3
α- Helical portion (%) 30 α- Helical portion (%) 31
β- Sheet portion (%) 13 β- Sheet portion (%) 10
Random portion (%) 56 Random portion (%) 58
Square distance (θ) 77 Square distance (θ) 398
Maximum error (%) 18.2 Maximum error (%) >22.7
pH 6 pH 2
α- Helical portion (%) 31 α- Helical portion (%) 41
β- Sheet portion (%) 10 β- Sheet portion (%) 16
Random portion (%) 59 Random portion (%) 43
Square distance (θ) 16 Square distance (θ) 545
Maximum error (%) 8 Maximum error (%) >22.7
Table 6.9: Deconvolution results from K2d[228]. The program takes a maximum relative error of  
22.7 as the uppermost cut-off for a reliable deconvolution. Only the deconvolution data within the  
mild pH range from 8 to 5 can be considered reliable, while the rest does not adjust well to the  
sample spectra employed during the deconvolution process.
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Results
pH Initial ΔH 
(kCal/mol)
Tm (°C) Quality of fit (R2)
10 -9.2±1.3 41.4±3.1 0.98
9 -8.1±1.0 31.7±4.7 0.99
8 -22.2±0.9 51.8±0.4 0.94
6 -19.2±0.3 41.4±0.2 0.99
5 -38.9±1.2 41.7±0.2 0.97
4 -35.2±1.1 50.4±0.2 0.97
3 -18.7±0.7 50.7±0.4 0.95





Tm (°C) Quality of fit (R2)





Table 6.10: Initial enthalpies and melting temperatures of the melting process of BabA 235 against  
pH. Although melting temperatures (Tm) are a measure of overall fold stability, initial enthalpies are 
a better measure of sigmoidicity in a melting curve (equation 5.19), and therefore fold compactness.  
A denaturation with an initial enthalpy of 0 will show a linear melting curve, while very negative  
initial enthalpies give very steep sigmoidal curves. All values calculated with QtiPlot and equations  
provided in [227]. The last two rows show the data for the spectra in Fig. 6.28 b and c, respectively.  
Data at pH 5.8 are calculated with a three state model based on the Greenfield equations, therefore  
it produces two melting temperatures and two initial enthalpies.
Interconvertibility between the two pH dependent conformations was tested by preparing two sets 
of samples. The control set was composed of two samples that had been directly refolded and buffer 
exchanged to pH 6 and pH 2.5 in 10 mM potassium phosphate buffer (Fig. 6.28 a and b). The 
transition set was composed of 1 aliquot of the control sample which had been diluted 4 times in 
0.1 M potassium phosphate buffer pH 6 for a final pH of 5.8 and incubated on ice for at least 2 
hours (Fig. 6.27 c) and table  6.10, last row). The results show that the protein is capable of  pH 
dependent interconversion, and that the resulting structure is very similar to the compact refolded 
state achieved when the protein is directly refolded at pH 6. Interconversion is not perfect, though, 
as some of the protein does not denature in the same manner, but presents much higher stability,  
resulting in two distinct transitions (Table 6.10 and Figure 6.27 c).
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Results
pH 6 pH 2.5 pH 5.8
α- Helical portion (%) 31 32 31
β- Sheet portion (%) 10 16 11
Random portion (%) 59 52 58
Square distance (θ) 16 48 28
Maximum error (%) 8.0 9.7 8.0
Table 6.11: K2d deconvolution results for the transition spectra in Fig. 6.26. The values for pH 6 are  
written for comparison purposes. For pH 2.5 the CD curve could be fitted properly, but most importantly the  
secondary structure values of the transition spectrum and at pH 6 correlate very well, pointing to a common  
structure.
129
Figure 6.27: Transition of the BabA 235 relaxed conformation to the compact conformation as monitored  
via CD spectroscopy.  Left,  black: native spectrum, red: denatured spectrum, blue: spectrum at  95 °C.  
Right, black: melting curve, red: cooling curve, green: result of K2d deconvolution (Table 4.10). a) Sample  
refolded with a final pH of 6. It is the same spectrum as Fig. 6.22 d, presented here for comparison. b)  
Sample  refolded  with  a  final  pH of  2.5.  c)  Sample  refolded  with  a  final  pH of  2.5,  which  was  then  
equilibrated with buffer at pH 6 for a final pH of 5.8. A 3-state denaturation can be observed in c
Results
6.2.4 pH dependent analytical gel filtration of BabA 235 fragment
Analytical gel filtration was performed to obtain a different, more structure-oriented perspective on 
the transition of the two BabA 235 conformations. Two gel filtrations were performed, one at pH 
2.5 and another at pH 6. In both cases, protein at 2 mg/ml was loaded in refolding buffer, as the  
buffer was directly exchanged within the column (Fig 6.28). It is apparent from these results that the 
protein is tightly packed at pH 6, while it is at least partially aggregated at pH 2.5. 
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Figure 6.28: Analytical gel filtrations of the BabA 235 fragment at different pHs. Gel-filtration at pH 2.5  
(red) shows a total of 3 peaks (I,II and III) of which I and II are the BabA 235 fragment, as demonstrated  
by SDS-PAGE (right). Peak I runs at an apparent molecular weight above 200 KDa, and therefore either  
represents an aggregated or a lax state of the protein. Peak II runs at an apparent molecular weight of  
~48 KDa, which is a good approximation to a dimeric protein. Peak III is not BabA 235, and was not  
further investigated. The gel-filtration at pH 5.8 (blue) shows only peak II and III, thus showing a more  
compact and defined fold under these conditions. The 12% SDS-PAGE gel (right) shows samples of all  
peaks, color-coded by curve of origin.
Results
6.2.5 High-throughput semi-quantitative binding assays of BabA 235
As with the Epa A domains, BabA 235 was tested for binding in cooperation with the Consortium 
for Functional Glycomics (CFG) on oligosaccharide-coated chips. In the case of BabA 235, the 
sample was stored at pH 2.5 and either exposed directly to the chip (Fig. 6.29 left), or after two hour 
equilibration in transition buffer at  a final pH of 5.8 (Fig. 6.29 right). 
The data showed a strong difference between the binding capacity at pH 2.5 and pH 5.8, with a 25 
fold stronger binding for the highest affinity carbohydrates at pH 5.8. That kind of difference could 
be  also  observed for  the   members  of  the  Lewis  antigen  family  (Fig.  6.30 and table  6.12).  A 
correlation  analysis  was  performed  for  the  two  conditions,  resulting  in  a  Pearson R²  value  of 
0.036% at a 95% confidence interval. These values indicate that there is no correlation between the 
measurements at pH 5.8 and at 2.5 as can be seen from the scatter plots presented at figure 6.31. 
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Figure 6.29: Binding of BabA 235 to the CFG V3.1 Chip at different pHs. Left: binding to the chip at pH  
2.5.  Right:  binding  to  the  chip  at  pH  5.8.  Each  number  on  the  x-axis  corresponds  to  a  unique  




Figure  6.30: Binding of the BabA 235 fragment to the different Lewis antigens  as  presented in the  
Glycan Array V3.1.  Gray: binding at  pH 5.8, Black: binding at  pH 2.5. carbohydrate numbers are  
given on the x-axis (table  6.9 or  Appendix I),  fluorescence intensity in arbitrary units on the y axis.  
Lewis  oligosaccharides  have  been  arranged  in  decreasing  binding  intensity  at  pH  5.8.  The  two  
strongest binders are a LeX dimer and LeY, while the putative LeB ligand for BabA is among the weak 
Lewis antigen ligands. Structures of the 3 ligands of interest are presented
Figure  6.31 Column scatter plots for BabA binding profiles on CFG glycan array V3.1. The point  
distribution within each pH is quite different, indicating a lack of correlation between the two.
Results
N carbohydrate structure
pH 5.8 pH 2.5
FI STD FI STD
337 GlcNAcα1-4Galb1-4GlcNAcb1-3LeX1-3LeX-Sp0 43347 1235 1507 100
67 LeY–Sp8 42098 1574 431 134
216 NeuAca2-3LeAb1-3LeX Sp0 18554 3601 147 65
352 KDNa2-3Galb1-4(Fuca1-3)GlcNAc-Sp0 17714 2274 639 225
361 LeAb1-2Mana1-3[LeAb1-2Man a1-6]Manb1-4GlcNAcb1-
4(Fuca1-6)GlcNAcb-Sp22
17080 5542 306 78
57 Fuca1-2Galb1-3GalNAca-Sp8 16909 1927 205 110
116 LeA–Sp8 16807 1102 178 52
272 LeAb1-3LeAb-Sp0 14773 3261 133 37
78 GalNAca1-3LeY-Sp0 14698 10736 499 53
206 Neu5Aca2-3(6-O-Su)LeX–Sp8 14315 2506 1000 123
143 Galb1-4GlcNAcb1-3LeX1-3LeX-Sp0 14295 1317 174 78
326 NeuAca2-3LeAb1-3LeAb-Sp0 13991 2803 528 186
280 LeX1-3LeAb-Sp0 13561 3358 161 37
135 LeX1-4LeX-Sp0 13397 2407 316 51
66 LeY–Sp0 12218 2740 264 29
227 Neu5Aca2-3LeX1-3LeX1-3LeX–Sp0 11978 6629 154 30
64 LeY1-3LeX-Sp0 11892 3301 259 49
114 LeAb1-3Galb1-4GlcNAcb-Sp0 11794 2103 156 61
133 LeX–Sp0 11499 4575 376 37
117 LeAb–Sp8 11345 2062 371 117
71 Fuca1-2Galb1-4GlcNAcb–Sp8 10873 3241 464 115
113 LeAb1-3LeX-Sp0 10407 2513 686 326
56 LeB–Sp8 10069 3387 525 247
94 Gala1-3LeY-Sp0 10011 2287 591 143
33 [3OSO3]LeX–Sp8 9625 2462 594 147
229 Neu5Aca2-3LeX–Sp8 9613 1299 435 148
215 Neu5Aca2-3LeAb–Sp8 9518 2660 519 114
228 Neu5Aca2-3LeX–Sp0 8827 1485 507 159
231 Neu5Aca2-3LeX1-3Galb1-4GlcNAcb-Sp8 8636 3900 956 180
257 Neu5Gca2-3LeX-Sp0 8141 3228 1032 427
350 LeAb1-2Mana1-3[LeAb1-2Mana1-6]Manb1-4GlcNAcb1-
4GlcNAcb-Sp19
7041 4486 659 112
133
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65 LeY1-3LeX1-3LeX-Sp0 6687 2305 453 107
232 Neu5Aca2-3Galb1-4GlcNAcb1-3LeX-Sp0 6098 1159 1372 242
134 LeX–Sp8 5488 1795 743 375
101 Gala1-3LeX–Sp8 4933 2925 478 204
368 Gala1-3LeX1-2Mana1-3[Gala1-3LeX1-2Mana1-6]Manb1-
4GlcNAcb1-4GlcNAcb-Sp20
4749 956 558 486
358 LeY1-2Mana1-3[LeY1-2Mana1-6]Manb1-4GlcNAcb1-
4GlcNAb-Sp20
4349 1048 489 93
364 Fuca1-2Galb1-3GlcNAcb1-3[LeX1-6]Galb1-4Glc-Sp21 4115 2582 291 80
245 Neu5Aca2-6Galb1-4GlcNAcb1-3LeX1-3LeX-Sp0 3974 1459 689 195
136 LeX1-4LeX1-4LeX–Sp0 3187 1518 735 242
230 Neu5Aca2-3LeX1-3Galb-Sp8 2609 371 743 340
Table 6.12: Binding of BabA 235 fragment to the Lewis antigen series present on the CFG 
glycan array 3.1 at pH 5.8 and 2.5. Oligosaccharides are ordered by decreasing binding intensity.  
Lewis X: Galb1-4(Fuca1-3)GlcNAcb. Lewis a: Galb1-3(Fuca1-4)GlcNAc. Lewis Y:Fuca1-2Galb1-
4(Fuca1-3)GlcNAcb.  Lewis b: Fuca1-2Galb1-3(Fuca1-4)GlcNAcb. Bold: Lewis antigen 
fragments. FI: fluorescence intensity. STD: standard deviation of fluorescence intensity.
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6.2.6 Other Strategies for BabA235
Several  other  strategies  were  pursued  for  the  expression,  purification  and  characterization  of 
BabA235. Even though no effort was spared to obtain BabA235 protein crystals, the concentration 
limitations at pH 5.8 and the aggregation proneness at pH 2.5 proved to be strong impediments. The 
strategies presented here where aimed to either produce pure, stable, homogeneous and  soluble 
protein or to find alternative ways to  structurally characterize BabA235.  None of them yielded 
conclusive results, and they were set aside to proceed with the working system as described above. 
In this section, a small sample of the results of these other strategies will be presented.
6.2.6.1 Alternative constructs to obtain soluble protein.
Several different constructs were tested for the BabA extracellular fragments in order to obtain 
soluble  protein,  as  opposed  to  inclusion  bodies.  Table  4.10 shows  all  the  different  constructs 
produced for BabA.
Three different strategies were pursued to try and obtain soluble protein, namely:
• Cloning  variants  from other  H. pylori  strains  (J99,  G21 and  P12),  which  had  all  been 
characterized as Lewisb binding. BabA is extremely polymorph, and therefore it is possible 
that different variants might present widely different physical properties (table 6.13).
• Targeting to the extracellular or periplasmic space through the use of the pET20 vector, 
which codes  for  an N-terminal  E. coli protein export  signal  peptide within the multiple 
cloning site.
• Generating fusions with thioredoxin (Trx), maltose binding protein (MBP) and glutathione 
S-transferase (GST), which are all classical, highly soluble proteins which can be used both 
as affinity tags and as a way to increase protein solubility (table 6.14).
Obtained constructs were subjected to a much more exhaustive screening than that presented in 
table 5.5, section 5.2.1.1. E.coli strains BL21(DE3) Gold, Origami 2, Arctic Express, Shuffle, RIL, 
Rosetta  and  Rosettagami  were  tested  at  temperatures  ranging  from  12  °C  to  37  °C,  IPTG 
concentrations  ranging from 0 to 1 mM and incubation periods from 4 to 72 hours (Data not 
shown). Under none of these conditions could soluble protein be obtained.
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Strain Gene ID Fragments length Molecular Weight pI Identity with 
26695
J99 890058 babA 
210 21-231 22.5 kDa 7.9
87%235 21-256 25.2 kDa 8.8
255 21-276 27.2 kDa 8.3
G27 6963184 babA 
210 21-231 22.4 kDa 5.49 90%
235 21-231 25.0 kDa 5.56 90%
255 21-276 27.1 kDa 5.6 89%
P12 7010027 babA
210 21-231 22.4 kDa 4.78 90%
235 21-231 25.1 kDa 5.02 90%
255 21-276 27.2 kDa 5.07 89%
Table 6.13: BabA fragments from alternative strains. Molecular weights and isoelectric points  
where calculated with the ProtParam web tool[170], sequence identity was calculated using the  
blast2seq server[144]. It is important that pIs, molecular weights and sequence identities were  
calculated for the fragments without including affinity, tags, start methionines, etc.
Vector feature
pET20b(+) Periplasmic secretion signal PelB
pETM-21 Trx ORF 
pETM-41 MBP ORF
pETM-30 GST ORF
Table 6.14 Alternative vectors used for optimizing expression.  
Vectors of the pETM series were kindly provided by by the  
Protein  Expression  and  Purification  Core  Facility,  EMBL  
Heidelberg, Germany.
 
6.2.6.2 Alternative analytical methods tested on BabA 235
Alternative  ways  to  characterize  the  BabA  extracellular 
fragments, 235 in particular, were tested in  cooperation with 
other research groups. 
In  order  to  characterize  the  different,  pH  dependent 
denaturation  pathways,  1D  H1NMR  spectra  were  to  be 
measured  by  Dr.  Xiulan  Xie,  Philipps  Universität  Marburg. 
Spectra could only be taken at pH 2.5, due to the concentration 
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Figure  6.32 Methylen  zone  of  the  
BabA235  NMR spectrum.  Very  low 
dispersion  of  peaks  indicates  a  
molten globule, or an unfolded state.
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limitations at  pH 6. The spectrum at pH 2.5 shows low dispersion within the methylene range, 
which is characteristic of molten globules[241] (Fig. 6.32). Thermal denaturation of BabA 235 at 
pH 2.5 could not be followed by this method, as the temperature range was not wide enough (the 
maximum  temperature  that  the  NMR  device  could  achieve  were  50°C)   the  concentration 
limitations made it impossible to proceed  in the same way at pH 6, and therefore no comparison 
was possible.
An attempt to characterize the BabA conformational transition was performed using the hydrogen 
deuterium exchange mass spectrometry (HXMS) method[242][243].  
BabA235 underwent an HXMS experiment at both pH 5.8 and pH 3 by Mrs. Katharina Krammer 
under supervision of Dr. Uwe Linne.  Manual measuring procedures and climatization problems 
made the resulting data very difficult to evaluate, and the constants were not readily usable (data not 
shown). 
6.2.7 Recombinant expression and purification of SabA extracellular fragments.
SabA is one of the other main adhesins in  H. pylori pathogenesis, binding mainly sialyl-Lewisx 
molecules expressed by inflamed epithelial cells.
[92] As such, it was another very good candidate 
for  characterization  of  pathogen-host  adhesion 
mechanisms, and is also a very interesting target 
for drug-development .
Three  different  SabA  gene  fragments  were 
isolated by PCR amplification from the genome 
of  H. pylori  26695 (Table 6.15) and cloned over 
NcoI and XhoI restriction sites into the pET28a 
vector  with  a  C-terminal  6-histidine-tag.  No 
signal  peptide  was  detected  by  the  SignalP 3.0 
server[244],  as was expected due to the genetic 
regulation  of  SabA  expression[245].  Finally, 
cloning success was validated by sequencing.
137
Figure  6.33:  SabA260  production  and 
purification.  Arrows mark the SabA260 band. a)  
Western  blot  of  a  solubility  test  of  a  SabA  
expression in E.coli BL21(DE3) Gold. b) Sample  
purification.  Left,  pooled  SabA260  containing  
fractions  after  NiNTA.  Right,  sample  fraction  
after Gel-filtration.
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Fragment length Molecular 
weight
pI
180 1-180 19.4 kDa 5.4
260 1-260 28.4 kDa 7.7
325 1-325 35.3 kDa 8.5
Table  6.15 SabA fragments. Data was predicted  
using  the  ProtParam  webtool,  no  tags  were  
included for these calculations.
After analytical expressions as described in table 5.5, Western blotting detected small but significant 
amounts of SabA260 in the supernatant (Fig. 6.33 a), while no expression could detected for any of 
the other two fragments (data not shown). Purification by Ni-affinity columns and Superdex 200 
size exclusion chromatography yielded relatively pure protein at a rate of ~0.1 mg per L of culture 
(Fig. 6.33 b). 
Crystallization  trials  have  been  started  without  any  positive  results  yet,  and  a  functional 




C. glabrata and H. pylori have received much attention in the field of infection biology, since they 
are considered to be to emergent, and widely spread pathogens[45][77]. The research performed on 
C. glabrata and H. pylori  has been mainly based on ex-vivo clinical samples or whole cell studies. 
This approach has the advantage of setting the organism within its native ecological niche, and 
therefore allows for system-wide information to be obtained. On the other hand, it can't  answer 
questions about the molecular nature of the interaction between the pathogen and its host, and is 
prone to  produce ambiguous results,  which are not  easy to  interpret.  The  in  vitro biochemical, 
functional and structural  studies performed in this  work address precisely these weak points in 
current research, and complement it with strong molecular evidence.
Interestingly,  the combination of  in vivo and  in vitro evidence highlights important similarities  in 
the adhesion behavior of such distant organisms as C. glabrata  and H. pylori. While the BabA and 
Epa  adhesins seem to  follow  completely  different  paths  to  be  exported  and  presented  on  the 
surface[63][106], they appear to show similarities in their binding specificities, targeting branches 
and cores of mucin O-glycans.  The adhesion behavior of both organisms could be shown to vary 
rapidly between different colonization sites[90][27][26]. Compelling evidence could be presented 
for how such changes can occur on the molecular level. Finally, a flocculation-like behavior could 
be postulated for H. pylori, reminiscent of the functions of fungal adhesins[1]. 
In conclusion,  the molecular evidence points towards a process  of convergent evolution towards 
the  mucin-mediated  colonization  of   human  epithelial  tissues  of  two  distantly  related,  but 
functionally similar, adhesion systems.
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7.1 H. pylori adhesin BabA
H. pylori  is one of the most prevalent pathogens in the human population[77],  And is therefore 
considered one of the main targets for drug development. One of the differential systems that could 
be used for efficient therapy is the adhesin system, which has been described as crucial for infection 
and persistent colonization of the stomach. First and foremost in the adhesion system is the blood 
group antigen binding adhesin (BabA), which acts as primary receptor during colonization[4].
In this study, BabA could be produced for the first time in large quantities, and reliably refolded into 
functional, soluble protein. New biophysical and biochemical insights could be obtained, showing 
that BabA presents an extremely dynamic structure. Finally, a strong pH dependent activity could be 
studied via the Consortium for Functional Glycomics technologies, which could be set in a wider,  
more physiological context[90]. 
7.1.1 The BabA extracellular domain can suffer profound pH-dependent conformational  
changes.
Even though the Hp_OMP domain (pfam accession number PF01856[246]) is unique to the  H. 
pylori species[123], it  has been shown that it  has the characteristic C-terminal outer membrane 
insertion sequence[89], consisting of a C-terminal phenylalanine (Hop family) or tyrosine (Y-Hop 
sub-family) and an 11 amino-acid long C-terminal sequence composed mainly of aromatic residues. 
The outer membrane insertion sequence is a characteristic of the vast majority of OMPs[124], and 
therefore, it can be assumed that the Hp_OMP domain will insert itself and show a similar β-barrel 
like  structure.  This  claim  was  further  supported  by  the  fact  that  the  C-terminal  region  of  all 
Hp_OMP domain containing proteins shows rows of amphipathic sequences, which are predicted to 
form anti-parallel β-sheets and can be modeled into β-barrels (figure  7.1). In the case of BabA, 
amino-acids 547 to 741 are predicted to contain a total of 5 to 7 long, amphipathic  β-strands, which 
is within the norm presented in the pfam curated model[246]. All members of the Hop family show 
very conserved C- terminal and N-terminal regions. A highly variable central to N-terminal region 
is supposed to confer ligand specificity in an unknown manner[42]. 
All this information suggests that BabA will insert itself into the membrane in a similar way than 
the outer membrane proteins of other organisms, like OmpA, for example. If this would be the case, 
the C-terminal β-barrel like Hp_OMP domain would first be built into the membrane, leaving the 
N-terminal region within the periplasmic space (figure 7.1). In an autotransporter like fashion, the 
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N-terminal region would then be “threaded” through the newly formed pore or passed through the 
membrane in a Bam system dependent manner and extruded into the extracellular space, where it 
would be folded[105][106][120].
The CD data in section 6.2.2 and the size exclusion chromatograms in section 6.2.3 support the idea 
that, once in the extracellular space, the N-terminal domain of BabA shows a high plasticity and 
flexibility. At very acidic or basic pHs, the BabA extracellular domain seems to aggregate even at 
relatively low concentrations and to be present in a relaxed, open conformation, as can be seen from 
the  temperature  dependent  changes  in  dichroic  behavior  and the  elution  profile  at  pH 2.5.   In 
contrast to the aggregation-prone behavior, solubility under these conditions is high. As soon as the 
protein  is  submitted  to  mildly  acidic  or neutral  pHs,  it  forms  a  much better  defined,  compact 
structure,  as  observed  on  the  elution  profiles  and  CD  melting  curves  at  pH  6.  Interestingly, 
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Figure 7.1: Transmembrane topology of the BabA HP_OMP domain based on a JpredV3 prediction[232].  
The putative transmembrane  β-barrel is formed by 5 to 7 antiparallel, transmembrane β-strands (β-1-3 and  
5 to 8), spanning through the outer membrane (OM). On the extracellular side, one short  β-strand ( β-4)  
and 3 α-helices can be found. The length of each secondary structure feature is given by the start and end 
amino-acids on the table  on the right.  Numbers  in  parentheses  imply  length discrepancies  between the  
different evaluation methods offered by the Jpred server.  β-strands marked with an asterisk (*) were given  
low confidence by the Jpred algorithm. With or without the low probability strands, the N-terminal adhesion  
domain of BabA (blue) topologically ends in the periplasm, and needs to be exported into the medium across  
the membrane. This will most likely be accomplished in an autotransporter-like fashion[106].
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solubility is very low at mildly acidic pHs, even though the theoretical pI of he protein is 7.7.
The contrast between these two structural isoforms suggests that the BabA extracellular domain 
does not fold entirely at extreme pHs, but forms a molten-globule like structure[247]. The  BabA 
molten  globule  structure  is  characterized by  a  strong  tendency  to  aggregate  maintaining  high 
solubility.  This suggests  small  sized  aggregates[248] as  corroborated  by  size  exclusion 
chromatography, where most of the BabA aggregates at pH 2.5 elute within the column volume. 
In contrast, at mildly acidic  pHs, the conformation is much tighter, but presents a much higher 
tendency to precipitate at mid to high concentrations. The aggregates formed upon concentrating are 
very large, as they immediately precipitate and were visibly removed from the suspension upon 
sterile filtering, as evidenced by a decrease in turbidity and a tendency to clot the filter. As, of 
course, unfiltered samples would clot the equipment and seriously damage it, no attempt was made 
to characterize the unfiltered suspension over size exclusion chromatography.
The compact state at mildly acidic pHs is the active state of the protein, probably stabilized by salt 
bridges, as is implied by the fact the the relaxed conformation is obtained by providing an excess of 
either  negative  or  positive  charges  to  the  protein  (Figure  7.2).  The  instability  of  the  active 
conformation might be explained through a still not completely folded state, which needs the ligand 
to perfectly fold, as was proposed before for some enzymes by Koshland[249]. This idea is further 
supported by the carbohydrate-binding profile of Fig. 6.28 b), which shows a moderate specificity, 
but high avidity for certain carbohydrates.
To summarize, BabA is present on the cell  surface of  H. pylori in a mixed state, ranging from 
completely molten globular at extreme pHs to partially folded at mild pHs. Upon binding to its  
ligand, BabA might undergo a third conformational change which yields the fully folded protein 
(Figure 7.2).
This model for BabA structure plasticity is in no way incompatible with previous studies, as the 
aggregation proneness of both the relaxed and compact conformations would be counteracted by the 
relative scarceness of BabA on the H. pylori surface, and the fact that it would only adopt its folded 
conformation upon entering the ecological niche where the ligand would be present (i.e., the deep 
mucous layer of the gastric antral region). It  is also not incompatible with the fact that no Lewisb 
binding activity has been characterized for  H. pylori strain 26695, as it could be shown that the 
specificity is shifted for the BabA presented in this work. Finally, it still holds true for any other H. 
pylori strain, because pH dependency in the binding and activity of H. pylori adhesion factors has 
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been studied and demonstrated for a wide variety of strains[90][250].
On the other hand, it very nicely complements BabA heterogeneity[122], polymorphisms[121] and 
H. pylori host-evasion mechanisms[251] by presenting an expression-independent and rapid BabA 
activity  regulation  mechanism.  A pH-dependent  conformational  transition  is  not  an  uncommon 
mechanism  to  modulate  activity,  as  has  been  shown  for  human  growth  hormone[243],  or 
γ-conglutin[252]. It has also been recently pointed out as a feature of H. pylori binding to the gastric 
mucosa[87], specifically for the BabA-Muc5A interaction over Lewisb antigens.
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Figure 7.2: The BabA extracellular domain has four possible conformational states. At mild pHs, low  
concentrations and no ligand (center), the BabA extracellular domain is in a compact, but not fully  
folded state, which is aggregation prone. If the concentration is raised to unphysiological levels, BabA 
aggregates and, after the aggregates reach a critical size, they precipitate (center, low). If the ligand is  
supplied, the BabA extracellular domain fully folds around it (top). If the pH is either lowered or raised  
dramatically, salt-bridge partners stabilizing the tertiary structure of the compact conformation lose  
their charge, and therefore the domain unfolds, showing larger hydrophobic patches (left and right).  
The protein then tends to aggregate through the hydrophobic patches, but a stronger positive (at acidic  
pHs) or negative (at basic pHs) nett charge prevents large aggregates from forming, and keeps small  
aggregates in solution. 
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7.1.2 H. pylori interacts with the host in a pH dependent manner
Recent results have shown that  H. pylori supports different binding modi for different anatomical 
parts of the host's gastrointestinal tract, and that the activation of the different binding modi is pH 
related[90]. The results in the present work (sections 6.2.2 to 6.2.4) highly support a pH dependent 
modulation of BabA binding activity (see 7.1.1.). 
It is therefore possible to postulate a model of  H. pylori  mucosal binding in which BabA is only 
active on the cell surface at mildly acidic to neutral pHs, while it will remain inactive at strongly 
acidic pHs, not unlike the conditions to be found within the gastric lumen (Fig.  7.3). Under this 
model, the conformational flexibility of BabA contributes to the positioning and permanence of H. 
pylori  in the antrum. As  H. pylori  would enter the gastric lumen, it would come in contact with 
highly glycosylated mucins in solution projected from the mucosal surface. With the gastric lumen 
at pHs well below four, BabA would not be active and no specific binding would occur under these 
conditions, only electrostatic interactions can take place[9][88]. The bacterium buries itself deeply 
into the mucin sheet above the epithelial cells in the lining of the stomach's antral region[128], the 
surrounding pH would start to raise, until it would surpass the threshold between three and four, at 
which point BabA would change its conformation and become active. The nearer H. pylori would 
get to  the  epithelial  layer,  the  longer  it  would  stay  stationary.  As peristaltic  mucous clearance 
eliminates layers of mucin surrounding H. pylori, the pH would start becoming more acidic again, 
at  which  point  BabA would  become  inactive,  thus  liberating  the  cell  from the  cleared  mucin 
molecules and allowing it to return to the mucous layer. As such, BabA conformational transitions 
would form a rapid and short range complement to other  conventional  chemotactic mechanisms 
described for  H. pylori, such as the CheA/Y system[83]. The mechanism of binding proposed in 
figure 7.3 would correlate quite well with other models, in which 4 different, tissue specific binding 
modi are proposed for H. pylori[90].
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7.1.3 BabA specificity shift towards LewisX and LewisY blood group antigens.
In vivo  analyses of  H. pylori have repeatedly shown that BabA binds preferentially Lewisb blood 
group antigens,  establishing  a  linear  relation  between pathogenicity  and BabA expression[120]. 
This information has been recently challenged by more detailed research, which portrays no simple 
relationship between strong Lewisb binding and BabA expression[121].
No BabA N-terminal consensus sequence responsible for  Lewisb-binding  has been characterized 
yet[122], only a 6 amino acid sequence whose deletion fully disables, but does not modulate, BabA 
activity [253]. BabA shows a rate of variability within the extracellular region which correlates well 
with the highly polymorphous  H. pylori[254]. Correspondingly, even though most bab- H. pylori 
strains do not bind Lewisb antigens, there are some that do, and within bab+ strains, affinity for the 
oligosaccharide can be extremely variable[42][122][255]. 
In  this  context,  the  seemingly  unexpected  result  that  the  refolded  BabA235  gene  product 
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Figure  7.3: Model for BabA dependent gastric colonization  by H. pylori  . I: H. pylori enters the human  
stomach through the oral cavity, and is chemotactically led to the epithelium of the antrum[83].II Once on 
the antral surface, H. pylori interacts electrostatically with the mucosal surface and (III) buries itself within  
it. BabA is in its relaxed conformation, and is not active under these conditions. IV: H. pylori enters the  
mucosal  region in  which the pH is  above  four.  Part  of  the  BabA population on the bacterial  surface  
transitions to the packed conformation and becomes active.  Around 90% of an  H. pylori colony will be  
found at this position[88].  V: H. pylori has reached the epithelial cell surface. After colonization, CagA  
mediated infection is  activated,  and as  a result,  the  stronger and more specific SabA binding is  made  
possible[92]. Under these conditions, peristaltic mucus clearance can liberate some of the colony members  
into  the  gastric  lumen (II)  at  which  point,  BabA would retransition to  the  relaxed  conformation,  thus  
becoming inactive. Again, chemotaxis can drive the first steps into the mucous layer or the bacterium might  
be washed from the stomach and into the duodenum (VI).
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preferentially  binds  LewisX and  LewisY instead  of  Lewisb (Fig.  6.29 and  table  6.10)  could be 
understood as a product of rapid evolution. The surface molecules of H. pylori are some of the most 
important targets in immune recognition of the pathogen, and are therefore subjected to a stronger 
evolutionary  pressure  than  other,  non-exposed  molecules.  Furthermore,  the  bab  system  is  in 
constant  fluctuation,  as  frequent  recombination  occurs  between  the baba and  the  babb gene 
loci[121], resulting in functional, yet varying gene products that are thought to keep the bacterium 
safe from immunological detection. 
Still, in the results presented in section 6.2, a completely different specificity has evolved, and not a 
modulation of the specificity or a cessation of activity. The question arises, as to why a shift towards 
LewisX and LewisY specificity for BabA might increase the survival potential of H. pylori within its 
human host.  H. pylori  produces LewisX  and LewisY antigens itself, and attaches them to its own 
lipopolysaccharide  (LPS)[256][257]. LPS-bound LewisX/Y recognition by epithelial cells is key in 
the  binding  of  the  gastric  surface,  even  though  the  putative  epithelial  lectin  has  not  been 
isolated[251], and can induce the production of anti-LewisX and anti-LewisY autoantibodies[258]. 
Anti-LewisX antibodies not only do not reduce H. pylori binding to epithelial surfaces, but make it 
better, and even increase both the epithelial damage and binding capacity in baba- mutants to levels 
that are superior to those of baba+ strains[127]. The model proposed by Sheu  et. al. was that  H. 
pylori  would  form  large  complexes  with  Anti-LewisX autoantibodies  and  epithelial  LewisX 
oligosaccharides present on tethered mucins, like muc5A, on the epithelial cell surface,  de facto 
avoiding completely  the  use of  a  lectin  and subverting  antibody function  (Figure  7.4 b)).  The 
resulting bacterial clusters would be fixed on the epithelial surface, resulting in several advantages 
for the pathogen. The clusters would present a much higher avidity for the human cell surfaces than 
the single  bacteria.  The individuals  within  the  cluster  would be  better  protected from both the 
extreme conditions of the stomach and, more importantly, from the host's immune response.
If a bab- strain, such as 26695, would manage to shift  BabA specificity towards LewisX or LewisY 
instead of Lewisb, it  would allow it to mimic Anti-LewisX  autoantibody behavior without having to 
rely on the host's specific immune response.  The result of such  a shift  would be an  H. pylori  
flocculating strain, which would not present a sparse Lewisb binding cells within the mucin matrix 
(Figure  7.4  a),  but  large,  highly  avid LewisX  binding  cell  aggregates  or  flocks  (Figure  7.4  c). 
Incidentally, a very similar survival strategy has long been described for the non-pathogenic yeast 
S. cerevisiae. In the baker's yeast, aggregation or flocculation, is mediated by the Flo5 adhesin[1], 
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whose A domain bears remarkable similarity to Epa1A from C. glabrata.
7.1.4 Outlook
The research presented in this work represents a first strong attempt to biochemically characterize 
BabA, one of H. pylori's main adhesins. Even though strong arguments could be delivered by these 
results, many questions remain open.
It is imperative to test the same procedures presented here for the H. pylori 26695 BabA with the 
equivalent adhesin from a Lewisb binding strain. Results in this direction would shed light on the 
nature of the specificity shift  of the 26695 BabA. The four-conformations model for the BabA 
extracellular domain predicts that protein stability should increase at mild pHs with a strong ligand. 
Stability tests through thermofluor assays might yield interesting results in this respect.
Obtaining soluble BabA through other methods than those attempted seems feasible, as for example 
the expression in Pichia pastoris has shown very good results in the expression of other recalcitrant, 
cysteine rich proteins (unpublished data). 
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Figure  7.4:  LewisX mediated, H. pylori-epithilium interactions.  a) Normal  H. pylori cells colonize the  
antral suface by binding LewisB antigens. b) In the model proposed by Sheu et. al. [127], anti-LewisX IgM 
auto-antibodies act as bridges between the LewisX molecules present on both the epithelial and bacterial  
cell-surfaces. b) In the model proposed here, specificity shifted BabA substitutes the IgMs to  produce the  
same result, but conferring the additional advantage for the pathogen of not having to wait until the  
specific immune response is activated by the host.
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7.2 Epithelial adhesins from C. glabrata
C. glabrata is an opportunistic pathogen which is responsible for the majority of iatrogenic fungal 
septicemia [44]. It can also be encountered in several, less severe diseases, like fungal vaginitis[45], 
infections of the oral cavity or the urinary tract[46].  A very important feature of C. glabrata is its 
extremely diverse and unique repertoire of adhesins, which allow it  to adhere in several different 
ways to its human host, and control the initial stages in pathogenesis[56]. It has been proposed, but 
never confirmed, that the different epithelial  adhesins (Epa) within the  C. glabrata  genome are 
responsible for the adhesion to different tissues[51][56]. 
The present work presents important discoveries for the understanding of the Epa adhesion system 
in the fields of biochemistry and structural biology. The structure of the A domain of Epa1 could be 
solved, yielding a profound and detailed knowledge of the carbohydrate binding pocket. As a result, 
the  Epa1A binding  pocket  could  be  transformed  through  mutagenesis  into  that  of  its  nearest 
relatives within the Epa family of proteins. These variant structures could be solved, and showed 
very enlightening differences within the Epa1A structure. The validity of the structural results was 
further confirmed through semi-quantitative, high-throughput binding assays in cooperation with 
the  Consortium  for  Functional  Glycomics  (CFG),  which  was  able  to  characterize  the 
oligosaccharide specificity for Epa1A and variants. Epa1→6A binding profiles could be compared 
with binding profiles for Epa6 found in literature[41]. The comparison showed that the specificity 




7.2.1 Comparison of the A domain from Epa adhesins with S. cerevisiae Flo5 flocculin
The  Epa1A domain  had  been  identified  as  a  PA14  domain  by  bioinformatic  analyses[64],  but 
sequence identity was very low when compared to other, structurally characterized PA14 containing 
proteins,  like  the  recently  published  Flo5A domain  structure[1],  or  the  name giving  protective 
antigen from B. anthracis[141]. It was especially surprising, therefore, that the structure of Epa1A 
could be solved by molecular replacement using a  highly simplified model based on Flo5A, as 
described in sections 5.5.1 and 6.1.1. 
The overall structure of Epa1A is quite similar to that of Flo5A, with an RMSD value of 1.34 Å 
over  122 common Cα atoms after aligning with the “super” command under pymol (Figure 7.5 a)). 
The entire β-sandwich is very well  conserved, while the loops surrounding it  are not,  and vary 
strongly in length between the two proteins. Epa1A is lacking a  Flo5-like subdomain from which 
several interactions with the α-1,2-mannobiose arise in Flo5A. This typical Flo5A like sub-structure 
had been predicted to be missing from Epa1A, as can be seen in the alignment on Fig. 6.2. 
Flo5A presents 4 disulfide bridges, two of which can also be found in Epa1A. These two cystins are 
formed by cysteins 49 and 178, and 179 and 262, respectively, and bind the C- and N-terminal 
regions together (Fig. 7.5 b and c). The result is a closed structure, where the C- and N-termini are 
grouped on one of the extremes, where the putative link with the B-domain  of the full  length  
adhesin should be.  The other two disulfide bridges of Flo5A are present within the subdomain, 
which is  missing in  Epa1A (blue region in Figure 7.5 a).  Epa1A presents  one disulfide bridge 
between C77 and C118 which is not found within Flo5A. This disulfide bridge could be of the 
utmost importance, as it covalently connects loop L1 and L2 (Figure 7.5 a), resulting in a firm outer 
shell for the binding pocket. 
Loops L1, L2 and L3 are  much more pronounced in Epa1A than in Flo5A and, although L2 is 
partially replaced by the subdomain, the Flo5A binding pocket is left much more exposed to solvent 
interaction (Figure 7.5 a). While both the CBL1 and the CBL2 loops are extremely well conserved 
in structure and position, there is no significant sequence homology in CBL2.  
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When compared to the prototypical PA14 domain[64], the superposition performed with “super” is 
much worse than for Flo5A, with an RMSD of 2.642 Å over only 71 common Cα atoms (Fig. 7.6). 
The  divergence  is  again  mainly  in  the  loop  regions,  with  L1,  L2  and  L3  loops  not  having 
counterparts  in  the PA14 domain.  The binding pocket  is  completely disrupted in  the protective 
antigen,  as  no  calcium ion  is  bound,  and  there  is  no  DcisD motif  on  CBL1,  with  one  of  the 
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Figure  7.5Comparison  between  Epa1A (grey)  and  Flo5A (green,  subdomain  in  blue).  a)  Whole  
structure alignment performed with the super command in pymol (RMSD 1.34Å over 122 common Cα 
atoms).  Numbering of the β-sheets is relative to Epa1A (Fig. 6.5).  Loops L1 and L2 are covalently  
bound by a disulfide bridge which cannot be found in Flo5A.  b)  Detail  of the  other two, highly  
conserved, disulfide bridges in Epa1A. c) Schematic view of Epa1A secondary structure and disulfide  
connectivity. 
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aspartates substituted for an asparagine and a trans-peptide bond. CBL2 does not align well, either, 
as it is prolonged over  β4 before connecting to a shortened  β-strand 13 equivalent (Fig 7.6). 
The  comparison  with  the  protective  antigen  domain  shows  that,  even  with  very  few common 
sequential  components,  a  β-sandwich motif  can be built.  The comparison with Flo5A is  more 
interesting though,  as  it  not  only explains  the  surprising results  that  led  to  the solution  of  the 
structure by molecular replacement, but it also sheds light on the structural basis for the differences 
in specificity and affinity towards carbohydrates between the two proteins[1][155].
7.2.2 The binding pocket of  
Epa1A
Despite  significant  similarities  in 
general  fold,  Epa1A appears  to  have 
quite  a  distinct  carbohydrate  binding 
mode from Flo5A. As could be shown 
previously[259], Epa1A binds calcium 
cations  at  trace  concentrations,  and 
does not need any calcium beyond the 
impurities present in the buffer to bind 
carbohydrates,  whereas Flo5A needs 
calcium  added to  the  buffer  to  be 
active[192]. On the other hand, Epa1A 
will not crystallize in the absence of a 
carbohydrate,  while crystallization of 
Flo5A could be achieved without both 
glycan and calcium[1]. Finally, the binding of Epa1A to the T-antigen was characterized to be in the 
low micromolar range, while that of Flo5A to α1,2 mannobiose is within the millimolar range[1].
With the crystal structure of Epa1A, it was possible to define the binding pocket, and to explain the 
functional differences in terms of structural features. While the binding pocket of Flo5A is highly 
accessible to bulk solvent, the binding pocket of Epa1A is a less exposed (Fig. 7.7 a). 
The binding of the calcium atom is very similar between the two proteins, with the DcisD motive on 
CBL1, the peptide backbone of CBL2 and an asparagine situated at the N-terminus of CBL2 as the 
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Figure  7.6: Structural  alignment  between Epa1A (grey) and  
the PA14 domain of the B. anthracis protective antigen. While  
the  core  β-sandwich  structure  is  well  conserved,  the  loops  
surrounding it are not. Of special interest is the fact that the  
entire binding pocket and associated loops (CBL1, CBL2, L1,  
L2  and  L3)  are  missing  or  in  a  completely  different  
conformation. CBL1 in particular does not present a D-cis-D  
motive anymore, with D84 and N85 in a trans conformation.
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main coordination partners. All three features are present in both proteins, and that region is almost 
super-imposable between the two (Figure  7.7 a). Out of the 4 amino acids composing the CBL2 
loop in Flo5A, one is polar (S227),  one is aromatic but does not interact with the glycan (W228) 
and the other two are aliphatic (A225 and V226). In contrast, Epa1A presents three charged amino 
acids (R226, E227 and D229) and a tyrosine which can perform a  π-C-H interaction  [260], and 
hydrogen bonds  (Figure  7.7  b  and c).  Furthermore,  W198 from loop L3 can  interact  with  the 
galactose moiety from the top of the binding pocket. The effects of the L3 interaction were further 
supported  by  calculating  the  interaction  surface  between  Epa1A and  the  galactose  with  the 
PDBePISA server[261].  While  the  calculated  surface  for  the  Epa1A-galactose  interaction  was 
160.1 Å², the one between Flo5A and the corresponding mannose was only 135.8 Å².
The interaction of the respective glycans with the pocket is, in both cases, much tighter for the 
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Figure 7.7: The binding pockets of Epa1A (grey) and Flo5A (green). a) Superposition of the binding pockets.  
Amino acid and β-strand positions in grey/white correspond to Epa1A, in green to Flo5A. b) Detail of the  
sugar binding for Epa1A with distances between putative hydrogen bond interaction partners. c) Detail on  
sugar binding for Flo5A with distances between putative hydrogen bond interaction partners.
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non-reducing end than the reducing one (Fig. 7.7 a and b). In Flo5A's case interactions exist mainly 
between the DcisD motive, the calcium cation and the equatorial hydroxyl groups on C2 and C3 of 
the non-reducing mannose (Figure 7.7 c). On the other hand, the presence of W198 and R226 in 
Epa1A forces  the  galactose  moiety  to  be  in  the  opposite  orientation,  with  the  equatorial  O2 
interacting with R226 at the N-terminus of CBL2 and D166 on CBL1. It is with O3 and O4 that  
most of the interactions between CBL1 aspartates and the calcium cation (Figure 7.7 b)) take place.
In contrast to the tight interaction of the non-reducing moiety, the reducing moiety is bound in a 
more relaxed manner, which is quite similar between the two proteins. PDBePISA results show that 
both Flo5A and Epa1A have very similar interaction surfaces with the corresponding saccharides, 
with 113.2  Å² for the Flo5A-mannose interface and 109.3  Å² for the Epa1A-glucose interface. In 
this case, the hydrogen bond between E227 on CBL2 and the O2 of the glucose seems to be crucial 
in stabilizing the binding of the glucose moiety.
7.2.3 A structural model for carbohydrate binding in Epa1A
As described previously, loops L1, L2 and L3 act as a secondary compartment for the binding 
pocket, shielding it further from solvent. From the three, it is L3 which probably shows the biggest 
effect, as W198 interacts directly with the galactose ring moiety (Fig.  7.8).  As a result,  Epa1A's 
occluded pocket can stabilize the protein-oligosaccharide interaction much better by numerous vdW 
interactions  than Flo5A, thus yielding higher affinities.  Interestingly, the L3 tripeptide S199K200T201 
proved to be difficult to model during the structure refinement process, with an average B-factor for 
the region of 26.3  Å², and the side chain of  Lys200 could not be modeled at all (in comparison, 
Trp198 has an average B-factor  of 13.2 Å² ). It is conceivable that, in the absence of ligand, loop 
L3 will recede from its position directly on top of the galactose moiety, leaving a large gap through 
which the ligand might enter the binding pocket (Fig. 7.8). The entirety of L3 will then probably 
strongly  shift  back  and  forth,  as  was  the  case  with  the  S199K200T201 tripeptide  in  the  complex 
structure, as the lack of interaction with the ligand will liberate the loop. As a result, the entire top 
region of the binding pocket will become much more flexible, hindering crystallization.
The shifting of L3 could act as a gate to the binding pocket, and explain both the stronger affinity of 
Epa1A, and its inability to crystallize in the absence of carbohydrates.
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7.2.4 The specificity of Epa1A and its variants.
Originally, epithelial adhesins from C. glabrata were characterized as binding lactosides[47], but 
more recent studies have challenged it[41]. The structural models of sections 6.1.1 and 6.1.6 present 
definite  proof  that  members  of  the Epa1 subclass  do not  share  a  high affinity  for  lactose,  but  
instead prefer β1-3 disaccharides
From the binding results presented in section 6.1.7, it is clear that Epa1A binds almost exclusively 
galactose in the sub-pocket comprising the calcium, CBL1 and W198 (Fig  6.18 a, b and c), while 
promiscuity  within  the  second  pocket  is  much  higher  (Fig.  6.19),  accepting  glucose,  N-
acetylglucosamine, galactose and N-acetyl-galactosamine. The preferred glycosydic bond between 
the two was β1-3, and especially at limiting concentrations no  β1-4 substrates were bound.
When compared with the available literature[41], these data correlate well, as the measurements at a 
limiting concentration of 1µg/ml (Fig. 6.15 a), highly increased the resolution of the assay, showing 
that the T-antigen (Galactoseβ1-3N-Acetyl-galactosamine) was the preferred binder of Epa1A. The 
-antigen is also called the core 1 mucin-type O-glycan[11] (Figure 2.6). This result is in itself quite 
remarkable, as it directly links C. glabrata epithelial adhesins to the cores of mucin-type O-glycans, 
which  constitute   the  basis  for  the  most  common  oligosaccharides  present  on  mucins[40]. 
Therefore, the mere expression  of Epa1p on the surface of C. glabrata should cause it to adhere to 
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Figure 7.8: Surface view of the binding pocket, without (left) and with (right) the corresponding area of the  
L3 loop missing in Flo5A. Van der Waals surface of the protein is shown in black, while solvent accessible  
surface is shown in transparent grey. Correspondingly, van der Waals surface of the glycan is shown in red,  
solvent accessible surface in blue. While L1 and L2 will probably remain quite constant in their topology,  
mainly due to the disulfide bond between both (Fig. 6.5), L3 could show high flexibility when no ligand is  
bound. If L3 would flip upwards, removing the Trp-galactose interaction, the entirety of the galactose ring  
moeity would be exposed to the solvent (left), while with the interaction, almost the entire ring is covered by  
L3.
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mucosas and epithelia, explaining the observed clinical behavior[234]. 
In  order  to  investigate  Epa  specificity  and  avidity  further,  the  Epa  family  was  divided  into 
evolutionary  subclasses  (Fig.  6.7),  from which  homology models  were  derived  (Fig.  6.8).  The 
selected epithelial adhesins were chosen regarding their respective A domain sequence identity with 
Epa1A as a primary criterion. Sequence identity had to be at least 45% for an Epa to be accepted as  
a suitable candidate for the project, which significantly increased the reliability of the models. It 
was assumed,  that any variation within the sequence corresponding to the β-sandwich structure 
would not be very significant and that differences in the specificity and avidity would be mainly 
centered  around  CBL1  and  CBL2..  The  reason  for  this  assumption  was  that  the  structural 
comparison of Epa1A and Flo5A (Fig. 7.5), presented a structurally highly conserved β-sandwich, 
but variable loops. 
While CBL1 was very strongly conserved within all tested Epa family members, CBL2 showed 
great variation, and three subclasses could be defined (Fig. 6.8). Variants Epa1→2A, Epa1→3A and 
Epa1→6A could be then generated by mutating the REYD CBL2 tetra-peptide of Epa1A to the 
corresponding tetra-peptide present in each of the subclass members. This tetra-peptide was part of 
the specificity determining penta-peptide presented by Zupancic et. al. in 2008[41].
The  Epa1→6A variant  results  could  be  compared  with  literature  as  Epa6p  had  already  been 
functionally characterized before, along with Epa1p and Epa7p[41]. A correlation analysis with the 
results  presented by Zupancic  et.  al. In 2008  [41] yielded a Pearson R² value of 54.6% for all 
common glycans with a confidence interval of 95%, showing that the Epa1→6A conversion was 
successful.  The  CFG  array  binding  profiles  are  very  similar  between  Epa1→6A and  Epa6p 
(Fig. 7.8). Both of them share a highly increased promiscuity in their  binding, not showing the 
marked preference for galactoseβ1- joined disaccharides that Epa1A presents, but indiscriminately 
binding galactoseβ1-3, β1-4 and α joined glycans (Fig. 6.15 b). Interestingly, the strong preference 
for galactose as the first glycan is maintained, as the primary binding pocket, formed by CBL1, the 
calcium cation and W198 from L3 are predicted to remain unchanged.
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The reasons for such remarkable behavior  could be easily explained after  the variant had been 
structurally characterized in complex with a  galactose-β1-3glucose disaccharide. The suspicions 
that  the galactose was solely bound by the primary binding pocket  could be corroborated,  and 
reasons for the increased promiscuity of the second binding pocket, where CBL2 is the main actor, 
became immediately evident. The Epa1A tetra-peptide REYD had been shifted to RDND (Fig. 6.8 
d)). The resulting pocket was much wider and more flexible (Fig. 6.13 a)), and the reducing sugar 
of the disaccharide could rotate in it. The carbohydrate appeared in two major conformations, one 
similar to the one seen in Epa1A (Fig. 7.7 b)), where both pyranose moieties are on the same plane, 
and another in which the glucose had rotated around 90° along the β1-3 axis. It is to be expected 
that in such a pocket more sterically challenging substrates could be accommodated, for example 
with larger substituents or even  α-bound disaccharides
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Figure 7.9: Glycan array profiles for S. cerevisiae presenting Epa6 from Zupancic et. al. 2008[41] (blue)  
and Epa1→6A  (orange). Maximum binding is clustered around the same types of glycans, namely galα 
linked, and galβ1-4 or  galβ1-3 joined oligosaccharides, without much differences in preference. In order to  
superimposed both  profiles,  only  common  oligosaccharides  were  presented.  Correlation  analysis  for  
common glycans yielded a Pearson coefficient of 0.74 and an R² Pearson of 54% for a confidence interval  
of 95% and a two tailed probability of less than 0.01%
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After the validity of the method could be addressed over the Epa1→6A variant, the other variants 
were  structurally  and  functionally  characterized.  The  Epa1→2A  variant  showed  a  marked 
preference for sulfated and α joined glycans,  albeit  with a much lower general affinity for any 
glycan than either Epa1A or Epa1→6A. Sulfated carbohydrates are common on a wide variety of 
mucins[7], and have been pointed at as major targets in the invasion of the oral cavity by different 
microorganisms[29].
The  only  change  within  CBL2  between  the  Epa2 
subclass  and  that  of  Epa6  is  the  substitution  of 
aspartate 229 for asparagine. The resulting reduction of 
negative  charges  within  the  binding  pocket  could 
explain the relative preference for sulfated sugars. This 
difference in behavior is still  puzzling,  though, since 
asparagine  229 does  not  interact  directly  with  the 
carbohydrate  over  the  side  chain  There  are  also  no 
major  differences  in  the  hydrogen  bonding  network 
and  conformation  between  it  and  its  equivalent 
aspartate  in  either  Epa1A or  Epa1→6A (Fig.  7.10). 
Finally,  although  this  single  amino-acid  change 
appears to promote the perpendicular conformation of 
the glycan (Fig. 6.3 b), this might be misleading, as the resolution for the Epa1→2A dataset was 
around 0.8 Å worse than that of Epa1→6A. It seems more feasible to think that the binding will be 
similar to that of Epa1→6A, with a relatively free, rotating glucose which will have both the planar  
and  the  perpendicular  conformations  as  preferred  states.  Epa1→2A was  also  by  far  the  most 
aggregation  prone  of  all  variants,  and  also  the  most  difficult  to  crystallize  How  the  D229N 
substitution  might  have  caused  this  is  again  challenging  to  explain,  and  might  need  further 
experiments, especially of a co-crystal structure with a sulfate glycan, to be fully comprehended.
The changes performed on CBL2 to shift Epa1A to the Epa3 subclass and generate the Epa1→3A 
variant where the most profound, as it involved changing the tetra-peptide from REYD to IGKD. 
The change of  R226 to isoleucine essentially  impeded the only interaction between CBL2 and 
galactose,  possibly  destabilizing  even  the  primary  binding  pocket.  Also,  while  the  rest  of  the 
variants have a CBL2 loop going from positive to negative in an N- to C-terminal fashion, the  
Epa1→3A CBL2  loop  behaves  completely  differently.  A  hydrophobic  N-terminal  portion  is 
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Figure  7.10: Hydrogen bond network of  
D/N229. D229 from Epa1A (grey) shows  
almost  the same behavior in orientation  
and  hydrogen  bonding  as  N229  from 
Epa1→2A (green)  which  makes  it  very  
difficult  to  understand  how  functional  
differences can arise by such a mutation.
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followed by a positive C-terminal region in the Epa3 sub-class. Accordingly, no strong affinity can 
be found for any carbohydrate, but Epa1→3A still appears to follow similar preference patterns as 
Epa1→2A (Fig.  6.18),  albeit  with  an  even  lower  affinity.  The  crystal  structure  of  Epa1→3A 
presents an even less defined disaccharide as in either of the other two variants. Here the galactose 
is even less defined, which is probably the result of the loss of the R226-galactose interaction. For 
Epa1→3A it is only possible to determine that galactose is within the primary binding pocket, and 
that there is a second monomer within the secondary binding pocket. It is very difficult to assess the 
nature of the second carbohydrate, and the type of bonding.
All  three  variants  were  very  different  in  their  specificities  to  the  original  Epa1A,  and  those 
specificities could be partially characterized. The CBL2-dependent specificity of the different Epa 
subclasses ties  in well  with Epa differential  expression,  pointing at  a specialization within Epa 
family. Specialized Epa subclasses that are activated according to the situation have been proposed 
as a very important colonization mechanism[56]. 
Expression of Epa6p has been shown to be activated in the presence of topic antimycotics used in 
vulvovaginitis treatment[27] or during urethral infection as a response to limiting nicotinic acid 
concentrations[26]. Epa6 and 7 have also been linked to biofilm formation on hydrophobic surfaces, 
while Epa1 to Epa5 did not contribute to it[66]. High substrate promiscuity could explain why Epa6 
is  immediately  expressed  in  any  of  these  stressful  situations,  as  the  adhesin  might  act  as  an 
emergency system, increasing adhesion to the substrate and protection through biofilm formation. 
Targeting Epa6 mediated emergency adhesion might be an interesting alternative or complementary 
therapy against candidiasis. A structure based explanation for Epa6 promiscuity was provided here, 
perhaps allowing the development of structure based anti-adhesive, antimycotic drugs against this 
protein.
The Epa2 subclass needs to be further studied, but it could be significant in the colonization of the 
oral or intestinal cavity, where sulfo-mucins are specially abundant, or it could be related to host 
evasion, as sulfo-mucins have been linked to lymphocytes and the immune system[7]. Epa3 has no 
reported function in literature, and from the characteristics presented in this work, it is difficult to 
predict a functionality for it.
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7.2.5 Epa A domains do not bind lactose
As previously mentioned, Epa1 was originally thought to bind lactose[47], but recent studies have 
shown otherwise[41].  The  CFG binding  profiles  show clearly  that  lactose  is  by  no  means  the 
preferred binder of either Epa1A or its variants (Fig  7.11),  but that it  is bound ~13 worse than 
lactose for an Epa1A concentration of 200 µg/ml. 
The dissociation constants (Kd) presented in this work clearly show that Epa1A binds the T-antigen 
at least ~20 better than lactose. These values are in accordance with the CFG measurements for 200 
µg/ml,  but  not  for  the measurements  performed at  more limiting protein concentrations,  where 
affinities are up to ~50 times better for the T-antigen than for lactose (Fig. 7.11). This discrepancy 
could be explained with the solution of the crystal structures of  Epa1A and Epa1→6A.
The  crystals  employed  to  obtain  the 
datasets  for these structures had been 
grown  in  the  presence of  50  mM 
lactose, so it was surprising to find no 
lactose  (galactose-β1-4glucose)  but  a 
galactose-β1-3 disaccharide within the 
binding pocket, which was modeled as 
galactose-β1-3glucose.  The 
explanation  for  such  an  occurrence 
could  be  the  fact  that  the  lactose 
employed  had  not  been  chemically 
synthesized,  but  isolated  from  milk, 
and  had  a  98%  purity.  It  has  been 
shown  that  bovine  muc1  is  present 
within  fat  glomerules  in  milk[262], 
and that human milk contains several 
carbohydrates  which  are  normally 
targeted by microbial lectins[2]. The function of such carbohydrates has been proposed to be the 
protection of the intestinal microbiota. It seems very much possible that the contaminating mucin-
type O- or N- glycans present in milk, and therefore present as impurities in the lactose isolate, 
would actually displace lactose from the binding pocket and bind instead.  
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Figure  7.11:  Relative  decrease  in  affinity  between best  
binder and the T-antigen versus lactose on the CFG V4.1  
glycan array.  Values were calculated by dividing  either 
the best binder  or the T-antigen  for each concentration  
and  or  variant  by  the  corresponding  intensity  of  the  
lactose.  While affinities The best binders for Epa1A and  
Epa1→6A are comparable  to  the  T-antigen,  Epa1→2A  
and Epa1→3A show a clearly different preference.
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The implication  of  this  theory,  of  course,  is   that  the  dissociation  constants  (Kd)  presented  by 
Kalugin [259], Eulenburg  [155] and the present work  for lactose would be wrong, as they were 
measured against a mixture of low affinity  lactose and high affinity contaminant. The resulting Kd 
would therefore be an “average” Kd of the two. It can be expected that  the Kd  for Epa1A and the 
contaminant will not be in the micromolar range, but in a range at least 13 times lower, I.e. the 
nanomolar range.  These assumptions are further supported by fluorescence titration results which 
present the T-antigen as being a ~20 times better binder than the contaminated lactose.
7.2.6 Outlook
The structural and functional characterization of Epa1A and variants yielded a profound knowledge 
on the binding mechanics of  the C. glabrata epithelial adhesins with unprecedented detail. Results 
corroborate  that,  at  least  Epa1,  has  a  high  affinity  for  β1-3 sugars,  while  Epa6 is  much more 
promiscuous[41]. It could also be shown that there is a definite and different specificity for each of 
the Epa family  members.  which coupled with their  differential  expression seems to point to a 
specialization of epithelial adhesins for different mucins or mucosas[56].
Even with such exceptional results, much remains unclear in the field, and the present work sets the 
basis to proceed in a structurally relevant way. In order to fully characterize the binding pocket, it  
will  be  necessary  to  obtain  affinity  constants  for  a  wider  variety  of  ligands.  Chemically 
synthesized,  pure  lactose  will  be  absolutely  necessary  to  clarify  the  affinity  towards  this 
disaccharide.  The T-antigen showed very promising results, but several other mucin-type O-glycan 
cores  are  also  good binding  candidates,  and  therefore  quantitative  titrations  will  be  performed 
against  them.  Type  1  and  type  2  N-lactosamine  branching  disaccharides  characteristic  of  the 
branching of O- and N- glycans[40] are very similar to the disaccharide found in the structures, and 
will be of primary interest. Also, obtaining the corresponding complex structures would result in an 
even more detailed knowledge of  the pocket.
On first sight, it appears that the contaminated lactose might explain the non-linear Scatchard plots 
which resulted from some of the fluorescence titrations (section 6.1.8). It has been conclusively 
demonstrated, though, that ligand-heterogeneity never mimics negative cooperativity or multiple 
classes of binding sites[263].  A second, low affinity binding site, as with Flo5A[1], would nicely 
explain the Scatchard plots, but no such secondary site could be found within the crystal structures. 
In order to test this hypothesis, T-antigen co-crystals will be obtained, as they will show whether, at 
high concentrations of a high affinity ligand, some other pocket is to be occupied. Protein instability 
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at low concentrations might be a different explanation, as aggregates would still bind the ligand, 
albeit at a much lower affinity than the free protein, resulting in two different binding site classes. 
Stability problems at low concentrations could be solved by performing the fluorescence titrations 
with a mixture of Epa1A and BSA, which would raise the protein concentration without interacting 
with the titration itself.
Finally, even with the same CBL2, Epa1p and Epa7p have been shown to have slightly different 
specificities[41], which points at  long range effects, as has previously been observed for Flo5[1]. 
Loops  L1 and L2  might be involved in such long range effects. It would be most interesting to 
characterize these more subtle differences either through the production of Epa7A or by shifting the 
L1 and L2 loops of Epa1A towards that of Epa7p.  Also, the Epa adhesin palette from C. glabrata is 
much wider than the ones presented here. The other members of the Epa family were not taken into  
account during this study because there were larger differences with Epa1A, and therefore it was 
deemed implausible that simple mutagenesis of Epa1A would yield reliable information about these 
other  proteins.  It  would  still  be  central  to  the  understanding  of  C.  glabrata's binding  and 
host-evasion abilities  to  study these other  Epa members.  For such an undertaking,  it  would be 
necessary to clone and produce the different gene products directly, an effort with exceeded the 
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9.1 Appendix I: Glycan Arrays
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Table 9.1: Glycan Array V3.1
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Table 9.2 Glycan Array V4.1
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9.2 Appendix II: Protein sequences
The sequences presented here are the ones obtained from sequencing of the generated constructs, 
and not from database searches.
9.2.1 Sequences of Epa1A and variants
9.2.1.1 Protein sequence from Epa1A
        10         20         30         40         50         60 
MGSSHHHHHH SSGLVPRGSH MTSSNDISLA SKDPTTFPLG CSPDITTPKK GLSMELYSYD 
        70         80         90        100        110        120 
FRKKGSYPCW DAAYLDPNYP RTGYKSHRLL AKVDGVTGNI NFYYHATKGC TPQLGHLPAS 
       130        140        150        160        170        180 
YNYPKPLTMT NFTMLLYGYF RPKVTGFHTF TISADDLLFV NFGAGNAFDC CRRDSSADHF 
       190        200        210        220        230        240 
GNYQAYAIWG SKTAKDELTV HLDAGVYYPI RLFYNNREYD GALSFTFKTE SNENTVSDFS 
       250        260        
EYFFSLDDTE EGCPGLISYD SS 
9.2.1.2 Protein sequence from Epa1→2A
        10         20         30         40         50         60 
MGSSHHHHHH SSGLVPRGSH MTSSNDISLA SKDPTTFPLG CSPDITTPKK GLSMELYSYD 
        70         80         90        100        110        120 
FRKKGSYPCW DAAYLDPNYP RTGYKSHRLL AKVDGVTGNI NFYYHATKGC TPQLGHLPAS 
       130        140        150        160        170        180 
YNYPKPLTMT NFTMLLYGYF RPKVTGFHTF TISADDLLFV NFGAGNAFDC CRRDSSADHF 
       190        200        210        220        230        240 
GNYQAYAIWG SKTAKDELTV HLDAGVYYPI RLFYNNRDNN GALSFTFKTE SNENTVSDFS 
       250        260        
EYFFSLDDTE EGCPGLISYD SS 
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9.2.1.3 Protein sequence from Epa1→3A
        10         20         30         40         50         60 
MGSSHHHHHH SSGLVPRGSH MTSSNDISLA SKDPTTFPLG CSPDITTPKK GLSMELYSYD 
        70         80         90        100        110        120 
FRKKGSYPCW DAAYLDPNYP RTGYKSHRLL AKVDGVTGNI NFYYHATKGC TPQLGHLPAS 
       130        140        150        160        170        180 
YNYPKPLTMT NFTMLLYGYF RPKVTGFHTF TISADDLLFV NFGAGNAFDC CRRDSSADHF 
       190        200        210        220        230        240 
GNYQAYAIWG SKTAKDELTV HLDAGVYYPI RLFYNNIGKD GALSFTFKTE SNENTVSDFS 
       250        260        
EYFFSLDDTE EGCPGLISYD SS 
9.2.1.4 Protein sequence from Epa1→6A
        10         20         30         40         50         60 
MGSSHHHHHH SSGLVPRGSH MTSSNDISLA SKDPTTFPLG CSPDITTPKK GLSMELYSYD 
        70         80         90        100        110        120 
FRKKGSYPCW DAAYLDPNYP RTGYKSHRLL AKVDGVTGNI NFYYHATKGC TPQLGHLPAS 
       130        140        150        160        170        180 
YNYPKPLTMT NFTMLLYGYF RPKVTGFHTF TISADDLLFV NFGAGNAFDC CRRDSSADHF 
       190        200        210        220        230        240 
GNYQAYAIWG SKTAKDELTV HLDAGVYYPI RLFYNNRDND GALSFTFKTE SNENTVSDFS 
       250        260        
EYFFSLDDTE EGCPGLISYD SS 
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9.2.2 Sequences of BabA extracellular fragments from H. pylori 26695
9.2.2.1 BabA 235
        10         20         30         40         50         60 
MEDDGFYTSV GYQIGEAAQM VTNTKGIQDL SDNYENLSKL LTRYSTLNTL IKLSADPSAI
 
        70         80         90        100        110        120 
NAARENLGAS AKNLIGDTKN SPAYQAVLLA INAAVGFWNV LGYATQCGGN ANGQESTSST 
       130        140        150        160        170        180 
TIFNNEPGYR STSITCSLNR YKPGYYGPMS IENFKKLNEA YQILQTALNK GLPALKENNG 
       190        200        210        220        230        240 
TVSVTYTYTC SGEGNDNCSK KATGVSDQNG GTKTKTQTID GKTVTTTISS KVVDSGLLPR 
GSHHHHHHH 
9.2.2.2 BabA 210
        10         20         30         40         50         60 
MEDDGFYTSV GYQIGEAAQM VTNTKGIQDL SDNYENLSKL LTRYSTLNTL IKLSADPSAI
 
        70         80         90        100        110        120 
NAARENLGAS AKNLIGDTKN SPAYQAVLLA INAAVGFWNV LGYATQCGGN ANGQESTSST 
       130        140        150        160        170        180 
TIFNNEPGYR STSITCSLNR YKPGYYGPMS IENFKKLNEA YQILQTALNK GLPALKENNG 
       190        200        210        220         
TVSVTYTYTC SGEGNDNCSK KATGVSDQNG GLLPRGSHHH HHHH 
9.2.2.3 BabA 144
        10         20         30         40         50         60 
MEDDGFYTSV GYQIGEAAQM VTNTKGIQDL SDNYENLSKL LTRYSTLNTL IKLSADPSAI
 
        70         80         90        100        110        120 
NAARENLGAS AKNLIGDTKN SPAYQAVLLA INAAVGFWNV LGYATQCGGN ANGQESTSST 
       130        140        150      
TIFNNEPGYR STSITCSLNR YKPGGLLPRG SHHHHHHH
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9.2.3 Sequences of BabA extracellular fragments from H. pylori J99
Sequences presented here are as they were cloned into the pET28a system.
9.2.3.1 BabA 210
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQD LSDRYESLNN LLNRYSTLNT LIKLSADPSA
 
        70         80         90        100        110        120 
INAVRENLGA SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQKSISS 
       130        140        150        160        170        180 
KTIFNNEPGY RSTSITCSLN GHSPGYYGPM SIENFKKLNE AYQILQTALK RGLPALKENN 
       190        200        210        
GKVNVTYTYT CSGDGNNNCS SQVTGVNNQK DGEHHHHHH
9.2.3.2 BabA235
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQD LSDRYESLNN LLNRYSTLNT LIKLSADPSA
 
        70         80         90        100        110        120 
INAVRENLGA SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQKSISS 
       130        140        150        160        170        180 
KTIFNNEPGY RSTSITCSLN GHSPGYYGPM SIENFKKLNE AYQILQTALK RGLPALKENN 
       190        200        210        220        230        240 
GKVNVTYTYT CSGDGNNNCS SQVTGVNNQK DGTKTKIQTI DGKSVTTTIS SKVVDSREHH 
HHHH
9.2.3.3 BabA 255
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQD LSDRYESLNN LLNRYSTLNT LIKLSADPSA
 
        70         80         90        100        110        120 
INAVRENLGA SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQKSISS 
       130        140        150        160        170        180 
KTIFNNEPGY RSTSITCSLN GHSPGYYGPM SIENFKKLNE AYQILQTALK RGLPALKENN 
       190        200        210        220        230        240 
GKVNVTYTYT CSGDGNNNCS SQVTGVNNQK DGTKTKIQTI DGKSVTTTIS SKVVDSRADG 
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       250        260 
NTTGVSYTEI TNKLEGVPEH HHHHH 
Primer name Primer sequence Tm (°C)
Primers yielding constructs with C-terminal His-tags
Forward universal GTT GT CCATGGGGGAAGACGACGGCTTTTACAC 66
Reverse 210 GGGGGCTCGAG TCCGTCTTTTTGATTATTTACACCTG 64.7
Reverse 235 GGGGGCTCGAG ACGACTATCAACCACTTTTGAAC 65.3
Reverse 255 GGGGCCTC GAG CACA CCT TCT AAT TTG TTG GTG 64.7
Primers yielding constructs with N-terminal His-tags
Forward universal GACTAGCATATGGAAGACGACGGCTTTTACAC 61.5
Reverse 210 GGCGGCCTCGAGCTATCCGTCTTTTTGATTATTTACACC 65.6
Reverse 235 GGCGTGCTCGAGCTAACGACTATCAACCACTTTTGAAC 65.9
Reverse 255 GGGGGCCTCGAGCTACACACCTTCTAATTTGTTGGT 67.1
Table 9.3: Primers used for the cloning of BabA extracellular fragments from H. pylori J99. All  
constructs, including fusion constructs, could be generated with these primers. Blue: Stop codon.  
Green: Restriction site. Red: required additional base pairs.
9.2.4 Sequences of BabA extracellular fragments from H. pylori P12
All sequences presented as a result from cloning into the pET28 system.
9.2.4.1 BabA 210
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDNYEKLNN LLNNYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGA SAKNLIGDTK NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQTSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYTPGYYGPM SIENFKKLNE AYQILQTALK QGLPALKENN 
       190        200        210 




        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDNYEKLNN LLNNYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGA SAKNLIGDTK NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQTSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYTPGYYGPM SIENFKKLNE AYQILQTALK QGLPALKENN 
       190        200        210        220        230        240 
GTVSVTYTYT CSGKGNDNCS PQTTGVNQQN DGTKTETQTI DGKQVNTTIS SKVVDSKLEH 
HHHH 
9.2.4.3 BabA 255
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDNYEKLNN LLNNYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGA SAKNLIGDTK NSPAYQAVLL AINAAVGFWN VVGYVTQCGG NANGQTSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYTPGYYGPM SIENFKKLNE AYQILQTALK QGLPALKENN 
       190        200        210        220        230        240 
GTVSVTYTYT CSGKGNDNCS PQTTGVNQQN DGTKTETQTI DGKQVNTTIS SKVVDSKASG 
       250        260 
NTSHVSYTEI TNKLEGVEHH HHHH 
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Primer name Primer sequence Tm 
(°C)
Primers yielding constructs with C-terminal His-tags
Forward universal GACTAGCCATGGGTGAAGACGACGGCTTTTACACAAGC 67
Reverse 210 GGGGCGCTCGAGTCCGTCGTTTTGTTGGTTTACAC 68.2
Reverse 235 GGGGCGCTCGAGTTTGCTATCAACCACTTTTGAACTG 66.6
Reverse 255 CGGGCGCTCGAGCACTCCTTCTAATTTGTTAGTGATTTCGG 67.2
Primers yielding constructs with N-terminal His-tags
Forward universal GACTAGCATATGGAAGACGACGGCTTTTACACAAGC 63.7
Reverse 210 GTGGTGCTCGAGCTATCCGTCGTTTTGTTGGTTTAC 65.3
Reverse 235 GTGGTGCTCGAGCTATTTGCTATCAACCACTTTTGAACTG 64.7
Reverse 255 CTGGTGCTCGAGCTACACTCCTTCTAATTTGTTAGTGATTTCGG 65.2
Table 9.4: Primers used for the cloning of BabA extracellular fragments from H. pylori P12. All  
constructs, including fusion constructs, could be generated with these primers. Blue: Stop codon.  
Green: Restriction site. Red: required additional base pairs.
9.2.5 Sequences of BabA extracellular fragments from H. pylori G27
All sequences presented as a result from cloning into the pET28 system.
9.2.5.1 BabA 210
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDRYESLNN LLTRYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGM SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYITQCGG NANGQKSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYNPGYYGPM SIENFKKLNK AYQILQTALK QGLPALKENN 
       190        200        210 




        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDRYESLNN LLTRYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGM SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYITQCGG NANGQKSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYNPGYYGPM SIENFKKLNK AYQILQTALK QGLPALKENN 
       190        200        210        220        230        240 
GTVSVTYTYT CSGNGNDNCS KEATGVDNQN SGTKTETQII DGKSVTTTIS SKVVDSSEHH 
HHHH 
9.2.5.3 BabA 255
        10         20         30         40         50         60 
MGEDDGFYTS VGYQIGEAAQ MVTNTKGIQE LSDRYESLNN LLTRYSTLNT LIKLSADPSA 
        70         80         90        100        110        120 
VNAARENLGM SAKNLIGDKA NSPAYQAVLL AINAAVGFWN VVGYITQCGG NANGQKSTSS 
       130        140        150        160        170        180 
TTIFNNEPGY RSTSITCSLN GYNPGYYGPM SIENFKKLNK AYQILQTALK QGLPALKENN 
       190        200        210        220        230        240 
GTVSVTYTYT CSGNGNDNCS KEATGVDNQN SGTKTETQII DGKSVTTTIS SKVVDSSASG
 
       250        260 
NTRGVSYTEI TNKLDGVEHH HHHH 
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Primer name Primer sequence Tm (°C)
Primers yielding constructs with C-terminal His-tags
Forward universal GAGGTGCCATGGGGGAAGACGACGGCTTTTAC 67.7
Reverse 210 CGGGCGCTCGAGTCCGCTGTTTTGATTATCTAC 65.6
Reverse 235 CGGGCGCTCGAGACTAGAATCAACGACTTTTGAAC 65.1
Reverse 255 CGGGCGCTCGAGCACACCATCTAATTTGTTGG 66.7
Primers yielding constructs with N-terminal His-tags
Forward universal GACTAGCATATGGAAGACGACGGCTTTTACACAAGC 63.7
Reverse 210 GTCCTGCTCGAGCTATCCGCTGTTTTGATTATCTAC 63.3
Reverse 235 GTCCTGCTCGAGCTAACTAGAATCAACGACTTTTGA AC 63.2
Reverse 255 GTCCTGCTCGAGCTACACACCATCTAATTTGTTGG 64.1
Table 9.5: Primers used for the cloning of BabA extracellular fragments from H. pylori G27. All  
constructs, including fusion constructs, could be generated with these primers. Blue: Stop codon.  
Green: Restriction site. Red: required additional base pairs.
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9.3 Appendix III: fluorescence spectroscopy data
The following plots show the results of all fluorescence titrations for Epa1A and all variants. The 
results are either normally plotted, with concentration on the X-axis and quench on the Y-axis, or as  
Scatchard plots. On Scatchard plots, the X-axis shows the Quench, while the Y axis shows Quench 
divided by ligand concentration. A Scatchard plot should result in a straight line, which should be 
fitted  by  a  single  linear  equation.  If  this  is  not  the  case,  cooperativity,  ligand  or  binding  site 
heterogeneity could have been present during measurements. Thus, Scatchard plots are very useful 
in quality control of titration experiments.
As some of the Scatchard plots presented deviations from linearity, a binding site heterogeneity 
model  with  two different  kinds  of  binding sites  was tested  (green)  versus  a  more  simple total 
binding model (red) (see section 5.3.5 for more  information on the two models). The results on 
Figures 9.1 and 9.2 show that, even though the fits with the two binding sites are marginally better, 
one of the two  resulting dissociation constants  is always very error prone, while the  other one is 
very similar to the  one obtained with the  total binding model. Therefore, it was decided that the 
total  binding model  represented,  at  least  for  comparison purposes,  a  better  balance between fit 









Figure 9.2: Fluorescence titrations for Epa1A and variants against the T-antigen
